US20070162152A1 - Artificial joints using agonist-antagonist actuators - Google Patents

Artificial joints using agonist-antagonist actuators Download PDF

Info

Publication number
US20070162152A1
US20070162152A1 US11/642,993 US64299306A US2007162152A1 US 20070162152 A1 US20070162152 A1 US 20070162152A1 US 64299306 A US64299306 A US 64299306A US 2007162152 A1 US2007162152 A1 US 2007162152A1
Authority
US
United States
Prior art keywords
ankle
spring
knee
flexion
joint
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/642,993
Inventor
Hugh Herr
Lee Magnusson
Ken Endo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/395,448 external-priority patent/US20060249315A1/en
Priority claimed from US11/495,140 external-priority patent/US20070043449A1/en
Priority claimed from US11/499,853 external-priority patent/US7313463B2/en
Priority claimed from US11/600,291 external-priority patent/US20070123997A1/en
Priority to US11/642,993 priority Critical patent/US20070162152A1/en
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Publication of US20070162152A1 publication Critical patent/US20070162152A1/en
Priority to US12/157,727 priority patent/US8512415B2/en
Priority to US12/608,627 priority patent/US8870967B2/en
Priority to US12/697,894 priority patent/US8500823B2/en
Priority to US12/698,128 priority patent/US8864846B2/en
Assigned to MASSACHUSETTS INSTITUTE OF TECHNOLOGY reassignment MASSACHUSETTS INSTITUTE OF TECHNOLOGY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ENDO, KEN, MAGNUSSON, LEE HARRIS, HERR, HUGH M.
Priority to US13/959,495 priority patent/US9149370B2/en
Priority to US13/970,094 priority patent/US10137011B2/en
Priority to US14/520,091 priority patent/US9539117B2/en
Priority to US15/342,661 priority patent/US10307272B2/en
Priority to US16/182,298 priority patent/US11278433B2/en
Priority to US16/427,646 priority patent/US11491032B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/60Artificial legs or feet or parts thereof
    • A61F2/64Knee joints
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/60Artificial legs or feet or parts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/60Artificial legs or feet or parts thereof
    • A61F2/66Feet; Ankle joints
    • A61F2/6607Ankle joints
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/68Operating or control means
    • A61F2/70Operating or control means electrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/68Operating or control means
    • A61F2/74Operating or control means fluid, i.e. hydraulic or pneumatic
    • A61F2/741Operating or control means fluid, i.e. hydraulic or pneumatic using powered actuators, e.g. stepper motors or solenoids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B25HAND TOOLS; PORTABLE POWER-DRIVEN TOOLS; MANIPULATORS
    • B25JMANIPULATORS; CHAMBERS PROVIDED WITH MANIPULATION DEVICES
    • B25J19/00Accessories fitted to manipulators, e.g. for monitoring, for viewing; Safety devices combined with or specially adapted for use in connection with manipulators
    • B25J19/0008Balancing devices
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B62LAND VEHICLES FOR TRAVELLING OTHERWISE THAN ON RAILS
    • B62DMOTOR VEHICLES; TRAILERS
    • B62D57/00Vehicles characterised by having other propulsion or other ground- engaging means than wheels or endless track, alone or in addition to wheels or endless track
    • B62D57/02Vehicles characterised by having other propulsion or other ground- engaging means than wheels or endless track, alone or in addition to wheels or endless track with ground-engaging propulsion means, e.g. walking members
    • B62D57/032Vehicles characterised by having other propulsion or other ground- engaging means than wheels or endless track, alone or in addition to wheels or endless track with ground-engaging propulsion means, e.g. walking members with alternately or sequentially lifted supporting base and legs; with alternately or sequentially lifted feet or skid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/60Artificial legs or feet or parts thereof
    • A61F2/605Hip joints
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/68Operating or control means
    • A61F2/70Operating or control means electrical
    • A61F2/72Bioelectric control, e.g. myoelectric
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2002/5003Prostheses not implantable in the body having damping means, e.g. shock absorbers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2002/5003Prostheses not implantable in the body having damping means, e.g. shock absorbers
    • A61F2002/5004Prostheses not implantable in the body having damping means, e.g. shock absorbers operated by electro- or magnetorheological fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2002/5016Prostheses not implantable in the body adjustable
    • A61F2002/503Prostheses not implantable in the body adjustable for adjusting elasticity, flexibility, spring rate or mechanical tension
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2002/5016Prostheses not implantable in the body adjustable
    • A61F2002/5033Prostheses not implantable in the body adjustable for adjusting damping
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2002/5072Prostheses not implantable in the body having spring elements
    • A61F2002/5073Helical springs, e.g. having at least one helical spring
    • A61F2002/5075Multiple spring systems including two or more helical springs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/60Artificial legs or feet or parts thereof
    • A61F2/66Feet; Ankle joints
    • A61F2002/6614Feet
    • A61F2002/6657Feet having a plate-like or strip-like spring element, e.g. an energy-storing cantilever spring keel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/68Operating or control means
    • A61F2002/6818Operating or control means for braking
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/68Operating or control means
    • A61F2/70Operating or control means electrical
    • A61F2002/701Operating or control means electrical operated by electrically controlled means, e.g. solenoids or torque motors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/68Operating or control means
    • A61F2/70Operating or control means electrical
    • A61F2002/704Operating or control means electrical computer-controlled, e.g. robotic control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/76Means for assembling, fitting or testing prostheses, e.g. for measuring or balancing, e.g. alignment means
    • A61F2002/7615Measuring means
    • A61F2002/7625Measuring means for measuring angular position
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/76Means for assembling, fitting or testing prostheses, e.g. for measuring or balancing, e.g. alignment means
    • A61F2002/7615Measuring means
    • A61F2002/763Measuring means for measuring spatial position, e.g. global positioning system [GPS]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/76Means for assembling, fitting or testing prostheses, e.g. for measuring or balancing, e.g. alignment means
    • A61F2002/7615Measuring means
    • A61F2002/7635Measuring means for measuring force, pressure or mechanical tension
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/76Means for assembling, fitting or testing prostheses, e.g. for measuring or balancing, e.g. alignment means
    • A61F2002/7615Measuring means
    • A61F2002/764Measuring means for measuring acceleration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/76Means for assembling, fitting or testing prostheses, e.g. for measuring or balancing, e.g. alignment means
    • A61F2002/7615Measuring means
    • A61F2002/7645Measuring means for measuring torque, e.g. hinge or turning moment, moment of force

Definitions

  • This invention relates to artificial joints and limbs for use in prosthetic, orthotic or robotic devices.
  • Biomimetic Hybrid Actuators employed in biologically-inspired musculoskeletal architectures as described in the above noted U.S. patent application Ser. No. 11/395,448 employ an electric motor for supplying positive energy to and storing negative energy from an artificial joint or limb, as well as elastic elements such as springs, and controllable variable damper components, for passively storing and releasing energy and providing adaptive stiffness to accommodate level ground walking as well as movement on stairs and surfaces having different slopes.
  • the above noted application Ser. No. 11/495,140 describes an artificial foot and ankle joint consisting of a curved leaf spring foot member that defines a heel extremity and a toe extremity, and a flexible elastic ankle member that connects said foot member for rotation at the ankle joint.
  • An actuator motor applies torque to the ankle joint to orient the foot when it is not in contact with the support surface and to store energy in a catapult spring that is released along with the energy stored in the leaf spring to propel the wearer forward.
  • a ribbon clutch prevents the foot member from rotating in one direction beyond a predetermined limit position, and a controllable damper is employed to lock the ankle joint or to absorb mechanical energy as needed.
  • the controller and a sensing mechanisms control both the actuator motor and the controllable damper at different times during the walking cycle for level walking, stair ascent and stair descent.
  • the above noted Application G-25 describes an exoskeleton worn by a human user consisting of a rigid pelvic harness worn about the waist of the user and exoskeleton leg structures each of which extends downwardly alongside one of the human user's legs.
  • the leg structures include hip, knee and ankle joints connected by adjustable length thigh and shin members.
  • the hip joint that attaches the thigh structure to the pelvic harness includes a passive spring or an active actuator to assist in lifting the exoskeleton and said human user with respect to the ground surface upon which the user is walking and to propel the exoskeleton and human user forward.
  • a controllable damper operatively arresting the movement of the knee joint at controllable times during the waking cycle, and spring located at the ankle and foot member stores and releases energy during walking.
  • an artificial limb system that mimics a biological limb ideally needs to fulfill a diverse set of requirements.
  • the artificial system must be a reasonable weight and have a natural morphological shape, but still have an operational time between refueling or battery recharges of at least one full day.
  • the system must also be capable of varying its position, stiffness, damping and nonconservative motive power in a comparable manner to that of a normal, healthy biological limb.
  • the system must be adaptive, changing its characteristics given such environmental disturbances as walking speed and terrain variation.
  • the current invention describes a novel actuator and limb architecture capable of achieving these many requirements.
  • An example of the use of more than one control strategy in a single biological joint is the ankle. See ⁇ 1 ⁇ and ⁇ 2 ⁇ .
  • the ankle behaves as a variable stiffness device during the early to midstance period, storing and releasing impact energies. Throughout terminal stance, the ankle acts as a torque source to power the body forward. In distinction, the ankle varies damping rather than stiffness during the early stance period of stair descent.
  • the current state of the art in prosthetic leg systems include a knee joint that can vary its damping via magnetorheological fluid as described in ⁇ 5 ⁇ , and a carbon fiber ankle which has no active control, but that can store energy in a spring structure for return at a later point in the gait cycle e.g. the Flex-Foot ⁇ 4 ⁇ or the Seattle-Lite ⁇ 6 ⁇ . None of these systems are able to add energy during the stride to help keep the body moving forward or to reduce impact losses at heel strike.
  • the use of the Series Elastic Actuator (SEA) enables robotic joints to control their position and torque, such that energy may be added to the system as needed. See ⁇ 7 ⁇ .
  • the SEA can emulate a physical spring or damper by applying torques based on the position or velocity of the joint.
  • the SEA requires a tremendous amount of electric power for its operation, resulting in a limited operational life or an overly large power supply.
  • Robotic joint designs in general use purely active components and often do not conserve electrical power through the use of variable-stiffness and variable-damping devices.
  • a synthetic actuator For an artificial joint to behave like a biological joint, a synthetic actuator must have the following properties:
  • the actuator must consume negligible power when exerting zero force. Near the equilibrium length of muscle (peak of active tension-length curve), the passive tension is typically zero. Thus a muscle-actuated joint goes limp when the muscles are not electrically stimulated.
  • the actuator must consume negligible power when outputting force at constant length (isometric) and while performing dissipative, nonconservative work. Muscle tissue is very efficient for isometric and dissipative control modes.
  • the actuator must be capable of independently engaging flexion and extension tendon-like, series springs. Since biological joints have at least one flexor muscle and at least one extensor muscle, the time at which a flexor tendon becomes taught or engaged can be independent of the time at which an extensor tendon becomes engaged. As an example, with a muscle-actuated joint, the elastic energy from one tendon can be released as a second tendon is being elongated.
  • the actuator must be capable of independently varying joint position and stiffness. Through co- contraction between a muscle flexor and extensor, joint stiffness can be modulated without changing joint position. Further, joint position can be varied while keeping joint stiffness constant.
  • the actuator must be capable of exploiting series elasticity for mechanical power amplification, or a “catapult” control modality.
  • a catapult control where the muscle belly stretches the series tendon, and later that stored elastic energy is released to achieve relatively higher joint powers than would be possible if the muscle belly were to generate that power directly.
  • FIG. 1 depicts the various subdivisions of the stance phase of walking
  • FIGS. 2A, 2B and 2 C show torque vs. angle plots in level-ground walking for slow speed, normal and fast walking;
  • FIG. 3 illustrates human ankle biomechanics for stair ascent
  • FIG. 4 illustrates human ankle-foot biomechanics for stair descent
  • FIGS. 5A and 5B illustrate the manner in which knee angle and knee power respectively vary during the walking cycle for level ground walking
  • FIGS. 6A and 6B are posterior and side elevational views respectively of an agonist-antagonist actuator embodying the invention.
  • FIGS. 7A and 7B are posterior and side elevational views of an agonist-antagonist actuator mechanism implementing an artificial ankle
  • FIGS. 8A and 8B are posterior and side elevational views of agonist-antagonist actuator mechanisms implementing an artificial knee
  • FIGS. 9A and 9B are side elevational and perspective views of an agonist-antagonist actuator mechanism positioned on both sides of the joint axis;
  • FIGS. 10A and 10B are posterior and side elevational views of an agonist-antagonist actuator mechanism using motor and spring combinations
  • FIGS. 11A shows a model of leg prothesis employing series-elastic clutches at the hip, knee and ankle joints
  • FIGS. 11B and 11C are graphs comparing the behaviors of biological ankle and knee joints respectively with the modeled joints of FIG. 11A ;
  • FIGS. 12A, 12B and 12 C are plots of the mechanical power of each model element is versus percentage gait cycle for ankle, knee and hip, respectively;
  • FIGS. 13A shows the major components of the transtibial system are shown
  • FIGS. 13B shows the monoarticular ankle mechanism of FIG. 13A in more detail
  • FIGS. 13C and 13D show elevational and schematic views respectively of the bi-articular ankle knee mechanism of FIG. 13A ;
  • FIGS. 14A and 14B shows the major components of an artificial ankle and knee system
  • FIGS. 14C is a schematic diagram of the artificial ankle and knee system seen in FIGS. 14A and 14B ;
  • FIG. 14D shows the knee's variable moment arm (VMA) device (seen at the top of FIGS. 14A and 14B ) in more detail.
  • VMA variable moment arm
  • a agonist-antagonist actuator design comprising a plurality of actuators and series elastic structures. Since it is desirable to minimize the overall weight of the limb design, the efficiency of the agonist-antagonist actuator design is critical, especially given the poor energy density of current power supplies, e.g. lithium-ion battery technology. By understanding human biomechanics, the lightest, most energy efficient agonist- antagonist actuator design can be achieved.
  • a level-ground walking gait cycle is typically defined as beginning with the heel strike of one foot seen at 103 in FIG. 1 and ending at the next heel strike of the same foot seen at 113 . See ⁇ 8 ⁇ .
  • the main subdivisions of the gait cycle are the stance phase ( ⁇ 60%) and the swing phase ( ⁇ 40%) which are illustrated in FIG. 1 .
  • the swing phase represents the portion of the gait cycle when the foot is off the ground.
  • the stance phase begins at heel strike when the heel touches the floor and ends at toe off when the same foot rises from the ground surface. Additionally, we can further divide the stance phase into three sub- phases: Controlled Plantar Flexion (CP), Controlled Dorsiflexion (CD), and Powered Plantar Flexion (PP).
  • CP Controlled Plantar Flexion
  • CD Controlled Dorsiflexion
  • PP Powered Plantar Flexion
  • CP begins at heel-strike 103 and ends at foot-flat shown at 105 .
  • CP describes the process by which the heel and forefoot initially make contact with the ground.
  • ⁇ 1 ⁇ and ⁇ 3 ⁇ researchers showed that CP ankle joint behavior is consistent with a linear spring being loaded or stretched where joint torque is proportional to joint position.
  • the spring behavior is, however, variable; joint stiffness is continuously modulated by the body from step to step.
  • the CD phase begins.
  • FIG. 2 the average torque versus angle curves are shown for 68 healthy, young participants walking on a level surface. As is shown, during CP (from 103 to 105 ), the ankle behaves as a linear spring of variable stiffness during the loading cycle, but the torque curve does not trace back to point 1, but rather assumes higher torque values during the early period of CD.
  • Ankle torque versus position during the CD period from 105 to 107 can often be described as a nonlinear spring being loaded or stretched where stiffness increases with increasing ankle position. It is noted that as walking speed increases, the extent to which the ankle behaves as a nonlinear spring increases, with the CD loading phase exhibiting distinct nonlinear behavior during fast walking (see fast walking, FIG. 2 ).
  • the main function of the ankle during CD is to store elastic energy to propel the body upwards and forwards during the PP phase. See ⁇ 9 ⁇ and ⁇ 3 ⁇ .
  • the PP phase begins at 107 after CD and ends at the instant of toe-off shown at 109 .
  • the ankle can be modeled as a catapult in series or in parallel with the CD spring or springs.
  • the catapult component includes an actuator that does work on a series spring during the CD phase and/or during the first half of the PP phase.
  • the catapult energy is then released along with the spring energy stored during the CD phase to achieve the high plantar flexion power during late stance.
  • This catapult behavior is necessary because the work generated during PP is more than the negative work absorbed during the CP and CD phases for moderate to fast walking speeds as clearly seen in FIGS. 2A-2C . See ⁇ 1 ⁇ , ⁇ 2 ⁇ , ⁇ 3 ⁇ and ⁇ 9 ⁇ .
  • FIGS. 2A, 2B and 2 C show torque vs. angle plots in level-ground walking for slow speed walking at 0.9 m/sec ( FIG. 2A ), normal walking speed at 1.25 m/sec ( FIG. 2B ) and fast walking at 1.79 m/sec. Only the stance period of a single foot is shown (heel strike to toe off). Point 1 on the charts denotes heel strike, point 2 foot flat, point 3 peak dorsiflexion, and point 4 toe off. Although during slow walking the loading curve (points 2 - 3 ) is approximately equal to the unloading curve (points 3 - 4 ), for higher walking speeds the torque assumes higher values during the unloading, PP phase (points 3 - 4 ).
  • the human ankle cannot be modeled as a series of coupled springs because the positive work performed by the ankle exceeds the negative work. It is noted that, as walking speed increases, the degree of nonlinear behavior during CD (points 2 - 3 ) increases along with the total amount of positive work production during PP (points 3 - 4 ), consistent with a catapult model where the soleus muscle belly slowly elongates the series Achilles tendon spring during CD, increasing the slope of the torque versus angle curve and the subsequent positive power output of the ankle.
  • FIG. 3 illustrates human ankle biomechanics for stair ascent;
  • the first phase of stair ascent is called Controlled Dorsiflexion 1 (CD 1 ), which begins with foot strike in a dorsiflexed position at 201 and continues to dorsiflex until the heel contacts the step surface at 203 .
  • the ankle can be modeled as a linear spring.
  • the second phase is Powered Plantar flexion 1 (PP 1 ), which begins at the instant of foot flat (when the ankle reaches its maximum dorsiflexion) at 203 and ends when dorsiflexion begins once again at 205 .
  • the human ankle behaves as a torque actuator to provide extra energy to support the body weight.
  • the third phase is Controlled Dorsiflexion 2 (CD 2 ), in which the ankle dorsiflexes as seen at 205 until heel-off at 207 .
  • the ankle can be modeled as a linear spring.
  • the fourth and final phase is Powered Plantar flexion 2 (PP 2 ).
  • PP 2 Powered Plantar flexion 2
  • the foot pushes off the step as seen at 207 , acting as a torque actuator in parallel with the CD 2 spring to propel the body upwards and forwards until toe-off occurs at 209 and the swing phase begins.
  • FIG. 4 illustrates the human ankle-foot biomechanics for stair descent.
  • the stance phase of stair descent is divided into three sub-phases: Controlled Dorsiflexion 1 (CD 1 ), Controlled Dorsiflexion 2 (CD 2 ), and Powered Plantar flexion (PP).
  • CD 1 begins at forefoot strike seen at 303 and ends at foot-flat seen at 305 .
  • the human ankle can be modeled as a variable damper.
  • CD 2 from foot flat at 305 , the ankle continues to dorsiflex forward until it reaches a maximum dorsiflexion posture at 307 .
  • the ankle acts as a linear spring in series with a variable-damper designed to effectively control the amount of energy stored by the linear spring.
  • the ankle plantar flexes until the foot lifts from the step at 309 .
  • the ankle releases stored CD 2 energy, propelling the body upwards and forwards. From toe off at 309 until the next foot strike at 313 , the foot in the swing phase.
  • FIG. 5A shows how the knee angle varies during the walking cycle
  • FIG. 5B shows how knee power varies.
  • the stance phase of walking can be divided into three sub-phases: Stance Flexion, Stance Extension, and Pre-Swing.
  • the swing phase is divided into two phases: Swing Flexion and Swing Extension.
  • FIG. 5B for level ground walking, the human knee does more negative work than positive work.
  • the stance knee begins to flex slightly. This flexion period, called the Stance Flexion phase, allows for shock absorption upon impact as well as to keep the body's center of mass at a more constant vertical level throughout the stance period. During this phase, the knee acts as a spring, storing energy in preparation for the Stance Extension phase.
  • the joint After maximum flexion is reached in the stance knee at 404 , the joint begins to extend, until maximum extension is reached as indicated at 406 .
  • This knee extension period is called the Stance Extension phase.
  • the knee acts as a spring, releasing the stored energy from the Stance Flexion phase of gait. This first release of energy corresponds to power output indicated at 501 in the graph at the bottom of FIG. 5B .
  • the knee absorbs energy in a second spring and then that energy is released during the next gait phase, or Pre-Swing.
  • the knee of the supporting leg begins its rapid flexion period in preparation for the swing phase.
  • the stored elastic energy from Stance Extension is released. This second release of energy corresponds to power output seen at 503 in FIG. 5B .
  • the leg leaves the ground at 407 and the knee continues to flex.
  • the Swing Flexion phase of gait begins.
  • knee power is generally negative where the knee's torque impedes knee rotational velocity.
  • the knee can be modeled as an extension spring in series with a variable damper, storing a small amount of energy in preparation for early Swing Extension.
  • the knee After reaching a maximum flexion angle during swing at 408 , the knee begins to extend forward. During the early Swing Extension period, the spring energy stored during late Swing Flexion is then released, resulting in power output seen at 505 in FIG. 5B . During the remainder of Swing Extension, the human knee outputs negative power (absorbing energy) to decelerate the swinging leg in preparation for the next stance period.
  • the knee can be modeled as a flexion spring in series with a variable damper, storing a small amount of energy in preparation for early stance (at 507 ). After the knee has reached full extension, the foot once again is placed on the ground, and the next walking cycle begins.
  • the actuator comprises a plurality of springs, mechanical transmissions, and active elements where each spring is in series with an active element via a transmission, and each spring-transmission-active element combination are in parallel and capable of opposing one another in an agonist-antagonist manner.
  • the components of the agonist-antagonist actuator are listed in Table 1 with their functional purposes outlined.
  • the Agonist-Antagonist Actuator An Example
  • the active element comprises a motor in parallel with a variable damper.
  • the flexion and extension motors can control the position of flexion and extension nuts, respectively, via ballscrew mechanical transmissions.
  • two side-by-side actuators are attached at their upper ends to a cross-rod 601 which provides a connection point to the upper link 603 of the joint mechanism.
  • the upper link 603 is connected to the lower link 605 at a joint 607 .
  • the actuator that extends along the left-hand side of the upper and lower links 603 and 605 as seen in FIG. 6 includes an extension nut 611 that engages with and compresses an extension spring 613 .
  • the extension spring 613 is positioned between the extension nut 611 and a linear bearing 617 which is attached to the lower link 605 .
  • An extension ballscrew seen at 621 connected via a gearbox (not shown) to the armature of an extension motor 623 .
  • An extension nut guidance shaft 625 is attached to the case of the motor 623 and extends downwardly from the motor 623 through the extension nut 611 and the linear bearing 617 to a shaft endcap 629 .
  • the guidance shaft 625 prevents the extension nut from rotating so that, as the extension motor 623 rotates the extension ballscrew 621 , the extension nut 611 moves longitudinally with respect to the cross-rod 601 and the motor 623 , varying the joint angle at which the extension nut engages with the extension spring 613 .
  • the extension motor 623 can compress the extension spring 613 as the extension nut 611 is driven downward to increase the length of the actuator and extend (increase) the joint angle.
  • the actuator that extends along the right-hand side of the upper and lower links 603 and 605 as seen in FIG. 6 includes a flexion nut 631 that engages with and compresses a flexion spring 633 .
  • the flexion spring 633 is positioned between the flexion nut 631 and a linear bearing 637 which is attached to the lower link 605 .
  • a flexion ballscrew seen at 641 connected via a gearbox (not shown) to the armature of a flexion motor 643 .
  • a flexion nut guidance shaft 645 is attached to the case of the flexion motor 643 and extends downwardly from the motor 643 through the linear bearing 637 and the flexion nut 631 and the to a flexion shaft endcap 649 .
  • the flexion nut guidance shaft 645 prevents the extension nut from rotating so that, as the flexion motor 643 rotates the flexion ballscrew 641 , the flexion nut 631 moves longitudinally with respect to the cross-rod 601 and the flexion motor 643 , varying the joint angle at which the flexion nut engages with the flexion spring 633 .
  • the flexion motor 623 can compress the flexion spring- 633 as the flexion nut 631 is driven upwardly to decrease the length of the actuator and decrease the joint angle during flexion.
  • a variable damper is connected in parallel with each of the motors.
  • An extension variable damper seen at 651 is connected in parallel with the extension motor 623 and a flexion variable damper seen at 653 is connected in parallel with the flexion motor 643 .
  • the actuator length at which the flexion and extension springs are engaged can be independently controlled (Muscle-Like Property 3 ). Furthermore, the flexion and extension motors can compress each series spring simultaneously without the joint rotating where each spring exerts an equal but oppositely opposed force.
  • variable dampers can output high damping levels to impede ballscrew rotation at low power requirements.
  • each motor is in parallel with each variable damper, both motors can be turned off while still maintaining spring deflection and overall actuator stiffness (Muscle-Like Property 2 ).
  • the actuator can also dissipate mechanical energy at low power (Muscle-Like Property 2 ).
  • the ballscrew transmissions are backdrivable.
  • energy can be dissipated using the variable dampers.
  • each variable damper is in parallel with each motor, during such a dissipative action, the motors can act as generators to store electrical power for later use.
  • zero actuator force can be achieved at zero power consumption (Muscle-Like Property 1 ). If the motors move the ballscrew nuts away from their respective spring element, the actuator will output zero force and no energy is required to maintain that force.
  • each active element could be either a motor or a variable damper/clutch, or a combination of these elements. If the active element includes a variable damper/clutch, it could be implemented using hydraulic, pneumatic, friction, electrorheological, magnetorhelogical, hysteresis brake, or magnetic particle brake damping/clutching strategies.
  • the preferred mechanism for damping control is a hysteresis brake because the zero power damping level is negligible. This feature is important because the variable damper is behind the mechanical transmission where any strain rate dependent, low-end viscous or frictional effect would likely be amplified.
  • the active element includes a motor, it could be any electric motor, brushed or brushless. It could also be a hydraulic or pneumatic cylinder or other mechanical power-producing elements such as artificial muscle, piezoelectrics or nitinol wire.
  • the springs could be implemented as linear or torsional spring elements. They may be metal die springs, carbon fiber leaf springs, elastomeric compression springs,or pneumatic springs. For the preferred implementations described in this specification, the springs are die compression springs.
  • the mechanical transmissions could be implemented as linear or torsional transmission elements. They could be harmonic drives, ballscrew drives, leadscrew drives, or any other mechanical transmission known in the art.
  • the transmission would simply be a material linkage, connecting spring to active element.
  • the mechanical transmissions are ballscrew transmissions.
  • the sensors required to enable general actuator operation and control are:
  • sensory information from # 1 can be employed.
  • the biomimetic joint angle By subtracting the biomimetic joint angle from the active element output shaft angle, it is possible to calculate the amount of energy stored in the motor series spring.
  • the series spring displacement sensor can be used to measure the torque borne by the joint because joint torque can be calculated from the series spring output force.
  • agonist-antagonist actuator capable of providing biologically realistic dynamic behaviors for an artificial ankle and knee joint.
  • the ankle design comprises flexion and extension motors for the active elements, and corresponding flexion and extension transmissions and springs.
  • the flexion and extension motors provide control of joint spring equilibrium position and stiffness, damping and nonconservative, motive force output.
  • FIGS. 7A and 7B The Agonist-antagonist actuator, as used in an artificial ankle application, is shown in FIGS. 7A and 7B .
  • An upper shin link 701 and a foot link 702 rotate with respect to one another about an ankle joint 705 as best seen in the side view, FIG. 7B .
  • Two actuators extend in parallel alongside the shin link 701 .
  • a plantar flexion motor 711 drives a flexion ballscrew 713 that extends through a linear bearing 715 , a plantar flexion spring 717 and a plantar flexion nut 719 to an endcap 720 .
  • the flexion motor 711 is attached to a crossrod 723 by a strut 725 .
  • the dorsiflexion actuator is seen at the right in FIG. 7A and includes a dorsiflexion motor 731 which is attached at its lower end by a strut 735 to the cross rod 723 .
  • a dorsiflexion ballscrew 741 is driven by the dorsiflexion motor and extends upwardly through a dorsflexion nut 743 , a dorsiflexion spring 747 , and a linear bearing 758 to an endcap 749 .
  • the foot link 702 is attached to a leaf spring foot plate seen at 750 .
  • the description that follows explains how, during level-ground walking, the joint might be controlled for the swing, controlled plantar flexion (CP), controlled dorsiflexion (CD), and powered plantar flexion (CP) phases of gait. In addition, the description will explain how the joint might be controlled for stair/slope ascent and descent.
  • CP controlled plantar flexion
  • CD controlled dorsiflexion
  • CP powered plantar flexion
  • the plantar flexion ballscrew nut 719 is positioned such that the ankle joint is dorsiflexed to achieve foot clearance.
  • three distinct control methods can be employed in preparation for heel strike and the CP phase.
  • the amount of energy stored during CP increases with increasing walking speed.
  • the total angular deflection of the ankle can be increased with increasing speed and/or the quasi-stiffness or the actual stiffness of the ankle can be increased.
  • the effective spring equilibrium length of the actuator at heel strike could be increased with increasing walking speed.
  • the spring equilibrium position of the joint is equal to the desired heel strike ankle angle.
  • the dorsiflexion motor 731 can be turned off to conserve power. If a lower quasi-joint stiffness is required, the dorsiflexion motor 731 can unwind the dorsiflexion spring 747 during CP, and if a greater quasi-joint stiffness is required, the motor can compress the spring 747 during CP.
  • the control algorithm of the artificial ankle will select the appropriate ankle spring equilibrium and stiffness values for terminal swing/CP to achieve a smooth heel strike to forefoot strike transition.
  • Controlling the joint spring set point at heel strike can be useful, for example, when the wearer switches shoes with different heel heights or when the terrain changes character (slopes/stairs and uneven terrain), thus changing the natural angle of the ankle joint when the foot is resting on a flat ground surface.
  • the ankle torque does not return to point 1 in FIG. 2 . Rather, the torque assumes a higher value compared to the torque values from points 1 to 2 .
  • the plantar flexion motor 711 has to move the plantar flexion nut 719 to reduce the gap between the nut and the plantar flexion spring 717 as the dorsiflexion spring 747 is being compressing during CP. This repositioning of the plantar flexion nut allows the plantar flexion spring to be engaged even before the dorsiflexion spring has released its energy, thus providing a higher torque during early CD than during CP.
  • the ankle torque versus angle curve becomes increasingly nonlinear as walking speed increases.
  • peak ankle power and the net ankle work during stance increases with increasing walking speed (see FIG. 2 ).
  • the mechanical response of the artificial ankle during CP will, on average, be dictated by the series, plantar flexion spring. That is to say, the stiffness of the plantar flexion spring will be tuned to correspond to the average, quasi-stiffness (slope of the torque-angle curve) of the human ankle during CD.
  • the plantar flexion motor would be controlled to unwind the plantar flexion spring, and to increase quasi-stiffness, the motor would compress the spring.
  • the plantar flexion motor would compress the plantar flexion spring during CD to achieve the following characteristics 1) to increase the quasi-stiffness of the artificial ankle during CD and 2) to increase the power output and the positive work performed during PP. It is noted here that to achieve a passive, spring response during the stance period of walking, the flexion and extension motors can be turned off to conserve power since the ballscrews are non-backdriveable.
  • the maximum dorsiflexion ankle torque during level-ground walking is in the range from 1.5 Nm/kg to 2 Nm/kg, i.e. around 150 Nm to 200 Nm for a 1.00 kg person.
  • the maximum controlled plantar flexion torque is relatively small, typically in the range of 0.3 Nm/kg to 0.4 Nm/kg. Because of these biomechanics, a uni-directional spring in parallel with the agonist-antagonist actuator of FIGS. 7A and 7B would lower the peak torque requirements of the actuator.
  • the uni-directional spring would engage at a small or zero dorsiflexion angle (90 degrees between foot and shank) and would lower the peak torque requirements of the Agonist-antagonist actuator since the peak controlled plantar flexion torque is considerably smaller than the peak dorsiflexion torque.
  • additional elements could be added to the design of FIG. 7 such as a parallel, uni- directional spring.
  • the dorsi and plantar flexion motors would move the nuts to reposition the ankle joint to an appropriate angle given the nature of the stair/slope.
  • the plantar flexion spring compresses and stores energy.
  • the plantar flexion motor can compress the spring farther so that additional power is delivered to the walking robot or prosthesis/orthosis user during PP.
  • the motors control the equilibrium position of the ankle in preparation for the next step.
  • the body During stair descent, the body has to be lowered after forefoot contact until the heel makes contact with the stair tread. See reference ⁇ 2 ⁇ .
  • the plantar flexion motor unwinds the plantar flexion spring as the spring is compressing to effectively dissipate mechanical energy.
  • the motor can be turned off so that the plantar flexion spring begins to store energy for release during PP.
  • the ankle response is similar, except that mechanical energy is absorbed by the dorsiflexion motor during CP instead of during CD.
  • the knee design comprises an extension motor and a flexion variable damper for the active elements, and corresponding flexion and extension transmissions and springs.
  • the extension motor and the flexion variable damper provide control of joint spring equilibrium position and stiffness, damping and nonconservative, motive force output.
  • a flexion motor is not included in an attempt to simplify the mechanism. Since only a flexion variable damper is present, the flexion nut is mechanically grounded to the linear bearing since a flexion motor is not present to actively reposition the flexion nut.
  • the flexion variable damper has a negligible low-end damping value.
  • a preferred method for the flexion variable damper is a hysteresis brake because of its minimal low-end damping value.
  • the agonist-antagonist actuator as used in an artificial knee application, is shown in FIGS. 8A and 8B .
  • the actuator consists of an upper (thigh) link 801 and a lower (shin) link 803 which are rotatably connected at a joint 805 .
  • an extension motor 811 drives an extension ballscrew 813 that extends downwardly from the motor 811 through an extension nut 815 , an extension spring 817 , and a linear bearing 819 .
  • An extension nut guidance shaft 825 prevents the extension nut from rotating as the extension ballscrew 813 rotates.
  • the mechanism on the right side of the lower link 803 is passive; that is, it does not include an active motor element but rather includes a flexion variable damper 831 and a flexion spring 833 .
  • a flexion ballscrew 841 extends from the damper 831 downwardly through a linear bearing 843 , the flexion spring 833 and a flexion nut 847 .
  • a flexion nut guidance shaft 851 prevents the flexion nut 847 from rotating as the extension ballscrew 841 rotates.
  • the joint is controlled for the swing, early stance flexion, mid-stance extension, and pre-swing phases of gait.
  • the joint may be controlled for stair/slope ascent and descent.
  • the stance knee begins to flex slightly in normal human walking ( FIG. 5 ).
  • this flexion period called the Stance Flexion phase, allows for shock absorption upon impact as well as to keep the body's center of mass at a more constant vertical level throughout the stance period.
  • the artificial knee shown in FIGS. 8A and 8B outputs a spring response, storing energy in preparation for the Stance Extension phase.
  • the extension spring 817 stores energy, and then that energy is released during the Stance Extension phase.
  • the extension ballscrew transmission is non-backdriveable.
  • the extension motor need not be active, reducing electrical power requirements.
  • the extension motor 811 can compress or unwind the extension spring 813 during early stance knee flexion, respectively, by repositioning the extension nut 815 that acts on the extension spring 817 .
  • the joint After maximum flexion is reached in the stance knee in normal human walking, the joint begins to extend, until maximum extension is reached. This knee extension period is called the Stance Extension phase. Throughout the first ⁇ 60% of Stance Extension, the knee acts as a spring, releasing the stored energy in the extension spring from the Stance Flexion phase of gait. This first release of energy corresponds to power output P 2 in FIG. 5B . During the last ⁇ 30% of Stance Extension, the artificial knee is controlled to absorb energy in the flexion spring 833 and then that energy is released during the next gait phase, or Pre-Swing. Here the energy from hip muscular work and the remaining stored energy in the extension spring 817 is then stored in the flexion spring 833 .
  • the flexion variable damper 831 To engage the flexion spring, the flexion variable damper 831 outputs a high damping value, locking the flexion ballscrew 841 , and forcing the flexion nut 847 to compress the flexion spring 833 . During this energy storage, if it is desirable to lower the effective quasi-stiffness of the joint, the flexion variable damper 831 can output lower damping values to allow the flexion ballscrew 841 to slip, and for energy to be dissipated as heat.
  • the flexion and extension springs of the agonist antagonist actuator of FIGS. 8A and 8B are precisely tuned such that biological knee mechanics can be achieved while minimizing power supply demands and overall artificial joint mass.
  • a normal human knee of the supporting leg begins its rapid flexion period in preparation for the swing phase.
  • the stored elastic energy in the flexion spring 833 stored during Stance Extension is released. This second release of energy corresponds to power output P 3 in FIG. 5B .
  • the flexion variable damper 831 can be used to modulate the amount of stored elastic energy in the flexion spring that is actually released to power the knee joint.
  • the leg leaves the ground and the knee continues to flex.
  • the Swing Flexion phase of gait begins.
  • human knee power is generally negative where the knee's torque impedes knee rotational velocity.
  • the knee joint typically has to absorb mechanical energy to decelerate the swinging lower leg. This can be done in two ways.
  • the flexion variable damper 831 can be used to dissipate mechanical energy as heat and to decelerate the swinging artificial leg.
  • the extension motor 811 can position the extension ballscrew nut 815 such that the extension spring 817 compresses and stores elastic energy for use during Swing Extension.
  • a normal human knee After reaching a maximum flexion angle during swing, a normal human knee begins to extend forward.
  • the elastic energy stored during late Swing Flexion in the extension spring 817 is released, resulting in power output P 4 in FIG. 5B .
  • This control action once again, reduces the energy demands from the knee's power supply.
  • the flexion variable damper 831 can be used to precisely modulate the amount of power delivered to the swinging artificial leg from the stored elastic energy.
  • the human knee typically outputs negative power (absorbing energy) to decelerate the swinging leg in preparation for the next stance period.
  • this can be done in two ways.
  • the flexion variable damper 831 can be used to dissipate mechanical energy as heat and to decelerate the swinging artificial leg.
  • the flexion variable damper 831 can output a relatively high damping value such that the flexion spring 833 compresses and stores elastic energy for use during Stance Flexion.
  • a small amount of energy is stored in preparation for early stance (power P 1 ).
  • the artificial knee shown in FIGS. 8A and 8B is capable of reproducing the positive power contributions P 1 , P 2 , P 3 and P 4 shown in FIG. 5 for level-ground walking.
  • a normal human knee performs negative work during stance where knee torque is in the opposite direction to knee rotational velocity.
  • the agonist-antagonist actuator of FIGS. 8A and 8B can perform this negative work in two ways.
  • the flexion variable damper 831 can be used to dissipate mechanical energy as heat and to decelerate the rotating artificial leg.
  • the extension motor 811 can position the extension ballscrew nut 815 such that the extension spring 817 compresses and stores elastic energy for use later to power Swing Extension to prepare the artificial leg for the next stance period.
  • the extension motor 811 can actively control knee position to accurately locate the foot on the next stair tread or slope foothold. Once the artificial foot is securely positioned on the stair tread or ground, the motor 811 can then deflect and store energy in the extension spring 817 . This stored elastic energy can then assist the knee wearer or humanoid robot to actively straighten the knee during the stance period, lifting the body upwards.
  • the agonist-antagonist actuator of FIGS. 8A and 8B allows for the “windup” phase of a catapult style control to occur at any desired time. This means much greater flexibility as to when large amounts of power can be efficiently generated and used. This flexibility is critical when designing an artificial knee that can be used for jumping. For such a movement task, energy has to be stored prior to the jump, and then the elastic energy has to be released at a precise time to facilitate a jumping action.
  • the flexion variable damper 831 would be controlled to output high damping to effectively lock the flexion ballscrew 841 . Following this action, the extension motor 811 would slowly compress the extension spring 817 . Once high powers are deemed necessary about the joint output, the flexion variable damper 831 would then be controlled to suddenly unlock to allow rapid rotation of the flexion ballscrew 841 and the release of elastic strain energy from the extension spring 817 .
  • the agonist-antagonist actuator described herein could be implemented in a number of different ways.
  • an active element and transmission-spring combination could be positioned on each side of the artificial joint.
  • This configuration shown in FIG. 9 , has the advantage that when only one spring is being compressed, no off-axis bending torques are borne by the lower link seen at 901 .
  • the lower link 901 is attached to the upper link 903 at a joint 905 .
  • a crossbar strut 907 is rigidly attached to the lower link 901 .
  • a linear bearing is attached to each end of the crossbar strut 907 and a ballscrew, one of which is seen at 909 , extends through the linear bearing.
  • the ballscrew seen at 909 extends downwardly from a drive motor 911 through a variable damper 913 , the linear bearing, a spring 915 , and a ballscrew nut 917 to an end cap 919 .
  • an agonist-antagonist actuation system can include active element-transmission-spring combinations than span two or more joints in a poly-articular architecture. The biomechanics of poly-articular actuation is discussed in the next section.
  • the joint attaches an upper link 1001 to a lower link 1003 for rotation about two orthogonal axes.
  • the upper link rotates in a first degree of freedom about an axis through the crossbar 1007 that is parallel to the long dimension of a crossbar 1009 , and in a second degree of freedom about an axis through the crossbar 1009 that is parallel to the crossbar 1007 .
  • Four different actuators are attached from the ends of the crossbars 1007 and 1009 and all four have a like structure illustrated by the actuator at the left in FIG. 10A .
  • An drive motor 1021 attached to the crossbar 1005 rotates a ballscrew 1022 that passes through variable damper 1027 and a linear bearing 1029 attached to the lower link 1003 .
  • the ballscrew 1022 further extends through a series spring 1031 and a ballscrew nut 1033 to an endcap 1040 .
  • one of the motor-spring-damper mechanisms controls the rotation of the upper link 1001 with respect to the lower link 103 in one direction while an opposing motor-spring-camper mechanism attached to other end of the same crossbar controls the rotation in that degree of freedom in the other direction, thus providing agonist-antagonist actuator control in both degrees of freedom.
  • the agonist-antagonist actuator mechanism contemplated by the present invention was described and specific examples were provided as to its use in ankle and knee actuation, and different illustrative implementations were described.
  • the agonist-antagonist actuator spanned a single joint.
  • an agonist-antagonist actuator may span more than one rotary joint.
  • the functional purpose of poly-articular muscle architectures in the human leg is to promote the transfer of mechanical energy from proximal muscular work to distal joint power generation. See reference ⁇ 10 ⁇ .
  • both muscle-like actuators and mono, bi, and poly-articular artificial musculoskeletal architectures are critical.
  • the agonist-antagonist actuator described herein could span more than one artificial joint.
  • an active element-transmission-spring combination could act across the hip and knee of an artificial leg, or across the knee and ankle of an artificial leg.
  • an agonist-antagonist actuator was described and specific examples were provided as to its use in ankle and knee actuation.
  • the actuator was used as a mono-articular device, spanning only a single joint.
  • mono-articular actuation strategies can be used in combination with bi-articular actuation strategies to better replicate biological limb dynamics and efficiency.
  • bi-articular muscle architectures in the human leg are to promote the transfer of mechanical energy from proximal muscular work to distal joint power generation ⁇ 10 ⁇ .
  • proximal muscular work to distal joint power generation ⁇ 10 ⁇ .
  • distal joint power generation ⁇ 10 ⁇ .
  • FIG. 11A a biomechanical model of the human musculoskeletal architecture
  • leg muscles and tendons work mechanically during walking in order to motivate the design of efficient prosthetic, orthotic, and robotic limbs.
  • FIG. 11A a simple leg prosthesis model, shown in FIG. 11A , that is motivated by the human leg musculoskeletal architecture ⁇ 11 ⁇ .
  • the model seen in FIG. 11 includes a drive motor 1101 at the hip, a knee joint 1103 and an ankle joint 1105 .
  • a musculo-skeletal model of human leg function in walking.
  • the model comprises seven mono-articular series-elastic clutches and four bi-articular series-elastic clutches/variable-dampers.
  • model predictions for ankle and knee are compared with human gait data, respectively.
  • gait data are shown for a 70 kg study participant with a 0.9 meter leg length and a walking speed of 1.2 m/s.
  • the model of (A) agrees well with the human gait data, suggesting that muscles that span the ankle and knee primarily act as variable-impedance devices during level-ground walking.
  • FIGS. 11B and 11C The capacity of the musculoskeletal leg model to capture human-like ankle and knee mechanics in level-ground walking is shown in FIGS. 11B and 11C , respectively.
  • the leg model At each joint state (position and velocity), the leg model is in good agreement with experimental values of joint torque and power, suggesting that a robotic leg can produce human-like walking dynamics through the control of only knee and ankle impedance.
  • the ankle mechanism comprises mono-articular dorsi and plantar flexion springs that can be engaged or disengaged with series elastic clutch mechanisms (see FIG. 11A ).
  • FIG. 12A the mechanical power for each ankle component is plotted versus percent gait cycle.
  • the clutch for the ankle dorsiflexion spring is engaged, causing the spring to stretch and store energy during early stance plantar flexion.
  • the ankle plantar flexion spring is engaged and continues to store energy throughout the controlled dorsiflexion phase, and then that stored energy is released to contribute to ankle powered plantar flexion at terminal stance.
  • Mechanical power output for each component of the human leg model of FIG. 11A In (A), (B) and (C), the mechanical power of each model element is plotted versus percentage gait cycle for ankle, knee and hip, respectively. Here the gait cycle begins at heel strike (0%) and ends with the heel strike of the same leg (100%).
  • the knee mechanism comprises mono-articular flexion and extension springs that can be engaged or disengaged with series elastic clutch mechanisms (see FIG. 11A ).
  • FIG. 12B the mechanical power for each knee mono-articular component is plotted versus percent gait cycle.
  • the clutch for the knee extensor spring is engaged, causing the spring to stretch during early stance knee flexion.
  • the knee extensor spring inhibits the knee from buckling.
  • the knee flexor spring is engaged at the point of maximum knee extension velocity, storing energy that is subsequently used during terminal stance to help lift the lower leg from the ground surface.
  • the leg model's ankle-knee bi-articular mechanism comprises a spring that can be engaged or disengaged with two clutch mechanisms (see FIG. 11A ).
  • a first clutch, or the distal clutch attaches the series spring to a point between the ankle and knee joint, and a second clutch, or the proximal clutch, attaches that same spring to a point above the knee axis.
  • the knee After heel strike in human walking, the knee typically undergoes a flexion period.
  • both the proximal and distal clutches are disengaged, and the bi-articular spring does not apply a force to the prosthesis skeleton.
  • the proximal clutch engages, and the bi-articular spring stretches.
  • the distal clutch changes from a disengaged state to an engaged state, and the proximal clutch disengages.
  • Engaging the distal clutch mechanically grounds the bi-articular spring below the knee rotational axis, changing the ankle-knee mechanism from a bi-articular to a mono-articular device.
  • all the energy stored in the bi-articular spring is used to power ankle plantar flexion during terminal stance.
  • the ankle-knee mechanism allows energy from hip muscular/actuator work to be transferred to the ankle for late stance powered plantar flexion.
  • Knee-Hip Bi-Articular Mechanism The leg model's knee-hip bi-articular mechanisms comprise a spring that can be engaged or disengaged with either a clutch or variable-damper mechanism (see FIG. 11A ). There are three knee-hip bi-articular mechanisms.
  • the clutch of the knee-hip flexor is engaged during swing phase knee extension and begins storing energy its series spring. As a result of this control action, the lower leg is decelerated smoothly prior to reaching full knee extension.
  • elastic energy is stored in the knee-hip flexor spring that is later released during the early stance period.
  • the knee-hip flexor also undergoes an energy storage/release sequence that begins during stance knee extension.
  • the stored energy is then released to power rapid knee flexion movements at terminal stance to lift the foot and lower leg from the ground surface.
  • the clutch of the knee-hip extensor is engaged during terminal stance, storing energy that is later released to enhance knee extension.
  • the iliotibial tract series-elastic variable-damper applies an extensor knee torque to offset the knee flexor torque applied by the ankle-knee bi-articular mechanism.
  • the ankle-knee bi-articular spring is elongated, exerting a torque about the knee.
  • the iliotibial tract series spring is elongated thereby applying an extensor torque at the knee.
  • the functional purpose of bi-articular muscle is to promote the transfer of mechanical energy from proximal muscular work to distal joint power generation ⁇ 10 ⁇ .
  • the robotic leg can achieve ankle powered plantar flexion without the requirement of powering a large motor located at the ankle joint. Approximately ten joules of net work are transferred to the ankle from the knee and hip in the modeling results shown in FIGS. 11 and 12 .
  • the prosthetic leg model of FIG. 11A suggests that leg prostheses could produce human-like joint mechanics during level-ground ambulation if a musculoskeletal leg architecture and a variable-impedance control paradigm were exploited.
  • the proposed biomimetic leg prosthesis does not eliminate the need for knee and ankle actuators, but the model does suggest that nonconservative joint actuator work need not be performed during normal, steady state walking.
  • positive joint actuator work is required.
  • some positive actuator work would be necessary, especially at the knee.
  • ankle and knee torque control would be necessary to reject large whole-body force disturbances that threaten balance.
  • joint actuation is still necessary, the proposed biomimetic design will increase the time between battery recharges or power supply refueling, and will reduce robotic limb noise production during level-ground walking.
  • FIG. 13 the design of the proposed transtibial ankle-foot system with mono and bi-articular mechanisms is shown.
  • FIG. 13A the major components of the transtibial system are shown, including the mono-articular ankle mechanism at 1303 , the bi-articular ankle-knee mechanism at 1305 , and a flexible nylon cord at 1307 .
  • FIG. 13B shows the monoarticular ankle mechanism in more detail. This mechanism comprising two motors 1313 , mechanical transmissions and series dorsiflexion springs at 1317 , and series plantar flexion springs at 1319 .
  • FIG. 13C shows the bi-articular mechanism ( 1305 in FIG. 13A ) and FIG.
  • 13D shows a schematic of the bi-articular mechanism, including two uni-directional clutches seen at 1321 and 1351 and a series spring at 1324 .
  • the limb architecture largely reflects the leg model shown in FIG. 11A , except the mono-articular knee mechanism has been excluded as this basic musculoskeletal structure is still intact in transtibial amputees.
  • the ankle mechanism 1305 seen in FIG. 13B comprises two agonist-antagonist, series-elastic actuators acting across the ankle joint.
  • the foot-ankle design is similar to that described earlier in FIG. 7 .
  • Each actuator has a small electric motor 1313 in series with one of the die springs 1317 or 1319 .
  • Each series spring is a nonlinear hardening spring where spring stiffness increases with increasing spring compression.
  • a non-backdriveable leadscrew 1331 is employed to covert rotary motor movement into linear movement of a leadscrew nut 1332 .
  • a slider mechanism is seen at 1334 and a guide rod at 1335 .
  • each motor 1313 can independently vary the position of the ankle joint at which the series spring 1317 or 1319 becomes engaged.
  • Such an ankle spring equilibrium control is important for many prosthesis functions, including slope and stair ascent and descent.
  • the mono-articular ankle mechanism can also change ankle spring stiffness.
  • each motor can simultaneously compress each nonlinear spring using a co-contraction control. Since spring stiffness increases with increasing deflection, the more the motor system compresses the springs, the stiffer the ankle joint becomes. Since the mechanical transmission is non-backdriveable, once a desired ankle stiffness has been achieved, the motors can be turned off to save electrical power.
  • the foot-ankle design is similar to that described earlier in FIG. 7 .
  • FIGS. 13C and 13D the bi-articular ankle-knee mechanism and schematic are shown, respectively.
  • the mechanism comprises two uni-directional clutches seen at 1351 and 1321 and a spring at 1324 .
  • Each clutch is formed by two opposing cams (see 1353 ) that press against a shaft that directly connects to the spring.
  • a foot assembly is seen at 1327 and the ankle axis is at 1328 .
  • the ankle joint connection is seen at 1329 .
  • the cam configuration only allows for shaft movement in one direction. As can be seen in FIG.
  • Series spring displacement sensors can be used to determine the torque borne by the ankle joint because joint torque can be calculated from the agonist-antagonist spring output forces.
  • a critical advantage of the human-like musculoskeletal prosthesis is that it allows the amputee user to directly control ankle powered plantar flexion. Because of the bi-articular ankle-knee mechanism, the extent of midstance knee extension defines how much energy is transferred to the prosthetic ankle for powering ankle plantar flexion at terminal stance. Since transtibial amputees generally have direct control over their knee, the biomimetic transtibial prosthesis allows for direct control over ankle power output.
  • the point in the gait cycle where the prosthesis series spring elements are engaged will largely be defined by joint state (position and velocity) and foot-ground interaction forces.
  • the spring equilibrium angle for the ankle mono-articular mechanism will be equal to the ankle angle at first heel strike.
  • heel strike will be detected using ankle torque sensing.
  • the heel strike ankle angle will be kept largely invariant with walking speed, but will be modulated from step to step for slope and stair ambulation.
  • the uni-directional clutch devices in the bi-articular mechanism will be controlled in a speed invariant manner.
  • the knee After heel strike in walking, the knee typically undergoes a flexion period.
  • both bi-articular clutches will be disengaged, and therefore the bi-articular spring will not apply a force to the prosthesis skeleton.
  • both clutches will be engaged, causing the bi-articular spring to stretch.
  • the bi-articular clutches will be disengaged so as to allow unrestricted knee and ankle movement throughout the swing phase.
  • EMG Electromyographic
  • a joint stiffness control signal is derived from the sum of the plantar flexion and dorsiflexion EMG amplitudes.
  • the stiffness control signal will be related to stiffness via a straight line relationship with a zero-level control signal signifying the minimum available stiffness level and the maximum-level control signal signifying the maximum available stiffness level.
  • a zero-level control signal signifying the minimum available stiffness level
  • the maximum-level control signal signifying the maximum available stiffness level.
  • FIGS. 13A-13D was described as a transtibial prosthesis, the mechanism could also be used as an orthosis or exoskeleton.
  • the mechanism would be useful as an orthosis for an individual that suffers from an ankle pathology but generally has normal knee and hip function.
  • the mechanism would be placed in parallel with the human leg to augment ankle mechanics as a permanent assistive device.
  • FIG. 14 A proposed artificial ankle and knee system is shown in FIG. 14 .
  • the mechanism could be employed for a transfemoral prosthesis, orthosis, leg exoskeleton, or robotic leg.
  • the mono-articular ankle-foot and knee designs are identical to the structures described in FIG. 13B and FIG. 8 , respectively.
  • the ankle-knee bi-articular mechanism is different from that proposed in FIGS. 13C and 13D .
  • the bi-articular device of FIG. 13 has to be attached above the knee axis.
  • the bi-articular device of FIGS. 14A-14D attaches adjacent to the knee axis.
  • the bi-articular ankle-knee mechanism of FIGS. 14A-14D comprises a motor 1411 , non-backdriveable mechanical transmission 1413 , screw nut 1414 , series spring 1417 , a knee bi-articular connection 1421 , an ankle bi-articular connection 1431 , and a knee variable moment arm (VMA) device 1441 (seen in more detail in FIG. 14D ).
  • VMA knee variable moment arm
  • ankle-knee bi-articular mechanism During level-ground walking, we describe how the ankle-knee bi-articular mechanism would be controlled for the swing, early stance flexion, mid-stance extension, and pre-swing phases of gait.
  • the screw nut 1414 is moved away from the series spring 1417 so that ankle and knee joint movements do not cause the spring to compress.
  • the lead screw nut 1414 is moved by the motor 1411 until it engages the series spring 1417 .
  • both knee extension and ankle dorsiflexion contributes to spring compression.
  • the VMA device 1441 minimizes the moment arm that the knee bi-articular connection makes with the knee axis of rotation. Because the knee moment arm is minimized, most of the strain energy stored in the bi-articular spring contributes to ankle powered plantar flexion at terminal stance.
  • the knee moment arm 1441 can be controlled to effectively modulate the amount of energy release that occurs through the knee joint.
  • the VMA device comprises a small motor 1451 plus gear train 1455 , non-backdriveable lead screw 1459 , lead screw nut 1461 , and variable moment arm pin 1466 .
  • a shin tube mount is seen at 1457 .
  • the motor 1451 rotates, the lead screw nut 1461 moves the variable moment arm pin 1466 across the variable moment arm slot 1471 .
  • the pin is attached to the knee bi-articular connection.
  • the VMA motor can actively control the perpendicular distance, or moment arm, between the knee bi-articular connection and the knee axis.
  • agonist-antagonist actuator variations comprising a plurality of active element transmission-spring combinations acting in parallel have described. These actuator embodiments combine active and passive elements in order to achieve high performance with minimal mass.
  • agonist-antagonist actuators as mono and poly-articular linear elements has been described.
  • the combination of biologically-inspired musculoskeletal architectures and agonist-antagonist actuation strategies as described above provide novel, low mass, efficient and quiet biomimetic artificial limbs. These artificial limb structures may be used to advantage to provide improved orthotic and prosthetic devices and legged robotic mechanisms.

Abstract

Artificial limbs and joints which behave like a biological limbs and joints employ a synthetic actuator which consume negligible power when exerting zero force, consume negligible power when outputting force at constant length (isometric) and while performing dissipative, nonconservative work, are capable of independently engaging flexion and extension tendon-like, series springs, are capable of independently varying joint position and stiffness, and exploit series elasticity for mechanical power amplification.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a non-provisional of U.S. patent application Ser. No. 60/751,680 filed on Dec. 19, 2005.
  • This application is a continuation in part of U.S. patent application Ser. No. 11/395,448 entitled “Artificial human limbs and joints employing actuators, springs, and Variable-Damper Elements” filed on Mar. 31, 2006 by Hugh M. Herr, Daniel Joseph Paluska, and Peter Dilworth. application Ser. No. 11/395,448 claims the benefit of the filing date of U.S. Provisional patent application Ser. No. 60/666,876 filed on Mar. 31, 2005 and the benefit of the filing date of U.S. Provisional patent application Ser. No. 60/704,517 filed on Aug. 1, 2005.
  • This application is also a continuation in part of U.S. patent application Ser. No. 11/499,853 entitled “Biomimetic motion and balance controllers for use in prosthetics, orthotics and robotics” filed on Aug. 4, 2006 by Hugh M. Herr, Andreas G. Hofmann, and Marko B. Popovic. application Ser. No. 11/499,853 claims the benefit of the filing date of, U.S. Provisional patent application Ser. No. 60/705,651 filed on Aug. 4, 2005.
  • This application is also a continuation in part of U.S. patent application Ser. No. 11/495,140 entitled “An Artificial Ankle-Foot System with Spring, Variable-Damping, and Series-Elastic Actuator Components” filed on Jul. 29, 2006 by Hugh M. Herr, Samuel K. Au, Peter Dilworth, and Daniel Joseph Paluska. application Ser. No. 11/495,140 claims the benefit of the filing date of U.S. Provisional patent application Ser. No. 60/704,517 filed on Aug. 1, 2005 and was also a continuation in part of the above-noted application Ser. No. 11/395,448.
  • This application is also a continuation in part of U.S. patent application Ser. No. 11/600,291 entitled “Exoskeletons for running and walking” filed on Nov. 15, 2006 by Hugh M. Herr, Conor Walsh, Daniel Joseph Paluska, Andrew Valiente, Kenneth Pasch, and William Grand. application Ser. No. 11/600,291 claims the benefit of the filing date of U.S. Provisional patent application Ser. No. 60/736,929 filed on Nov. 15, 2005 and is a continuation in part of the above noted applications Ser. Nos. 11/395,448, 11/499,853 and 11/495,140.
  • The present application claims the benefit of the filing date of each of the foregoing patent applications and incorporates the disclosure of each of the foregoing applications herein by reference.
  • FIELD OF THE INVENTION
  • This invention relates to artificial joints and limbs for use in prosthetic, orthotic or robotic devices.
  • BACKGROUND OF THE INVENTION
  • Biomimetic Hybrid Actuators employed in biologically-inspired musculoskeletal architectures as described in the above noted U.S. patent application Ser. No. 11/395,448 employ an electric motor for supplying positive energy to and storing negative energy from an artificial joint or limb, as well as elastic elements such as springs, and controllable variable damper components, for passively storing and releasing energy and providing adaptive stiffness to accommodate level ground walking as well as movement on stairs and surfaces having different slopes.
  • The above noted application Ser. No. 11/495,140 describes an artificial foot and ankle joint consisting of a curved leaf spring foot member that defines a heel extremity and a toe extremity, and a flexible elastic ankle member that connects said foot member for rotation at the ankle joint. An actuator motor applies torque to the ankle joint to orient the foot when it is not in contact with the support surface and to store energy in a catapult spring that is released along with the energy stored in the leaf spring to propel the wearer forward. A ribbon clutch prevents the foot member from rotating in one direction beyond a predetermined limit position, and a controllable damper is employed to lock the ankle joint or to absorb mechanical energy as needed. The controller and a sensing mechanisms control both the actuator motor and the controllable damper at different times during the walking cycle for level walking, stair ascent and stair descent.
  • The above noted Application G-25 describes an exoskeleton worn by a human user consisting of a rigid pelvic harness worn about the waist of the user and exoskeleton leg structures each of which extends downwardly alongside one of the human user's legs. The leg structures include hip, knee and ankle joints connected by adjustable length thigh and shin members. The hip joint that attaches the thigh structure to the pelvic harness includes a passive spring or an active actuator to assist in lifting the exoskeleton and said human user with respect to the ground surface upon which the user is walking and to propel the exoskeleton and human user forward. A controllable damper operatively arresting the movement of the knee joint at controllable times during the waking cycle, and spring located at the ankle and foot member stores and releases energy during walking.
  • The additional references listed below identify materials which are referred to in the description that follows. When cited, each reference is identified by a single number in brackets; for example, the first reference below is cited using the notation “{1 }.”
      • 1. Palmer, Michael. Sagittal Plane Characterization of Normal Human Ankle Function across a Range of Walking Gait Speeds. Massachusetts Institute of Technology Master's Thesis, 2002.
      • 2. Gates Deanna H., Characterizing ankle function during stair ascent, descent, and level walking for ankle prosthesis and orthosis design. Master thesis, Boston University, 2004.
      • 3. Hansen, A., Childress, D. Miff, S. Gard, S. and Mesplay, K., The human ankle during walking: implication for the design of biomimetic ankle prosthesis, Journal of Biomechanics, 2004 (In Press).
      • 4. Koganezawa, K. and Kato, I., Control aspects of artificial leg, IFAC Control Aspects of Biomedical Engineering, 1987, pp.71-85.
      • 5. Herr H, Wilkenfeld A. User-Adaptive Control of a Magnetorheological Prosthetic Knee. Industrial Robot: An International Journal 2003; 30: 42-55.
      • 6. Seymour Ron, Prosthetics and Orthotics: Lower limb and Spinal, Lippincott Williams & Wilkins, 2002.
      • 7. G. A. Pratt and M. M. Williamson, “Series Elastic Actuators,” presented at 1995 IEEE/RSJ International Conference on Intelligent Robots and Systems, Pittsburgh, Pa., 1995.
      • 8. Inman V T, Ralston H J, Todd F. Human walking. Baltimore: Williams and Wilkins; 1981.
      • 9. Hof. A. L. Geelen B. A., and Berg, J. W. Van den, “Calf muscle moment, work and efficiency in level walking; role of series elasticity,” Journal of Biomechanics, Vol 16, No. 7, pp. 523-537, 1983.
      • 10. Gregoire, L., and et al, Role of mono- and bi-articular muscles in explosive movements, International Journal of Sports Medicine 5, 614-630.
      • 11. Endo, K., Paluska D., Herr, H. A quasi-passive model of human leg function in level-ground walking. IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS); Oct. 9-16, 2006; Beijing, China.
  • As noted in references {1 }, {2 }, {3 }, and {4} above, an artificial limb system that mimics a biological limb ideally needs to fulfill a diverse set of requirements. The artificial system must be a reasonable weight and have a natural morphological shape, but still have an operational time between refueling or battery recharges of at least one full day. The system must also be capable of varying its position, stiffness, damping and nonconservative motive power in a comparable manner to that of a normal, healthy biological limb. Still further, the system must be adaptive, changing its characteristics given such environmental disturbances as walking speed and terrain variation. The current invention describes a novel actuator and limb architecture capable of achieving these many requirements.
  • From recent biomechanical studies described in references {1 }, {2 } and {3 } above, researchers have determined that biological joints have a number of features. Among these are:
      • (a) the ability to vary stiffness and damping;
      • (b) the ability to generate large amounts of positive mechanical work (nonconservative motive output); and
      • (c) the ability to produce large amounts of power and torque when needed.
  • An example of the use of more than one control strategy in a single biological joint is the ankle. See {1 } and {2}. For level ground ambulation, the ankle behaves as a variable stiffness device during the early to midstance period, storing and releasing impact energies. Throughout terminal stance, the ankle acts as a torque source to power the body forward. In distinction, the ankle varies damping rather than stiffness during the early stance period of stair descent. These biomechanical findings suggest that in order to mimic the actual behavior of a human joint or joints, stiffness, damping, and nonconservative motive power must be actively controlled in the context of an efficient, high cycle-life, quiet and cosmetic biomimetic limb system, be it for a prosthetic or orthotic device. This is also the case for a biomimetic robot limb since it will need to satisfy the same mechanical and physical laws as its biological counterpart, and will benefit from the same techniques for power and weight savings.
  • The current state of the art in prosthetic leg systems include a knee joint that can vary its damping via magnetorheological fluid as described in {5}, and a carbon fiber ankle which has no active control, but that can store energy in a spring structure for return at a later point in the gait cycle e.g. the Flex-Foot {4} or the Seattle-Lite {6}. None of these systems are able to add energy during the stride to help keep the body moving forward or to reduce impact losses at heel strike. In the case of legged robotic systems, the use of the Series Elastic Actuator (SEA) enables robotic joints to control their position and torque, such that energy may be added to the system as needed. See {7}. In addition, the SEA can emulate a physical spring or damper by applying torques based on the position or velocity of the joint. However, for most applications, the SEA requires a tremendous amount of electric power for its operation, resulting in a limited operational life or an overly large power supply. Robotic joint designs in general use purely active components and often do not conserve electrical power through the use of variable-stiffness and variable-damping devices.
  • SUMMARY OF THE INVENTION
  • The following summary provides a simplified introduction to some aspects of the invention as a prelude to the more detailed description that is presented later, but is not intended to define or delineate the scope of the invention.
  • In this specification and the claims, the following terms have the following meanings:
  • actuator: see the definition of “motor” below;
      • agonist: A contracting element that is resisted or counteracted by another element, the antagonist;
      • agonist-antagonist actuator: a mechanism comprising (at least) two actuators that operate in opposition to one another: an agonist actuator that, when energized, draws two elements together and an antagonist actuator that, when energized, urges the two elements apart;
      • antagonist: An expanding element that is resisted or counteracted by another element, the agonist;
      • biomimetic: a man-made structure or mechanism that mimics the properties and behavior of biological structures or mechanisms, such as joints or limbs;
      • dorsiflexion: bending the ankle joint so that the end of the foot moves upward;
      • elastic: capable of resuming an original shape after deformation by stretching or compression;
      • extension: A bending movement around a joint in a limb that increases the angle between the bones of the limb at the joint;
      • flexion: A bending movement around a joint in a limb that decreases the angle between the bones of the limb at the joint;
      • motor: an active element that produces or imparts motion by converting supplied energy into mechanical energy, including electric, pneumatic or hydraulic motors and actuators;
      • plantarflexion: bending the ankle joint so that the end of the foot moves downward;
      • spring: an elastic device, such as a metal coil or leaf structure, which regains its original shape after being compressed or extended.
  • For an artificial joint to behave like a biological joint, a synthetic actuator must have the following properties:
  • 1) The actuator must consume negligible power when exerting zero force. Near the equilibrium length of muscle (peak of active tension-length curve), the passive tension is typically zero. Thus a muscle-actuated joint goes limp when the muscles are not electrically stimulated.
  • 2) The actuator must consume negligible power when outputting force at constant length (isometric) and while performing dissipative, nonconservative work. Muscle tissue is very efficient for isometric and dissipative control modes.
  • 3) The actuator must be capable of independently engaging flexion and extension tendon-like, series springs. Since biological joints have at least one flexor muscle and at least one extensor muscle, the time at which a flexor tendon becomes taught or engaged can be independent of the time at which an extensor tendon becomes engaged. As an example, with a muscle-actuated joint, the elastic energy from one tendon can be released as a second tendon is being elongated.
  • 4) The actuator must be capable of independently varying joint position and stiffness. Through co- contraction between a muscle flexor and extensor, joint stiffness can be modulated without changing joint position. Further, joint position can be varied while keeping joint stiffness constant.
  • 5) The actuator must be capable of exploiting series elasticity for mechanical power amplification, or a “catapult” control modality. For motion tasks that require high mechanical power, muscle-tendon units in animals and humans often employ a catapult control where the muscle belly stretches the series tendon, and later that stored elastic energy is released to achieve relatively higher joint powers than would be possible if the muscle belly were to generate that power directly.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • In the detailed description which follows, frequent reference will be made to the attached drawings, in which:
  • FIG. 1 depicts the various subdivisions of the stance phase of walking;
  • FIGS. 2A, 2B and 2C show torque vs. angle plots in level-ground walking for slow speed, normal and fast walking;
  • FIG. 3 illustrates human ankle biomechanics for stair ascent;
  • FIG. 4 illustrates human ankle-foot biomechanics for stair descent;
  • FIGS. 5A and 5B illustrate the manner in which knee angle and knee power respectively vary during the walking cycle for level ground walking;
  • FIGS. 6A and 6B are posterior and side elevational views respectively of an agonist-antagonist actuator embodying the invention;
  • FIGS. 7A and 7B are posterior and side elevational views of an agonist-antagonist actuator mechanism implementing an artificial ankle;
  • FIGS. 8A and 8B are posterior and side elevational views of agonist-antagonist actuator mechanisms implementing an artificial knee;
  • FIGS. 9A and 9B are side elevational and perspective views of an agonist-antagonist actuator mechanism positioned on both sides of the joint axis;
  • FIGS. 10A and 10B are posterior and side elevational views of an agonist-antagonist actuator mechanism using motor and spring combinations;
  • FIGS. 11A shows a model of leg prothesis employing series-elastic clutches at the hip, knee and ankle joints;
  • FIGS. 11B and 11C are graphs comparing the behaviors of biological ankle and knee joints respectively with the modeled joints of FIG. 11A;
  • FIGS. 12A, 12B and 12C are plots of the mechanical power of each model element is versus percentage gait cycle for ankle, knee and hip, respectively;
  • FIGS. 13A shows the major components of the transtibial system are shown;
  • FIGS. 13B shows the monoarticular ankle mechanism of FIG. 13A in more detail;
  • FIGS. 13C and 13D show elevational and schematic views respectively of the bi-articular ankle knee mechanism of FIG. 13A;
  • FIGS. 14A and 14B shows the major components of an artificial ankle and knee system;
  • FIGS. 14C is a schematic diagram of the artificial ankle and knee system seen in FIGS. 14A and 14B; and
  • FIG. 14D shows the knee's variable moment arm (VMA) device (seen at the top of FIGS. 14A and 14B) in more detail.
  • DETAILED DESCRIPTION
  • In the construction of a biologically realistic limb system that is high performance, light weight, quiet and power efficient, a agonist-antagonist actuator design is proposed herein comprising a plurality of actuators and series elastic structures. Since it is desirable to minimize the overall weight of the limb design, the efficiency of the agonist-antagonist actuator design is critical, especially given the poor energy density of current power supplies, e.g. lithium-ion battery technology. By understanding human biomechanics, the lightest, most energy efficient agonist- antagonist actuator design can be achieved.
  • In the next section, the key features of biomechanical systems are highlighted. A more complete description of biomechanical systems is found in the patent applications cited in the foregoing “Cross Reference to Related Applications” whose disclosures are incorporated herein by reference.
  • Joint Biomechanics: The Human Ankle
  • Understanding normal walking biomechanics provides the basis for the design and development of the agonist-antagonist actuator design. Specifically, the function of human ankle under sagittal plane rotation is described for different locomotor conditions including level-ground walking and stair/slope ascent and descent. In addition, the function of the human knee during level ground walking is described. From these biomechanical descriptions, the justifications for key mechanical components and configurations of the actuator invention are established.
  • Level-Ground Walking
  • A level-ground walking gait cycle is typically defined as beginning with the heel strike of one foot seen at 103 in FIG. 1 and ending at the next heel strike of the same foot seen at 113. See {8}. The main subdivisions of the gait cycle are the stance phase (˜60%) and the swing phase (˜40%) which are illustrated in FIG. 1. The swing phase represents the portion of the gait cycle when the foot is off the ground. The stance phase begins at heel strike when the heel touches the floor and ends at toe off when the same foot rises from the ground surface. Additionally, we can further divide the stance phase into three sub- phases: Controlled Plantar Flexion (CP), Controlled Dorsiflexion (CD), and Powered Plantar Flexion (PP).
  • Detailed descriptions for each phase and the corresponding ankle functions are described in FIG. 1. CP begins at heel-strike 103 and ends at foot-flat shown at 105. Simply speaking, CP describes the process by which the heel and forefoot initially make contact with the ground. In {1} and {3}, researchers showed that CP ankle joint behavior is consistent with a linear spring being loaded or stretched where joint torque is proportional to joint position.
  • During the loading process, the spring behavior is, however, variable; joint stiffness is continuously modulated by the body from step to step. After the CP period, the CD phase begins. In FIG. 2, the average torque versus angle curves are shown for 68 healthy, young participants walking on a level surface. As is shown, during CP (from 103 to 105), the ankle behaves as a linear spring of variable stiffness during the loading cycle, but the torque curve does not trace back to point 1, but rather assumes higher torque values during the early period of CD.
  • Ankle torque versus position during the CD period from 105 to 107 can often be described as a nonlinear spring being loaded or stretched where stiffness increases with increasing ankle position. It is noted that as walking speed increases, the extent to which the ankle behaves as a nonlinear spring increases, with the CD loading phase exhibiting distinct nonlinear behavior during fast walking (see fast walking, FIG. 2). The main function of the ankle during CD is to store elastic energy to propel the body upwards and forwards during the PP phase. See {9} and {3}.
  • The PP phase begins at 107 after CD and ends at the instant of toe-off shown at 109. During PP in moderate to fast walking speeds, the ankle can be modeled as a catapult in series or in parallel with the CD spring or springs. Here the catapult component includes an actuator that does work on a series spring during the CD phase and/or during the first half of the PP phase. The catapult energy is then released along with the spring energy stored during the CD phase to achieve the high plantar flexion power during late stance. This catapult behavior is necessary because the work generated during PP is more than the negative work absorbed during the CP and CD phases for moderate to fast walking speeds as clearly seen in FIGS. 2A-2C. See {1}, {2}, {3} and {9}.
  • FIGS. 2A, 2B and 2C show torque vs. angle plots in level-ground walking for slow speed walking at 0.9 m/sec (FIG. 2A), normal walking speed at 1.25 m/sec (FIG. 2B) and fast walking at 1.79 m/sec. Only the stance period of a single foot is shown (heel strike to toe off). Point 1 on the charts denotes heel strike, point 2 foot flat, point 3 peak dorsiflexion, and point 4 toe off. Although during slow walking the loading curve (points 2-3) is approximately equal to the unloading curve (points 3-4), for higher walking speeds the torque assumes higher values during the unloading, PP phase (points 3-4). Hence, for walking speeds greater than 0.9 m/s (slow speed), the human ankle cannot be modeled as a series of coupled springs because the positive work performed by the ankle exceeds the negative work. It is noted that, as walking speed increases, the degree of nonlinear behavior during CD (points 2-3) increases along with the total amount of positive work production during PP (points 3-4), consistent with a catapult model where the soleus muscle belly slowly elongates the series Achilles tendon spring during CD, increasing the slope of the torque versus angle curve and the subsequent positive power output of the ankle.
  • Stair Ascent and Descent
  • FIG. 3 illustrates human ankle biomechanics for stair ascent; The first phase of stair ascent is called Controlled Dorsiflexion 1 (CD 1), which begins with foot strike in a dorsiflexed position at 201 and continues to dorsiflex until the heel contacts the step surface at 203. In this phase, the ankle can be modeled as a linear spring. The second phase is Powered Plantar flexion 1 (PP 1), which begins at the instant of foot flat (when the ankle reaches its maximum dorsiflexion) at 203 and ends when dorsiflexion begins once again at 205. The human ankle behaves as a torque actuator to provide extra energy to support the body weight. The third phase is Controlled Dorsiflexion 2(CD 2), in which the ankle dorsiflexes as seen at 205 until heel-off at 207. For that phase, the ankle can be modeled as a linear spring. The fourth and final phase is Powered Plantar flexion 2 (PP 2). Here the foot pushes off the step as seen at 207, acting as a torque actuator in parallel with the CD 2 spring to propel the body upwards and forwards until toe-off occurs at 209 and the swing phase begins.
  • FIG. 4 illustrates the human ankle-foot biomechanics for stair descent. The stance phase of stair descent is divided into three sub-phases: Controlled Dorsiflexion 1 (CD1), Controlled Dorsiflexion 2 (CD2), and Powered Plantar flexion (PP). CD1 begins at forefoot strike seen at 303 and ends at foot-flat seen at 305. In this phase, the human ankle can be modeled as a variable damper. In CD2, from foot flat at 305, the ankle continues to dorsiflex forward until it reaches a maximum dorsiflexion posture at 307. Here the ankle acts as a linear spring in series with a variable-damper designed to effectively control the amount of energy stored by the linear spring. During PP, beginning at 307, the ankle plantar flexes until the foot lifts from the step at 309. In this final phase, the ankle releases stored CD2 energy, propelling the body upwards and forwards. From toe off at 309 until the next foot strike at 313, the foot in the swing phase.
  • Because the kinematic and kinetic patterns at the ankle during stair ascent/descent are significantly different from that of level-ground walking (see {2}), a description of such ankle-foot biomechanics seems appropriate. For stair ascent, the human ankle-foot can be effectively modeled using a combination of an actuator and a variable stiffness mechanism. However, for stair descent, variable damping needs also to be included for modeling the ankle-foot complex; the power absorbed by the human ankle is much greater during stair descent than the power released by 2.3 to 11.2 J/kg. See reference {2}.
  • Joint Biomechanics: The Human Knee
  • There are five distinct phases to knee operation throughout a level-ground walking cycle as illustrated in FIG. 5A and 5B. See reference {8}. FIG. 5A shows how the knee angle varies during the walking cycle, and FIG. 5B shows how knee power varies. As seen in FIG. 5A, the stance phase of walking can be divided into three sub-phases: Stance Flexion, Stance Extension, and Pre-Swing. The swing phase is divided into two phases: Swing Flexion and Swing Extension. As seen in FIG. 5B, for level ground walking, the human knee does more negative work than positive work.
  • Beginning at heel strike indicated at 403, the stance knee begins to flex slightly. This flexion period, called the Stance Flexion phase, allows for shock absorption upon impact as well as to keep the body's center of mass at a more constant vertical level throughout the stance period. During this phase, the knee acts as a spring, storing energy in preparation for the Stance Extension phase.
  • After maximum flexion is reached in the stance knee at 404, the joint begins to extend, until maximum extension is reached as indicated at 406. This knee extension period is called the Stance Extension phase. Throughout the first ˜60% of Stance Extension, the knee acts as a spring, releasing the stored energy from the Stance Flexion phase of gait. This first release of energy corresponds to power output indicated at 501 in the graph at the bottom of FIG. 5B. During the last ˜30% of Stance Extension, the knee absorbs energy in a second spring and then that energy is released during the next gait phase, or Pre-Swing.
  • During late stance or Pre-Swing from 406 to 407, the knee of the supporting leg begins its rapid flexion period in preparation for the swing phase. During early Pre-Swing, as the knee begins to flex in preparation for toe- off, the stored elastic energy from Stance Extension is released. This second release of energy corresponds to power output seen at 503 in FIG. 5B.
  • As the hip is flexed, and the knee has reached a certain angle in Pre-Swing, the leg leaves the ground at 407 and the knee continues to flex. At toe-off 407, the Swing Flexion phase of gait begins. Throughout this period, knee power is generally negative where the knee's torque impedes knee rotational velocity. During terminal Swing Flexion, the knee can be modeled as an extension spring in series with a variable damper, storing a small amount of energy in preparation for early Swing Extension.
  • After reaching a maximum flexion angle during swing at 408, the knee begins to extend forward. During the early Swing Extension period, the spring energy stored during late Swing Flexion is then released, resulting in power output seen at 505 in FIG. 5B. During the remainder of Swing Extension, the human knee outputs negative power (absorbing energy) to decelerate the swinging leg in preparation for the next stance period. During terminal Swing Extension, the knee can be modeled as a flexion spring in series with a variable damper, storing a small amount of energy in preparation for early stance (at 507). After the knee has reached full extension, the foot once again is placed on the ground, and the next walking cycle begins.
  • An agonist-antagonist actuator described below implements these muscle-like actuation properties. The actuator comprises a plurality of springs, mechanical transmissions, and active elements where each spring is in series with an active element via a transmission, and each spring-transmission-active element combination are in parallel and capable of opposing one another in an agonist-antagonist manner. The components of the agonist-antagonist actuator are listed in Table 1 with their functional purposes outlined.
  • The Agonist-Antagonist Actuator: An Example
  • In FIG. 6, one implementation of the actuator is shown as an example. For this particular actuator form, the active element comprises a motor in parallel with a variable damper. The flexion and extension motors can control the position of flexion and extension nuts, respectively, via ballscrew mechanical transmissions. As seen in FIG. 6, two side-by-side actuators are attached at their upper ends to a cross-rod 601 which provides a connection point to the upper link 603 of the joint mechanism. The upper link 603 is connected to the lower link 605 at a joint 607.
  • The actuator that extends along the left-hand side of the upper and lower links 603 and 605 as seen in FIG. 6 includes an extension nut 611 that engages with and compresses an extension spring 613. The extension spring 613 is positioned between the extension nut 611 and a linear bearing 617 which is attached to the lower link 605. An extension ballscrew seen at 621 connected via a gearbox (not shown) to the armature of an extension motor 623. An extension nut guidance shaft 625 is attached to the case of the motor 623 and extends downwardly from the motor 623 through the extension nut 611 and the linear bearing 617 to a shaft endcap 629. The guidance shaft 625 prevents the extension nut from rotating so that, as the extension motor 623 rotates the extension ballscrew 621, the extension nut 611 moves longitudinally with respect to the cross-rod 601 and the motor 623, varying the joint angle at which the extension nut engages with the extension spring 613. Thus, the extension motor 623 can compress the extension spring 613 as the extension nut 611 is driven downward to increase the length of the actuator and extend (increase) the joint angle.
  • The actuator that extends along the right-hand side of the upper and lower links 603 and 605 as seen in FIG. 6 includes a flexion nut 631 that engages with and compresses a flexion spring 633. The flexion spring 633 is positioned between the flexion nut 631 and a linear bearing 637 which is attached to the lower link 605. A flexion ballscrew seen at 641 connected via a gearbox (not shown) to the armature of a flexion motor 643. A flexion nut guidance shaft 645 is attached to the case of the flexion motor 643 and extends downwardly from the motor 643 through the linear bearing 637 and the flexion nut 631 and the to a flexion shaft endcap 649. The flexion nut guidance shaft 645 prevents the extension nut from rotating so that, as the flexion motor 643 rotates the flexion ballscrew 641, the flexion nut 631 moves longitudinally with respect to the cross-rod 601 and the flexion motor 643, varying the joint angle at which the flexion nut engages with the flexion spring 633. Thus, the flexion motor 623 can compress the flexion spring- 633 as the flexion nut 631 is driven upwardly to decrease the length of the actuator and decrease the joint angle during flexion.
  • A variable damper is connected in parallel with each of the motors. An extension variable damper seen at 651 is connected in parallel with the extension motor 623 and a flexion variable damper seen at 653 is connected in parallel with the flexion motor 643.
  • Through the independent control of flexion and extension nut positions, the actuator length at which the flexion and extension springs are engaged can be independently controlled (Muscle-Like Property 3). Furthermore, the flexion and extension motors can compress each series spring simultaneously without the joint rotating where each spring exerts an equal but oppositely opposed force.
  • If the series springs are hardening springs where spring stiffness increases with increasing compression, joint stiffness can be effectively controlled through this agonist-antagonist motor action (Muscle-like property 4). After the motors co-contract and compress the flexion and extension springs to a desired spring deflection and a desired actuator stiffness, to maintain that stiffness, the variable dampers can output high damping levels to impede ballscrew rotation at low power requirements.
  • Since each motor is in parallel with each variable damper, both motors can be turned off while still maintaining spring deflection and overall actuator stiffness (Muscle-Like Property 2). The actuator can also dissipate mechanical energy at low power (Muscle-Like Property 2).
  • In the actuator form of FIG. 6, the ballscrew transmissions are backdrivable. Hence, when an external agent compresses or lengthens the actuator, energy can be dissipated using the variable dampers. Since each variable damper is in parallel with each motor, during such a dissipative action, the motors can act as generators to store electrical power for later use. Finally, zero actuator force can be achieved at zero power consumption (Muscle-Like Property 1). If the motors move the ballscrew nuts away from their respective spring element, the actuator will output zero force and no energy is required to maintain that force.
  • Component Implementations
  • Active Element. Depending on the application, each active element could be either a motor or a variable damper/clutch, or a combination of these elements. If the active element includes a variable damper/clutch, it could be implemented using hydraulic, pneumatic, friction, electrorheological, magnetorhelogical, hysteresis brake, or magnetic particle brake damping/clutching strategies. The preferred mechanism for damping control is a hysteresis brake because the zero power damping level is negligible. This feature is important because the variable damper is behind the mechanical transmission where any strain rate dependent, low-end viscous or frictional effect would likely be amplified.
  • If the active element includes a motor, it could be any electric motor, brushed or brushless. It could also be a hydraulic or pneumatic cylinder or other mechanical power-producing elements such as artificial muscle, piezoelectrics or nitinol wire.
  • Spring. The springs could be implemented as linear or torsional spring elements. They may be metal die springs, carbon fiber leaf springs, elastomeric compression springs,or pneumatic springs. For the preferred implementations described in this specification, the springs are die compression springs.
  • Mechanical Transmission. The mechanical transmissions could be implemented as linear or torsional transmission elements. They could be harmonic drives, ballscrew drives, leadscrew drives, or any other mechanical transmission known in the art. For the case where the active element and the series spring are both linear or both rotary elements, and no gear reduction is deemed necessary, the transmission would simply be a material linkage, connecting spring to active element. For example, if the active element is a linear artificial muscle, and the spring a linear, elastomeric element, then the spring would simply be attached directly to the artificial muscle. For the preferred embodiments described in FIGS. 6-10, the mechanical transmissions are ballscrew transmissions.
    TABLE 1
    Mechanical components of the Agonist-Antagonist
    Actuator System
    Component Function
    Spring Store and release energy, absorb shock, provide
    stiffness
    Active Element Control positive and negative work and power,
    control effective spring equilibrium length and
    stiffness, generate electrical power, clutch to
    engage series elasticity
    Mechanical Transmission Couple spring to active element, offer gear
    reduction between active element and output,
    convert rotary active element to linear spring
    element
  • Sensing Implementations
  • For the Agonist-antagonist actuator to function properly, there are various sensors required to measure the state of the various actuator components. The sensors required to enable general actuator operation and control are:
      • 1) Position sensors located at the biomimetic joint axis to measure joint angle (a rotary potentiometer), and at the active element (motor/variable damper/clutch) rotor to measure total displacement of the element's drive shaft and additionally the active element's velocity (a shaft encoder).
      • 2) A force sensor (strain gauges) to measure the actual torque borne by the joint.
      • 3) A displacement sensor on each spring in order to measure the amount of energy stored.
  • Instead of directly measuring the deflection of the series springs (#3), sensory information from #1 can be employed. By subtracting the biomimetic joint angle from the active element output shaft angle, it is possible to calculate the amount of energy stored in the motor series spring. Also, the series spring displacement sensor can be used to measure the torque borne by the joint because joint torque can be calculated from the series spring output force.
  • Many variations exist in the particular sensing methodologies employed in the measurement of the listed parameters. Although preferred sensory methods have been specified, it is noted here that what is critical is to capture the energy state of the spring elements and the velocities of interior points.
  • In the remaining sections, we present embodiments of the agonist-antagonist actuator capable of providing biologically realistic dynamic behaviors for an artificial ankle and knee joint.
  • An Agonist-Antagonist Actuator for an Artificial Ankle Joint
  • Mechanical Design
  • The ankle design comprises flexion and extension motors for the active elements, and corresponding flexion and extension transmissions and springs. The flexion and extension motors provide control of joint spring equilibrium position and stiffness, damping and nonconservative, motive force output. In the section to follow, we provide an example of how the agonist-antagonist actuator could be employed as an artificial ankle.
  • The Agonist-antagonist actuator, as used in an artificial ankle application, is shown in FIGS. 7A and 7B. An upper shin link 701 and a foot link 702 rotate with respect to one another about an ankle joint 705 as best seen in the side view, FIG. 7B. Two actuators extend in parallel alongside the shin link 701. In the actuator seen at the left in FIG. 7A, a plantar flexion motor 711 drives a flexion ballscrew 713 that extends through a linear bearing 715, a plantar flexion spring 717 and a plantar flexion nut 719 to an endcap 720. The flexion motor 711 is attached to a crossrod 723 by a strut 725. The dorsiflexion actuator is seen at the right in FIG. 7A and includes a dorsiflexion motor 731 which is attached at its lower end by a strut 735 to the cross rod 723. A dorsiflexion ballscrew 741 is driven by the dorsiflexion motor and extends upwardly through a dorsflexion nut 743, a dorsiflexion spring 747, and a linear bearing 758 to an endcap 749. The foot link 702 is attached to a leaf spring foot plate seen at 750.
  • The description that follows explains how, during level-ground walking, the joint might be controlled for the swing, controlled plantar flexion (CP), controlled dorsiflexion (CD), and powered plantar flexion (CP) phases of gait. In addition, the description will explain how the joint might be controlled for stair/slope ascent and descent.
  • Level-Ground Walking: Swing Phase and CP
  • During early swing, the plantar flexion ballscrew nut 719 is positioned such that the ankle joint is dorsiflexed to achieve foot clearance. During terminal stance, three distinct control methods can be employed in preparation for heel strike and the CP phase. In human walking, the amount of energy stored during CP increases with increasing walking speed. To achieve this increase in energy with speed, the total angular deflection of the ankle can be increased with increasing speed and/or the quasi-stiffness or the actual stiffness of the ankle can be increased. Thus, in a first control approach, the effective spring equilibrium length of the actuator at heel strike could be increased with increasing walking speed. Here the spring equilibrium position of the joint is equal to the desired heel strike ankle angle. The effect of this control would be that more mechanical energy is stored in the dorsiflexion spring during CP as walking speed increases. In an alternate approach, during terminal swing both dorsi and plantar flexion motors 731 and 711 could do work on their respective series springs in a co-contraction control scheme. If the series springs are hardening springs (stiffness increases with increasing deflection), this co-contraction action would effectively increase the actual stiffness of the actuator, and the ankle joint across which the actuator spans. Still further, in a third approach, the quasi-stiffness of the actuator/joint could be increased or decreased during CP. For the ankle system shown in FIGS. 7A and 7B, the flexion and extension ballscrews are non-backdriveable. Hence, during CP, if the desired ankle stiffness can be achieved simply by compressing the dorsiflexion spring 747, the dorsiflexion motor 731 can be turned off to conserve power. If a lower quasi-joint stiffness is required, the dorsiflexion motor 731 can unwind the dorsiflexion spring 747 during CP, and if a greater quasi-joint stiffness is required, the motor can compress the spring 747 during CP. Depending on the terrain (smooth or uneven), walking speed, and power consumption constraints, the control algorithm of the artificial ankle will select the appropriate ankle spring equilibrium and stiffness values for terminal swing/CP to achieve a smooth heel strike to forefoot strike transition.
  • It is noted here that in the invention described herein, there can be separate series spring stiffnesses for joint dorsi and plantar flexion, and these two sets of springs 717 and 747 can be selected to give distinct flexion and extension joint stiffnesses at little to no power consumption. If the motors change ankle position when minimal torques are applied to the joint, such as during the swing phase of walking, very little electrical power is required to change the spring equilibrium position of the joint. In the embodiment seen in FIGS. 7A and 7B, where the ballscrews 713 and 741 are non-backdriveable, the motors need not consume any electrical power to hold the joint's position even during ground contact. Controlling the joint spring set point at heel strike can be useful, for example, when the wearer switches shoes with different heel heights or when the terrain changes character (slopes/stairs and uneven terrain), thus changing the natural angle of the ankle joint when the foot is resting on a flat ground surface.
  • Level-Ground Walking: CD and CP Phases
  • During early CD in human walking, the ankle torque does not return to point 1 in FIG. 2. Rather, the torque assumes a higher value compared to the torque values from points 1 to 2. To achieve this higher torque output, the plantar flexion motor 711 has to move the plantar flexion nut 719 to reduce the gap between the nut and the plantar flexion spring 717 as the dorsiflexion spring 747 is being compressing during CP. This repositioning of the plantar flexion nut allows the plantar flexion spring to be engaged even before the dorsiflexion spring has released its energy, thus providing a higher torque during early CD than during CP.
  • During mid to terminal CD in human walking, the ankle torque versus angle curve becomes increasingly nonlinear as walking speed increases. In addition, peak ankle power and the net ankle work during stance increases with increasing walking speed (see FIG. 2). Thus, at 0.9 m/sec, when the human ankle, on average, stores as much energy as it releases, the mechanical response of the artificial ankle during CP will, on average, be dictated by the series, plantar flexion spring. That is to say, the stiffness of the plantar flexion spring will be tuned to correspond to the average, quasi-stiffness (slope of the torque-angle curve) of the human ankle during CD. To decrease the quasi- stiffness of the artificial ankle during CP, the plantar flexion motor would be controlled to unwind the plantar flexion spring, and to increase quasi-stiffness, the motor would compress the spring. Thus, as walking speed increases above 0.9m/sec, the plantar flexion motor would compress the plantar flexion spring during CD to achieve the following characteristics 1) to increase the quasi-stiffness of the artificial ankle during CD and 2) to increase the power output and the positive work performed during PP. It is noted here that to achieve a passive, spring response during the stance period of walking, the flexion and extension motors can be turned off to conserve power since the ballscrews are non-backdriveable.
  • From {1 } {2 }, it has been shown that the maximum dorsiflexion ankle torque during level-ground walking is in the range from 1.5 Nm/kg to 2 Nm/kg, i.e. around 150 Nm to 200 Nm for a 1.00 kg person. Further, the maximum controlled plantar flexion torque is relatively small, typically in the range of 0.3 Nm/kg to 0.4 Nm/kg. Because of these biomechanics, a uni-directional spring in parallel with the agonist-antagonist actuator of FIGS. 7A and 7B would lower the peak torque requirements of the actuator. The uni-directional spring would engage at a small or zero dorsiflexion angle (90 degrees between foot and shank) and would lower the peak torque requirements of the Agonist-antagonist actuator since the peak controlled plantar flexion torque is considerably smaller than the peak dorsiflexion torque. Thus, additional elements could be added to the design of FIG. 7 such as a parallel, uni- directional spring.
  • Stair/Slope Ascent and Descent
  • For ascending a stair or slope, the dorsi and plantar flexion motors would move the nuts to reposition the ankle joint to an appropriate angle given the nature of the stair/slope. Once the artificial toe is loaded at first ground contact, the plantar flexion spring compresses and stores energy. During this CD process the plantar flexion motor can compress the spring farther so that additional power is delivered to the walking robot or prosthesis/orthosis user during PP. After toe-off, the motors control the equilibrium position of the ankle in preparation for the next step.
  • During stair descent, the body has to be lowered after forefoot contact until the heel makes contact with the stair tread. See reference {2}. During this CD phase, the plantar flexion motor unwinds the plantar flexion spring as the spring is compressing to effectively dissipate mechanical energy. Once the heel makes contact with the stair tread, the motor can be turned off so that the plantar flexion spring begins to store energy for release during PP. For slope descent, the ankle response is similar, except that mechanical energy is absorbed by the dorsiflexion motor during CP instead of during CD.
  • An Agonist-antagonist actuator for an Artificial Knee Joint
  • The knee design comprises an extension motor and a flexion variable damper for the active elements, and corresponding flexion and extension transmissions and springs. The extension motor and the flexion variable damper provide control of joint spring equilibrium position and stiffness, damping and nonconservative, motive force output. In this implementation of the agonist-antagonist actuator, a flexion motor is not included in an attempt to simplify the mechanism. Since only a flexion variable damper is present, the flexion nut is mechanically grounded to the linear bearing since a flexion motor is not present to actively reposition the flexion nut. Hence, when the knee joint flexes and extends, the flexion ballscrew rotations, but that rotation does not introduce significant zero-power joint resistance because 1) the flexion ballscrew is highly backdriveable and 2) the flexion variable damper has a negligible low-end damping value. A preferred method for the flexion variable damper is a hysteresis brake because of its minimal low-end damping value. In the section to follow, I provide an example of how the agonist-antagonist actuator could be employed as an artificial knee.
  • The agonist-antagonist actuator, as used in an artificial knee application, is shown in FIGS. 8A and 8B. The actuator consists of an upper (thigh) link 801 and a lower (shin) link 803 which are rotatably connected at a joint 805. As seen at the left of the lower link 803, an extension motor 811 drives an extension ballscrew 813 that extends downwardly from the motor 811 through an extension nut 815, an extension spring 817, and a linear bearing 819. An extension nut guidance shaft 825 prevents the extension nut from rotating as the extension ballscrew 813 rotates.
  • The mechanism on the right side of the lower link 803 is passive; that is, it does not include an active motor element but rather includes a flexion variable damper 831 and a flexion spring 833. A flexion ballscrew 841 extends from the damper 831 downwardly through a linear bearing 843, the flexion spring 833 and a flexion nut 847. A flexion nut guidance shaft 851 prevents the flexion nut 847 from rotating as the extension ballscrew 841 rotates.
  • Level-Ground Walking
  • During level-ground walking, the joint is controlled for the swing, early stance flexion, mid-stance extension, and pre-swing phases of gait. In addition, as described below, the joint may be controlled for stair/slope ascent and descent. Beginning at heel strike, the stance knee begins to flex slightly in normal human walking (FIG. 5). As was noted earlier, this flexion period, called the Stance Flexion phase, allows for shock absorption upon impact as well as to keep the body's center of mass at a more constant vertical level throughout the stance period. During this phase, the artificial knee shown in FIGS. 8A and 8B outputs a spring response, storing energy in preparation for the Stance Extension phase. Here the extension spring 817 stores energy, and then that energy is released during the Stance Extension phase. In this implementation of the agonist-antagonist actuator, the extension ballscrew transmission is non-backdriveable. Thus, if the desired actuator stiffness during Stance Flexion corresponds to the extension spring stiffness, the extension motor need not be active, reducing electrical power requirements. If a higher or lower quasi-joint stiffness is desired, the extension motor 811 can compress or unwind the extension spring 813 during early stance knee flexion, respectively, by repositioning the extension nut 815 that acts on the extension spring 817.
  • After maximum flexion is reached in the stance knee in normal human walking, the joint begins to extend, until maximum extension is reached. This knee extension period is called the Stance Extension phase. Throughout the first ˜60% of Stance Extension, the knee acts as a spring, releasing the stored energy in the extension spring from the Stance Flexion phase of gait. This first release of energy corresponds to power output P2 in FIG. 5B. During the last ˜30% of Stance Extension, the artificial knee is controlled to absorb energy in the flexion spring 833 and then that energy is released during the next gait phase, or Pre-Swing. Here the energy from hip muscular work and the remaining stored energy in the extension spring 817 is then stored in the flexion spring 833. To engage the flexion spring, the flexion variable damper 831 outputs a high damping value, locking the flexion ballscrew 841, and forcing the flexion nut 847 to compress the flexion spring 833. During this energy storage, if it is desirable to lower the effective quasi-stiffness of the joint, the flexion variable damper 831 can output lower damping values to allow the flexion ballscrew 841 to slip, and for energy to be dissipated as heat. Here again, as in the artificial ankle joint of FIGS. 7A and 7B, the flexion and extension springs of the agonist antagonist actuator of FIGS. 8A and 8B are precisely tuned such that biological knee mechanics can be achieved while minimizing power supply demands and overall artificial joint mass.
  • During late stance or Pre-Swing, a normal human knee of the supporting leg begins its rapid flexion period in preparation for the swing phase. During early Pre-Swing in the artificial knee joint of FIGS. 8A and 8B, as the knee begins to flex in preparation for toe-off, the stored elastic energy in the flexion spring 833 stored during Stance Extension is released. This second release of energy corresponds to power output P3 in FIG. 5B. During this process, the flexion variable damper 831 can be used to modulate the amount of stored elastic energy in the flexion spring that is actually released to power the knee joint.
  • In normal human walking, as the hip is flexed, and the knee has reached a certain angle in Pre-Swing, the leg leaves the ground and the knee continues to flex. At toe-off, the Swing Flexion phase of gait begins. Throughout this period, human knee power is generally negative where the knee's torque impedes knee rotational velocity. In the artificial knee joint of FIGS. 8A and 8B, once the elastic energy from the flexion spring 833 has been released and the artificial leg has entered the swing phase, the knee joint typically has to absorb mechanical energy to decelerate the swinging lower leg. This can be done in two ways. First, the flexion variable damper 831 can be used to dissipate mechanical energy as heat and to decelerate the swinging artificial leg. In addition, during late Swing Flexion, the extension motor 811 can position the extension ballscrew nut 815 such that the extension spring 817 compresses and stores elastic energy for use during Swing Extension.
  • After reaching a maximum flexion angle during swing, a normal human knee begins to extend forward. For the artificial knee of FIGS. 8A and 8B, during the early Swing Extension period, the elastic energy stored during late Swing Flexion in the extension spring 817 is released, resulting in power output P4 in FIG. 5B. This control action, once again, reduces the energy demands from the knee's power supply. In all cases, the flexion variable damper 831 can be used to precisely modulate the amount of power delivered to the swinging artificial leg from the stored elastic energy.
  • During the remainder of Swing Extension, the human knee typically outputs negative power (absorbing energy) to decelerate the swinging leg in preparation for the next stance period. As with Swing Flexion, this can be done in two ways. First, the flexion variable damper 831 can be used to dissipate mechanical energy as heat and to decelerate the swinging artificial leg. In addition, during late Swing Extension, the flexion variable damper 831 can output a relatively high damping value such that the flexion spring 833 compresses and stores elastic energy for use during Stance Flexion. Here a small amount of energy is stored in preparation for early stance (power P1). After the knee has reached full extension, the foot once again is placed on the ground, and the next walking cycle begins.
  • In summary, the artificial knee shown in FIGS. 8A and 8B is capable of reproducing the positive power contributions P1, P2, P3 and P4 shown in FIG. 5 for level-ground walking.
  • Stair/Slope Ascent and Descent
  • For stair/slope descent, a normal human knee performs negative work during stance where knee torque is in the opposite direction to knee rotational velocity. The agonist-antagonist actuator of FIGS. 8A and 8B can perform this negative work in two ways. First, the flexion variable damper 831 can be used to dissipate mechanical energy as heat and to decelerate the rotating artificial leg. In addition, during terminal stance, the extension motor 811 can position the extension ballscrew nut 815 such that the extension spring 817 compresses and stores elastic energy for use later to power Swing Extension to prepare the artificial leg for the next stance period.
  • For stair/slope ascent, during the swing phase the extension motor 811 can actively control knee position to accurately locate the foot on the next stair tread or slope foothold. Once the artificial foot is securely positioned on the stair tread or ground, the motor 811 can then deflect and store energy in the extension spring 817. This stored elastic energy can then assist the knee wearer or humanoid robot to actively straighten the knee during the stance period, lifting the body upwards.
  • Finally, the agonist-antagonist actuator of FIGS. 8A and 8B allows for the “windup” phase of a catapult style control to occur at any desired time. This means much greater flexibility as to when large amounts of power can be efficiently generated and used. This flexibility is critical when designing an artificial knee that can be used for jumping. For such a movement task, energy has to be stored prior to the jump, and then the elastic energy has to be released at a precise time to facilitate a jumping action. Specifically for the agonist-antagonist actuator of FIGS. 8A and 8B, the flexion variable damper 831 would be controlled to output high damping to effectively lock the flexion ballscrew 841. Following this action, the extension motor 811 would slowly compress the extension spring 817. Once high powers are deemed necessary about the joint output, the flexion variable damper 831 would then be controlled to suddenly unlock to allow rapid rotation of the flexion ballscrew 841 and the release of elastic strain energy from the extension spring 817.
  • Alternative Configurations of the Agonist-Antagonist Actuator
  • It should be understood that the agonist-antagonist actuator described herein could be implemented in a number of different ways. For example, an active element and transmission-spring combination could be positioned on each side of the artificial joint. This configuration, shown in FIG. 9, has the advantage that when only one spring is being compressed, no off-axis bending torques are borne by the lower link seen at 901. The lower link 901 is attached to the upper link 903 at a joint 905. A crossbar strut 907 is rigidly attached to the lower link 901. A linear bearing is attached to each end of the crossbar strut 907 and a ballscrew, one of which is seen at 909, extends through the linear bearing. The ballscrew seen at 909 extends downwardly from a drive motor 911 through a variable damper 913, the linear bearing, a spring 915, and a ballscrew nut 917 to an end cap 919.
  • In the agonist-antagonist actuator implementations shown in FIGS. 6, 7 and 8, when only a single spring is being compressed, the upper and lower links experience a bending torque because the pair of active element- transmission-spring combinations are on the same side of the joint axis. It should also be understood that more than two active element-transmission-spring combinations could be employed to actuate multiple degrees of freedom. For example, in FIG. 10, four active element- transmission-spring combinations are shown to actuate a two degree of freedom joint. Still further, it should be understood that an agonist-antagonist actuation system can include active element-transmission-spring combinations than span two or more joints in a poly-articular architecture. The biomechanics of poly-articular actuation is discussed in the next section.
  • In the arrangement shown in FIG. 10, the joint attaches an upper link 1001 to a lower link 1003 for rotation about two orthogonal axes. As seen in FIG. 10B, the upper link rotates in a first degree of freedom about an axis through the crossbar 1007 that is parallel to the long dimension of a crossbar 1009, and in a second degree of freedom about an axis through the crossbar 1009 that is parallel to the crossbar 1007. Four different actuators are attached from the ends of the crossbars 1007 and 1009 and all four have a like structure illustrated by the actuator at the left in FIG. 10A. An drive motor 1021 attached to the crossbar 1005 rotates a ballscrew 1022 that passes through variable damper 1027 and a linear bearing 1029 attached to the lower link 1003. The ballscrew 1022 further extends through a series spring 1031 and a ballscrew nut 1033 to an endcap 1040. For each degree of freedom, one of the motor-spring-damper mechanisms controls the rotation of the upper link 1001with respect to the lower link 103 in one direction while an opposing motor-spring-camper mechanism attached to other end of the same crossbar controls the rotation in that degree of freedom in the other direction, thus providing agonist-antagonist actuator control in both degrees of freedom.
  • Agonist-Antagonist Actuators Spanning More than One Joint
  • In the foregoing description, the agonist-antagonist actuator mechanism contemplated by the present invention was described and specific examples were provided as to its use in ankle and knee actuation, and different illustrative implementations were described. For each of these implementations, the agonist-antagonist actuator spanned a single joint. In other implementations, an agonist-antagonist actuator may span more than one rotary joint. The functional purpose of poly-articular muscle architectures in the human leg is to promote the transfer of mechanical energy from proximal muscular work to distal joint power generation. See reference {10}. To capture truly biomimetic limb function, both muscle-like actuators and mono, bi, and poly-articular artificial musculoskeletal architectures are critical. Hence, it should be understood that the agonist-antagonist actuator described herein could span more than one artificial joint. For example, an active element-transmission-spring combination could act across the hip and knee of an artificial leg, or across the knee and ankle of an artificial leg.
  • The Biomechanics of Mono and Bi-Articular Leg Actuation
  • In the previous sections, an agonist-antagonist actuator was described and specific examples were provided as to its use in ankle and knee actuation. For each of these descriptions, the actuator was used as a mono-articular device, spanning only a single joint. In subsequent embodiments, we describe how mono-articular actuation strategies can be used in combination with bi-articular actuation strategies to better replicate biological limb dynamics and efficiency.
  • The functional purpose of bi-articular muscle architectures in the human leg is to promote the transfer of mechanical energy from proximal muscular work to distal joint power generation {10}. To better explain how bi-articular actuation effects biological limb energetics, we present a biomechanical model of the human musculoskeletal architecture in FIG. 11A{ 11 }. By modeling the human leg, we seek to understand how leg muscles and tendons work mechanically during walking in order to motivate the design of efficient prosthetic, orthotic, and robotic limbs.
  • We hypothesize that a robotic leg comprising only knee and ankle variable-impedance elements, including springs, clutches and variable-damping components, can capture the dominant mechanical behavior of the human knee and ankle for level-ground ambulation. As a preliminary evaluation of this hypothesis, we put forth a simple leg prosthesis model, shown in FIG. 11A, that is motivated by the human leg musculoskeletal architecture {11}. The model seen in FIG. 11 includes a drive motor 1101 at the hip, a knee joint 1103 and an ankle joint 1105. A musculo-skeletal model of human leg function in walking. The model comprises seven mono-articular series-elastic clutches and four bi-articular series-elastic clutches/variable-dampers. Only a single actuator 1101 acts at the model's hip joint. In (B) and (C), model predictions for ankle and knee are compared with human gait data, respectively. Here gait data are shown for a 70 kg study participant with a 0.9 meter leg length and a walking speed of 1.2 m/s. The model of (A) agrees well with the human gait data, suggesting that muscles that span the ankle and knee primarily act as variable-impedance devices during level-ground walking. We vary quasi-passive model parameters, or spring constants, damping levels and times when series-elastic clutches are engaged, using an optimization scheme where errors between model joint behaviors and normal human joint biomechanics are minimized.
  • The capacity of the musculoskeletal leg model to capture human-like ankle and knee mechanics in level-ground walking is shown in FIGS. 11B and 11C, respectively. At each joint state (position and velocity), the leg model is in good agreement with experimental values of joint torque and power, suggesting that a robotic leg can produce human-like walking dynamics through the control of only knee and ankle impedance.
  • Mono-articular ankle mechanism. The ankle mechanism comprises mono-articular dorsi and plantar flexion springs that can be engaged or disengaged with series elastic clutch mechanisms (see FIG. 11A). In FIG. 12A, the mechanical power for each ankle component is plotted versus percent gait cycle. At heel strike (0% cycle), the clutch for the ankle dorsiflexion spring is engaged, causing the spring to stretch and store energy during early stance plantar flexion. When the tibia begins rotating forwardly after forefoot contact, the ankle plantar flexion spring is engaged and continues to store energy throughout the controlled dorsiflexion phase, and then that stored energy is released to contribute to ankle powered plantar flexion at terminal stance. Mechanical power output for each component of the human leg model of FIG. 11A. In (A), (B) and (C), the mechanical power of each model element is plotted versus percentage gait cycle for ankle, knee and hip, respectively. Here the gait cycle begins at heel strike (0%) and ends with the heel strike of the same leg (100%).
  • Mono-articular knee mechanism. The knee mechanism comprises mono-articular flexion and extension springs that can be engaged or disengaged with series elastic clutch mechanisms (see FIG. 11A). In FIG. 12B, the mechanical power for each knee mono-articular component is plotted versus percent gait cycle. At heel strike (0% cycle), the clutch for the knee extensor spring is engaged, causing the spring to stretch during early stance knee flexion. Here the knee extensor spring inhibits the knee from buckling. As the knee extends from a flexed posture, the knee flexor spring is engaged at the point of maximum knee extension velocity, storing energy that is subsequently used during terminal stance to help lift the lower leg from the ground surface.
  • Ankle-Knee Bi-Articular Mechanism. The leg model's ankle-knee bi-articular mechanism comprises a spring that can be engaged or disengaged with two clutch mechanisms (see FIG. 11A). A first clutch, or the distal clutch, attaches the series spring to a point between the ankle and knee joint, and a second clutch, or the proximal clutch, attaches that same spring to a point above the knee axis. After heel strike in human walking, the knee typically undergoes a flexion period. During that phase of gait, both the proximal and distal clutches are disengaged, and the bi-articular spring does not apply a force to the prosthesis skeleton. However, as the knee begins to extend (˜10% cycle), the proximal clutch engages, and the bi-articular spring stretches. When the knee is fully extended, the distal clutch changes from a disengaged state to an engaged state, and the proximal clutch disengages. Engaging the distal clutch mechanically grounds the bi-articular spring below the knee rotational axis, changing the ankle-knee mechanism from a bi-articular to a mono-articular device. As a consequence of this action, all the energy stored in the bi-articular spring is used to power ankle plantar flexion during terminal stance. Thus in summary, the ankle-knee mechanism allows energy from hip muscular/actuator work to be transferred to the ankle for late stance powered plantar flexion.
  • Knee-Hip Bi-Articular Mechanism. The leg model's knee-hip bi-articular mechanisms comprise a spring that can be engaged or disengaged with either a clutch or variable-damper mechanism (see FIG. 11A). There are three knee-hip bi-articular mechanisms. The clutch of the knee-hip flexor is engaged during swing phase knee extension and begins storing energy its series spring. As a result of this control action, the lower leg is decelerated smoothly prior to reaching full knee extension. In addition, elastic energy is stored in the knee-hip flexor spring that is later released during the early stance period. The knee-hip flexor also undergoes an energy storage/release sequence that begins during stance knee extension. The stored energy is then released to power rapid knee flexion movements at terminal stance to lift the foot and lower leg from the ground surface. The clutch of the knee-hip extensor is engaged during terminal stance, storing energy that is later released to enhance knee extension. Finally, the iliotibial tract series-elastic variable-damper applies an extensor knee torque to offset the knee flexor torque applied by the ankle-knee bi-articular mechanism. During stance knee extension, the ankle-knee bi-articular spring is elongated, exerting a torque about the knee. At the same time the iliotibial tract series spring is elongated thereby applying an extensor torque at the knee. Thus, through the action of the iliotibial tract mechanism, the effect of the ankle-knee bi-articular mechanism on net knee torque is minimized.
  • In the human leg, the functional purpose of bi-articular muscle is to promote the transfer of mechanical energy from proximal muscular work to distal joint power generation {10}. Using the biomimetic architecture shown in FIG. 11A, the robotic leg can achieve ankle powered plantar flexion without the requirement of powering a large motor located at the ankle joint. Approximately ten joules of net work are transferred to the ankle from the knee and hip in the modeling results shown in FIGS. 11 and 12.
  • In subsequent embodiments, we motivate the design of prosthetic, orthotic and robotic leg structures using the leg model of FIG. 11.
  • Mono and Bi-Articular Actuation for a Transtibial Prosthetic Leg System
  • The prosthetic leg model of FIG. 11A suggests that leg prostheses could produce human-like joint mechanics during level-ground ambulation if a musculoskeletal leg architecture and a variable-impedance control paradigm were exploited. However, the proposed biomimetic leg prosthesis does not eliminate the need for knee and ankle actuators, but the model does suggest that nonconservative joint actuator work need not be performed during normal, steady state walking. For some situations, positive joint actuator work is required. For example, for uphill locomotory function, some positive actuator work would be necessary, especially at the knee. Furthermore, ankle and knee torque control would be necessary to reject large whole-body force disturbances that threaten balance. Although joint actuation is still necessary, the proposed biomimetic design will increase the time between battery recharges or power supply refueling, and will reduce robotic limb noise production during level-ground walking.
  • In FIG. 13, the design of the proposed transtibial ankle-foot system with mono and bi-articular mechanisms is shown. In FIG. 13A, the major components of the transtibial system are shown, including the mono-articular ankle mechanism at 1303, the bi-articular ankle-knee mechanism at 1305, and a flexible nylon cord at 1307. FIG. 13B shows the monoarticular ankle mechanism in more detail. This mechanism comprising two motors 1313, mechanical transmissions and series dorsiflexion springs at 1317, and series plantar flexion springs at 1319. FIG. 13C shows the bi-articular mechanism (1305 in FIG. 13A) and FIG. 13D shows a schematic of the bi-articular mechanism, including two uni-directional clutches seen at 1321 and 1351 and a series spring at 1324. The limb architecture largely reflects the leg model shown in FIG. 11A, except the mono-articular knee mechanism has been excluded as this basic musculoskeletal structure is still intact in transtibial amputees.
  • The ankle mechanism 1305 seen in FIG. 13B comprises two agonist-antagonist, series-elastic actuators acting across the ankle joint. The foot-ankle design is similar to that described earlier in FIG. 7. Each actuator has a small electric motor 1313 in series with one of the die springs 1317 or 1319. Each series spring is a nonlinear hardening spring where spring stiffness increases with increasing spring compression. A non-backdriveable leadscrew 1331 is employed to covert rotary motor movement into linear movement of a leadscrew nut 1332. A slider mechanism is seen at 1334 and a guide rod at 1335. By re-positioning the leadscrew nut 1332, each motor 1313 can independently vary the position of the ankle joint at which the series spring 1317 or 1319 becomes engaged. Such an ankle spring equilibrium control is important for many prosthesis functions, including slope and stair ascent and descent. The mono-articular ankle mechanism can also change ankle spring stiffness. During the swing phase each motor can simultaneously compress each nonlinear spring using a co-contraction control. Since spring stiffness increases with increasing deflection, the more the motor system compresses the springs, the stiffer the ankle joint becomes. Since the mechanical transmission is non-backdriveable, once a desired ankle stiffness has been achieved, the motors can be turned off to save electrical power. The foot-ankle design is similar to that described earlier in FIG. 7.
  • In FIGS. 13C and 13D, the bi-articular ankle-knee mechanism and schematic are shown, respectively. The mechanism comprises two uni-directional clutches seen at 1351 and 1321 and a spring at 1324. Each clutch is formed by two opposing cams (see 1353) that press against a shaft that directly connects to the spring. At the bottom of FIG. 13C, a foot assembly is seen at 1327 and the ankle axis is at 1328. The ankle joint connection is seen at 1329. In an engaged state, the cam configuration only allows for shaft movement in one direction. As can be seen in FIG. 13D, if both uni-directional clutches A and B are in the disengaged state, with each cam pair rotated outwardly with a small cam motor, the ankle and knee can freely rotate without the bi-articular spring exerting a force. When the ankle dorsi and plantar flexes in this disengaged state, the lower floating cam-clutch assembly 1321 translates on the linear guide rail 1367. Furthermore, when the knee flexes and extends, the entire spring assembly translates on the linear guide rail 1367. In distinction, when both clutches are in their engaged state, both ankle dorsiflexion and knee extension cause the bi-articular spring 1324 to stretch and store energy. Since the flexible nylon cord 1307 can resist tension but not compression, once the knee has reached full extension during the stance phase, knee flexion throughout terminal stance is not restricted by the bi-articular assembly, and all the stored energy in the bi-articular spring augments ankle powered plantar flexion.
  • Sensors for Active Ankle-Foot Prosthesis
  • For the active transtibial prosthesis to function properly, there are various sensors required to measure the state of the various system components and the intent of the amputee user. The additional sensors required to enable general prosthesis operation and control are:
      • 4) position sensors located at the knee and ankle axes to measure joint angles (rotary potentiometers), and on each motor shaft to measure total displacement and velocity of each motor (a shaft encoder);
      • 5) an inertial measurement unit (IMU) to determine the absolute position of the prosthesis in space;
      • 6) a displacement sensor on each spring in order to measure the amount of force borne by a spring and the torque borne by the ankle joint; and
      • 7) electromyographic (EMG) sensors to determine residual limb muscle activity.
  • Series spring displacement sensors can be used to determine the torque borne by the ankle joint because joint torque can be calculated from the agonist-antagonist spring output forces.
  • Control for Active Ankle-Foot Prosthesis
  • Local Prosthesis Control. A critical advantage of the human-like musculoskeletal prosthesis is that it allows the amputee user to directly control ankle powered plantar flexion. Because of the bi-articular ankle-knee mechanism, the extent of midstance knee extension defines how much energy is transferred to the prosthetic ankle for powering ankle plantar flexion at terminal stance. Since transtibial amputees generally have direct control over their knee, the biomimetic transtibial prosthesis allows for direct control over ankle power output.
  • The point in the gait cycle where the prosthesis series spring elements are engaged will largely be defined by joint state (position and velocity) and foot-ground interaction forces. The spring equilibrium angle for the ankle mono-articular mechanism will be equal to the ankle angle at first heel strike. Here heel strike will be detected using ankle torque sensing. For level ground ambulation, the heel strike ankle angle will be kept largely invariant with walking speed, but will be modulated from step to step for slope and stair ambulation.
  • The uni-directional clutch devices in the bi-articular mechanism will be controlled in a speed invariant manner. After heel strike in walking, the knee typically undergoes a flexion period. During that phase of gait, both bi-articular clutches will be disengaged, and therefore the bi-articular spring will not apply a force to the prosthesis skeleton. However, as the knee begins to extend (˜10% cycle), both clutches will be engaged, causing the bi-articular spring to stretch. Once the prosthesis enters the swing phase as detected by zero ankle torque, the bi-articular clutches will be disengaged so as to allow unrestricted knee and ankle movement throughout the swing phase.
  • Electromyographic (EMG) Control of Prosthetic Ankle Stiffness. The residual anatomy will allow amputees to voluntarily control joint stiffness via activation of the muscles in the residual limb. When walking on a rigid ground surface, the amputee user can select a low ankle stiffness, whereas when walking on a compliant terrain, the amputee can exploit a relatively high ankle stiffness.
  • Within the human body, such voluntary changes in joint stiffness are modulated by muscular co-activation. When antagonist muscles are simultaneously recruited, the net torque produced about the joint is related to the difference between the forces generated by the activated muscles, while the joint stiffness is related to their sum. Thus, activity from residual muscles is a natural control source for specifying the desired level of ankle stiffness. Since EMG provides a measure of muscular effort, it can be used in a “natural” manner to control stiffness of a joint. For a transtibial amputee, the muscles of the anterior and posterior compartment of the leg form the natural location from which to derive stiffness control signals.
  • A joint stiffness control signal is derived from the sum of the plantar flexion and dorsiflexion EMG amplitudes. The stiffness control signal will be related to stiffness via a straight line relationship with a zero-level control signal signifying the minimum available stiffness level and the maximum-level control signal signifying the maximum available stiffness level. Thus, limited muscle effort results in a low ankle stiffness while high muscular effort results in a high ankle stiffness. Using this control strategy, stiffness can be volitionally controlled by the amputee in a natural manner.
  • Although the device of FIGS. 13A-13D was described as a transtibial prosthesis, the mechanism could also be used as an orthosis or exoskeleton. The mechanism would be useful as an orthosis for an individual that suffers from an ankle pathology but generally has normal knee and hip function. For such an application, the mechanism would be placed in parallel with the human leg to augment ankle mechanics as a permanent assistive device.
  • Mono and Bi-articular actuation for an Artificial Ankle and Knee System
  • Description
  • A proposed artificial ankle and knee system is shown in FIG. 14. The mechanism could be employed for a transfemoral prosthesis, orthosis, leg exoskeleton, or robotic leg. The mono-articular ankle-foot and knee designs are identical to the structures described in FIG. 13B and FIG. 8, respectively. However, the ankle-knee bi-articular mechanism is different from that proposed in FIGS. 13C and 13D. The bi-articular device of FIG. 13 has to be attached above the knee axis. In distinction, the bi-articular device of FIGS. 14A-14D attaches adjacent to the knee axis.
  • The bi-articular ankle-knee mechanism of FIGS. 14A-14D comprises a motor 1411, non-backdriveable mechanical transmission 1413, screw nut 1414, series spring 1417, a knee bi-articular connection 1421, an ankle bi-articular connection 1431, and a knee variable moment arm (VMA) device 1441 (seen in more detail in FIG. 14D).
  • During level-ground walking, we describe how the ankle-knee bi-articular mechanism would be controlled for the swing, early stance flexion, mid-stance extension, and pre-swing phases of gait.
  • During the swing phase and early stance knee flexion, the screw nut 1414 is moved away from the series spring 1417 so that ankle and knee joint movements do not cause the spring to compress. However, when stance knee extension begins (18% gait cycle), the lead screw nut 1414 is moved by the motor 1411 until it engages the series spring 1417. As a consequence of this control action, both knee extension and ankle dorsiflexion contributes to spring compression. Once the knee has reached full extension, the VMA device 1441 then minimizes the moment arm that the knee bi-articular connection makes with the knee axis of rotation. Because the knee moment arm is minimized, most of the strain energy stored in the bi-articular spring contributes to ankle powered plantar flexion at terminal stance. Generally, the knee moment arm 1441 can be controlled to effectively modulate the amount of energy release that occurs through the knee joint.
  • The VMA device comprises a small motor 1451 plus gear train 1455, non-backdriveable lead screw 1459, lead screw nut 1461, and variable moment arm pin 1466. A shin tube mount is seen at 1457. When the motor 1451 rotates, the lead screw nut 1461 moves the variable moment arm pin 1466 across the variable moment arm slot 1471. The pin is attached to the knee bi-articular connection. Thus, the VMA motor can actively control the perpendicular distance, or moment arm, between the knee bi-articular connection and the knee axis.
  • SUMMARY
  • Several agonist-antagonist actuator variations comprising a plurality of active element transmission-spring combinations acting in parallel have described. These actuator embodiments combine active and passive elements in order to achieve high performance with minimal mass. In addition, the use of agonist-antagonist actuators as mono and poly-articular linear elements has been described. The combination of biologically-inspired musculoskeletal architectures and agonist-antagonist actuation strategies as described above provide novel, low mass, efficient and quiet biomimetic artificial limbs. These artificial limb structures may be used to advantage to provide improved orthotic and prosthetic devices and legged robotic mechanisms.
  • CONCLUSION
  • It is to be understood that the methods and apparatus which have been described above are merely illustrative applications of the principles of the invention. Numerous modifications may be made by those skilled in the art without departing from the true spirit and scope of the invention.

Claims (1)

1. An artificial limb comprising, in combination,
first and second members connected for movement relative to one another at a joint,
a flexion actuator connected between said first and second members, said extendable flexion actuator comprising the series combination of a first motor and a first elastic element drawing said first and second members together to reduce the angle between said first and second members at said joint,
a extension actuator connected between said first and second members, said extension actuator comprising the series combination of a second motor and a second elastic for urging said first and second members apart to increase the angle between said first and second members at said joint, and
a controller for independently energizing said first motor and said second motor at different times to control the movement of said artificial limb.
US11/642,993 2005-03-31 2006-12-19 Artificial joints using agonist-antagonist actuators Abandoned US20070162152A1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
US11/642,993 US20070162152A1 (en) 2005-03-31 2006-12-19 Artificial joints using agonist-antagonist actuators
US12/157,727 US8512415B2 (en) 2005-03-31 2008-06-12 Powered ankle-foot prothesis
US12/608,627 US8870967B2 (en) 2005-03-31 2009-10-29 Artificial joints using agonist-antagonist actuators
US12/697,894 US8500823B2 (en) 2005-03-31 2010-02-01 Powered artificial knee with agonist-antagonist actuation
US12/698,128 US8864846B2 (en) 2005-03-31 2010-02-01 Model-based neuromechanical controller for a robotic leg
US13/959,495 US9149370B2 (en) 2005-03-31 2013-08-05 Powered artificial knee with agonist-antagonist actuation
US13/970,094 US10137011B2 (en) 2005-03-31 2013-08-19 Powered ankle-foot prosthesis
US14/520,091 US9539117B2 (en) 2005-03-31 2014-10-21 Method for controlling a robotic limb joint
US15/342,661 US10307272B2 (en) 2005-03-31 2016-11-03 Method for using a model-based controller for a robotic leg
US16/182,298 US11278433B2 (en) 2005-03-31 2018-11-06 Powered ankle-foot prosthesis
US16/427,646 US11491032B2 (en) 2005-03-31 2019-05-31 Artificial joints using agonist-antagonist actuators

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US66687605P 2005-03-31 2005-03-31
US70451705P 2005-08-01 2005-08-01
US70565105P 2005-08-04 2005-08-04
US73692905P 2005-11-15 2005-11-15
US75168005P 2005-12-19 2005-12-19
US11/395,448 US20060249315A1 (en) 2005-03-31 2006-03-31 Artificial human limbs and joints employing actuators, springs, and variable-damper elements
US11/495,140 US20070043449A1 (en) 2005-03-31 2006-07-29 Artificial ankle-foot system with spring, variable-damping, and series-elastic actuator components
US11/499,853 US7313463B2 (en) 2005-03-31 2006-08-04 Biomimetic motion and balance controllers for use in prosthetics, orthotics and robotics
US11/600,291 US20070123997A1 (en) 2005-03-31 2006-11-15 Exoskeletons for running and walking
US11/642,993 US20070162152A1 (en) 2005-03-31 2006-12-19 Artificial joints using agonist-antagonist actuators

Related Parent Applications (5)

Application Number Title Priority Date Filing Date
US11/395,448 Continuation-In-Part US20060249315A1 (en) 2005-03-31 2006-03-31 Artificial human limbs and joints employing actuators, springs, and variable-damper elements
US11/495,140 Continuation-In-Part US20070043449A1 (en) 2005-03-31 2006-07-29 Artificial ankle-foot system with spring, variable-damping, and series-elastic actuator components
US11/499,853 Continuation-In-Part US7313463B2 (en) 2005-03-31 2006-08-04 Biomimetic motion and balance controllers for use in prosthetics, orthotics and robotics
US11/600,291 Continuation-In-Part US20070123997A1 (en) 2005-03-31 2006-11-15 Exoskeletons for running and walking
US12/608,627 Continuation-In-Part US8870967B2 (en) 2005-03-31 2009-10-29 Artificial joints using agonist-antagonist actuators

Related Child Applications (5)

Application Number Title Priority Date Filing Date
US11/395,448 Continuation-In-Part US20060249315A1 (en) 2005-03-31 2006-03-31 Artificial human limbs and joints employing actuators, springs, and variable-damper elements
US11/495,140 Continuation-In-Part US20070043449A1 (en) 2005-03-31 2006-07-29 Artificial ankle-foot system with spring, variable-damping, and series-elastic actuator components
US12/157,727 Continuation-In-Part US8512415B2 (en) 2005-03-31 2008-06-12 Powered ankle-foot prothesis
US12/608,627 Continuation US8870967B2 (en) 2005-03-31 2009-10-29 Artificial joints using agonist-antagonist actuators
US12/698,128 Continuation-In-Part US8864846B2 (en) 2005-03-31 2010-02-01 Model-based neuromechanical controller for a robotic leg

Publications (1)

Publication Number Publication Date
US20070162152A1 true US20070162152A1 (en) 2007-07-12

Family

ID=46326877

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/642,993 Abandoned US20070162152A1 (en) 2005-03-31 2006-12-19 Artificial joints using agonist-antagonist actuators
US12/608,627 Active US8870967B2 (en) 2005-03-31 2009-10-29 Artificial joints using agonist-antagonist actuators

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/608,627 Active US8870967B2 (en) 2005-03-31 2009-10-29 Artificial joints using agonist-antagonist actuators

Country Status (1)

Country Link
US (2) US20070162152A1 (en)

Cited By (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040181289A1 (en) * 2002-08-22 2004-09-16 Stephane Bedard Actuated prosthesis for amputees
US20050107889A1 (en) * 2003-11-18 2005-05-19 Stephane Bedard Instrumented prosthetic foot
US20060122711A1 (en) * 2002-08-22 2006-06-08 Stephane Bedard Actuated leg prosthesis for above-knee amputees
US20060224246A1 (en) * 2004-02-12 2006-10-05 Clausen Arinbjorn V Systems and methods for adjusting the angle of a prosthetic ankle based on a measured surface angle
US20070050045A1 (en) * 2005-09-01 2007-03-01 Clausen Arinbjorn V Sensing system and method for motion-controlled foot unit
US20070056592A1 (en) * 2005-04-13 2007-03-15 The Regents Of University Of California Semi-powered lower extremity exoskeleton
US20070155557A1 (en) * 2005-12-30 2007-07-05 Horst Robert W Deflector assembly
US20070233279A1 (en) * 2006-03-09 2007-10-04 The Regents Of The University Of California Power generating leg
US20070257490A1 (en) * 2006-05-05 2007-11-08 Sri International Wave powered generation using electroactive polymers
US20070257491A1 (en) * 2006-05-05 2007-11-08 Sri International Wave powered generation
US20090204038A1 (en) * 2008-02-08 2009-08-13 Tibion Corporation Multi-fit orthotic and mobility assistance apparatus
WO2009120637A1 (en) * 2008-03-24 2009-10-01 Ossur Hf Transfemoral prosthetic systems and methods for operating the same
US20090299480A1 (en) * 2007-01-05 2009-12-03 Victhom Human Bionics Inc. Joint Actuation Mechanism for a Prosthetic and/or Orthotic Device Having a Compliant Transmission
US20090306548A1 (en) * 2008-06-05 2009-12-10 Bhugra Kern S Therapeutic method and device for rehabilitation
WO2010019917A1 (en) * 2008-08-14 2010-02-18 Tibion Corporation Actuator system with a multi-motor assembly for extending and flexing a joint
WO2010025403A1 (en) * 2008-08-28 2010-03-04 Raytheon Sarcos, Llc Control logic for biomimetic joint actuators
US20100160844A1 (en) * 2007-01-05 2010-06-24 Benoit Gilbert High Torque Active Mechanism for Orthotic and/or Prosthetic Devices
US20100174384A1 (en) * 2008-09-04 2010-07-08 Iwalk, Inc. Hybrid terrain-adaptive lower-extremity systems
WO2010088616A1 (en) * 2009-01-30 2010-08-05 Massachusetts Institute Of Technology Powered artificial knee with agonist-antagonist actuation
US7811333B2 (en) 2004-12-22 2010-10-12 Ossur Hf Systems and methods for processing limb motion
US7815689B2 (en) 2003-11-18 2010-10-19 Victhom Human Bionics Inc. Instrumented prosthetic foot
US20110098606A1 (en) * 2005-02-02 2011-04-28 Ossur Hf Sensing systems and methods for monitoring gait dynamics
US20110105966A1 (en) * 2008-07-23 2011-05-05 Berkeley Bionics Exoskeleton and Method for Controlling a Swing Leg of the Exoskeleton
US7949429B2 (en) * 2007-12-27 2011-05-24 Murata Manufacturing Co., Ltd. Plural actuator system and control method thereof
US20110213599A1 (en) * 2008-08-28 2011-09-01 Raytheon Company Method of Sizing Actuators for a Biomimetic Mechanical Joint
US20110214524A1 (en) * 2008-08-28 2011-09-08 Raytheon Company Biomimetic Mechanical Joint
US8048172B2 (en) 2005-09-01 2011-11-01 össur hf Actuator assembly for prosthetic or orthotic joint
US8048007B2 (en) 2005-02-02 2011-11-01 össur hf Prosthetic and orthotic systems usable for rehabilitation
FR2968538A1 (en) * 2010-12-09 2012-06-15 Pierre Chabloz PROSTHETIC FOR LOWER MEMBER
US20120153875A1 (en) * 2009-06-22 2012-06-21 Brian Glaister Controllable transverse rotation adaptor
US20120165983A1 (en) * 2010-12-22 2012-06-28 Samsung Electronics Co., Ltd. Walking robot and control method thereof
WO2012125562A1 (en) * 2011-03-11 2012-09-20 Iwalk, Inc. Biomimetic joint actuators
US8274244B2 (en) 2008-08-14 2012-09-25 Tibion Corporation Actuator system and method for extending a joint
US8287477B1 (en) 2003-09-25 2012-10-16 Massachusetts Institute Of Technology Active ankle foot orthosis
US8353854B2 (en) 2007-02-14 2013-01-15 Tibion Corporation Method and devices for moving a body joint
US20130054021A1 (en) * 2011-08-26 2013-02-28 Disney Enterprises, Inc. Robotic controller that realizes human-like responses to unexpected disturbances
US8500823B2 (en) 2005-03-31 2013-08-06 Massachusetts Institute Of Technology Powered artificial knee with agonist-antagonist actuation
US8512415B2 (en) 2005-03-31 2013-08-20 Massachusetts Institute Of Technology Powered ankle-foot prothesis
US8551184B1 (en) 2002-07-15 2013-10-08 Iwalk, Inc. Variable mechanical-impedance artificial legs
WO2013157965A1 (en) * 2012-04-19 2013-10-24 CONTUR 2000 s. c. Active prosthetic shin
US8617254B2 (en) 2004-03-10 2013-12-31 Ossur Hf Control system and method for a prosthetic knee
US8639455B2 (en) 2009-02-09 2014-01-28 Alterg, Inc. Foot pad device and method of obtaining weight data
US8702811B2 (en) 2005-09-01 2014-04-22 össur hf System and method for determining terrain transitions
US8734528B2 (en) 2005-03-31 2014-05-27 Massachusetts Institute Of Technology Artificial ankle-foot system with spring, variable-damping, and series-elastic actuator components
US8801802B2 (en) 2005-02-16 2014-08-12 össur hf System and method for data communication with a mechatronic device
US8814949B2 (en) 2005-04-19 2014-08-26 össur hf Combined active and passive leg prosthesis system and a method for performing a movement with such a system
US20140276304A1 (en) * 2013-03-14 2014-09-18 Yale University Friction-Based Orthotic Impedence Modulation Device
US8864846B2 (en) 2005-03-31 2014-10-21 Massachusetts Institute Of Technology Model-based neuromechanical controller for a robotic leg
US8870967B2 (en) 2005-03-31 2014-10-28 Massachusetts Institute Of Technology Artificial joints using agonist-antagonist actuators
US20140330393A1 (en) * 2013-05-03 2014-11-06 Springactive, Inc. Quasi-Active Prosthetic Joint System
US8915968B2 (en) 2010-09-29 2014-12-23 össur hf Prosthetic and orthotic devices and methods and systems for controlling the same
US20150089455A1 (en) * 2013-09-26 2015-03-26 Fujitsu Limited Gesture input method
US9017419B1 (en) 2012-03-09 2015-04-28 össur hf Linear actuator
US9032635B2 (en) 2011-12-15 2015-05-19 Massachusetts Institute Of Technology Physiological measurement device or wearable device interface simulator and method of use
US9060884B2 (en) 2011-05-03 2015-06-23 Victhom Human Bionics Inc. Impedance simulating motion controller for orthotic and prosthetic applications
US20150297365A1 (en) * 2014-04-17 2015-10-22 Worcester Polytechnic Institute Flexible prosthetic appliance
US9221177B2 (en) 2012-04-18 2015-12-29 Massachusetts Institute Of Technology Neuromuscular model-based sensing and control paradigm for a robotic leg
US9333097B2 (en) 2005-03-31 2016-05-10 Massachusetts Institute Of Technology Artificial human limbs and joints employing actuators, springs, and variable-damper elements
US9351855B2 (en) 2008-06-16 2016-05-31 Ekso Bionics, Inc. Powered lower extremity orthotic and method of operation
US20160151921A1 (en) * 2013-07-02 2016-06-02 Fondazione Istituto Italiano Di Technologia Improved agonist - antagonist actuated joint
US20160374834A1 (en) * 2013-07-03 2016-12-29 Otto Bock Healthcare Gmbh Orthopedic joint device and method for controlling same
US9561118B2 (en) 2013-02-26 2017-02-07 össur hf Prosthetic foot with enhanced stability and elastic energy return
CN106457566A (en) * 2014-07-22 2017-02-22 谷歌公司 Hybrid hydraulic and electrically actuated mobile robot
US20170056275A1 (en) * 2015-08-31 2017-03-02 Korea Institute Of Science And Technology Recognition method of human walking speed intention from surface electromyogram signals of plantar flexor and walking speed control method of a lower-limb exoskeleton robot
US9610208B2 (en) 2008-05-20 2017-04-04 Ekso Bionics, Inc. Device and method for decreasing energy consumption of a person by use of a lower extremity exoskeleton
WO2017091456A1 (en) * 2015-11-24 2017-06-01 Greenville Health System Dynamic linear adjustable prosthetic
US9687377B2 (en) 2011-01-21 2017-06-27 Bionx Medical Technologies, Inc. Terrain adaptive powered joint orthosis
US9693883B2 (en) 2010-04-05 2017-07-04 Bionx Medical Technologies, Inc. Controlling power in a prosthesis or orthosis based on predicted walking speed or surrogate for same
US9707104B2 (en) 2013-03-14 2017-07-18 össur hf Prosthetic ankle and method of controlling same based on adaptation to speed
US9731416B1 (en) * 2015-03-11 2017-08-15 Google Inc. Legged robot passive fluid-based ankles with spring centering
US9737419B2 (en) 2011-11-02 2017-08-22 Bionx Medical Technologies, Inc. Biomimetic transfemoral prosthesis
WO2017180970A1 (en) * 2016-04-14 2017-10-19 Marquette University Passive ankle prosthesis with energy return
US9808357B2 (en) 2007-01-19 2017-11-07 Victhom Laboratory Inc. Reactive layer control system for prosthetic and orthotic devices
US9839552B2 (en) 2011-01-10 2017-12-12 Bionx Medical Technologies, Inc. Powered joint orthosis
CN107468387A (en) * 2017-09-13 2017-12-15 上海理工大学 A kind of artificial limb knee-joint test equipment
US9878751B1 (en) * 2015-10-08 2018-01-30 Boston Dynamics, Inc. Three-piston ankle mechanism of a legged robot and associated control system
US9889058B2 (en) 2013-03-15 2018-02-13 Alterg, Inc. Orthotic device drive system and method
US9895240B2 (en) 2012-03-29 2018-02-20 Ösur hf Powered prosthetic hip joint
US9949850B2 (en) 2015-09-18 2018-04-24 Össur Iceland Ehf Magnetic locking mechanism for prosthetic or orthotic joints
US20180228684A1 (en) * 2017-02-16 2018-08-16 Samsung Electronics Co., Ltd. Motion assistance apparatus
US10080672B2 (en) 2005-03-31 2018-09-25 Bionx Medical Technologies, Inc. Hybrid terrain-adaptive lower-extremity systems
US10189519B2 (en) * 2015-05-29 2019-01-29 Oregon State University Leg configuration for spring-mass legged locomotion
US10285828B2 (en) 2008-09-04 2019-05-14 Bionx Medical Technologies, Inc. Implementing a stand-up sequence using a lower-extremity prosthesis or orthosis
US10307272B2 (en) 2005-03-31 2019-06-04 Massachusetts Institute Of Technology Method for using a model-based controller for a robotic leg
US10390974B2 (en) 2014-04-11 2019-08-27 össur hf. Prosthetic foot with removable flexible members
US10485681B2 (en) 2005-03-31 2019-11-26 Massachusetts Institute Of Technology Exoskeletons for running and walking
US10531965B2 (en) 2012-06-12 2020-01-14 Bionx Medical Technologies, Inc. Prosthetic, orthotic or exoskeleton device
US10537449B2 (en) 2011-01-12 2020-01-21 Bionx Medical Technologies, Inc. Controlling powered human augmentation devices
US10537987B2 (en) 2009-07-01 2020-01-21 Rex Bionics Limited Control system for a mobility aid
US10543109B2 (en) 2011-11-11 2020-01-28 Össur Iceland Ehf Prosthetic device and method with compliant linking member and actuating linking member
US10575970B2 (en) 2011-11-11 2020-03-03 Össur Iceland Ehf Robotic device and method of using a parallel mechanism
US20200069441A1 (en) * 2017-05-12 2020-03-05 Exonetik Inc. Exoskeleton, orthosis, wearable device or mobile robots using magnetorheological fluid clutch apparatus
US20200206899A1 (en) * 2018-03-22 2020-07-02 HAWE Altenstadt Holding GmbH Human exoskeleton
US10786371B2 (en) * 2012-06-21 2020-09-29 Scuola Superiore Di Studi Universitari E Di Perfezionamento Sant'anna Technological aid for transfemoral amputees
US10918558B2 (en) 2013-08-10 2021-02-16 Imobilities Incorporated Portable human exoskeleton system
US11045154B2 (en) * 2016-12-28 2021-06-29 Medicaroid Corporation Robotic operating table and hybrid operating system
CN113329720A (en) * 2019-01-17 2021-08-31 奥托·博克保健产品有限公司 Method for controlling an orthopaedic or prosthetic device and orthopaedic or prosthetic device
CN113456322A (en) * 2021-06-30 2021-10-01 吉林大学 Bionic knee joint based on motor drive
US11185460B2 (en) 2007-12-26 2021-11-30 Rex Bionics Limited Self contained powered exoskeleton walker for a disabled user
US11278434B2 (en) * 2017-06-06 2022-03-22 Ottobock Se & Co. Kgaa Orthopedic joint device
US11278433B2 (en) 2005-03-31 2022-03-22 Massachusetts Institute Of Technology Powered ankle-foot prosthesis
CN116729520A (en) * 2023-08-11 2023-09-12 太原理工大学 Bionic four-foot robot based on double-layer corrugated pipe pneumatic soft driver

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790282B2 (en) * 2007-11-08 2014-07-29 Advensys, Llc Neuromorphic controlled powered orthotic and prosthetic system
DE102010053226A1 (en) * 2010-12-03 2012-06-06 Stabilus Gmbh driving means
US9789603B2 (en) 2011-04-29 2017-10-17 Sarcos Lc Teleoperated robotic system
US9604368B2 (en) 2011-11-11 2017-03-28 Springactive, Inc. Active compliant parallel mechanism
US9498401B2 (en) 2011-12-20 2016-11-22 Massachusetts Institute Of Technology Robotic system for simulating a wearable device and method of use
US9682005B2 (en) 2012-02-24 2017-06-20 Massachusetts Institute Of Technology Elastic element exoskeleton and method of using same
US9183346B2 (en) * 2012-03-12 2015-11-10 Empire Technology Development Llc Robotic appendages
US9616580B2 (en) 2012-05-14 2017-04-11 Sarcos Lc End effector for a robotic arm
WO2014016424A1 (en) * 2012-07-27 2014-01-30 Proteor Hydraulic system for a knee-ankle assembly controlled by a microprocessor
USD738889S1 (en) 2013-06-09 2015-09-15 Apple Inc. Display screen or portion thereof with animated graphical user interface
CN103303388B (en) * 2013-07-08 2016-01-20 北京理工大学 The comprehensive self adaptation elastic foot of quadruped robot
US9120227B2 (en) * 2013-08-15 2015-09-01 Disney Enterprises, Inc. Human motion tracking control with strict contact force constraints for floating-base humanoid robots
US9568075B2 (en) * 2013-10-28 2017-02-14 Seiko Epson Corporation Robot, robot control device, and robot system
US9044859B2 (en) * 2013-10-31 2015-06-02 Disney Enterprises, Inc. Method for gait generation and tracking control for a bipedal walking robot
US10561563B2 (en) 2013-12-16 2020-02-18 Massachusetts Institute Of Technology Optimal design of a lower limb exoskeleton or orthosis
US9194403B2 (en) * 2014-02-23 2015-11-24 Dylan Pierre Neyme Modular hinged joint for use with agonist-antagonist tensile inputs
US9849003B2 (en) * 2014-03-19 2017-12-26 Mayo Foundation For Medical Education And Research System for powered ankle-foot prosthesis with active control of dorsiflexion-plantarflexion and inversion-eversion
US10766133B2 (en) 2014-05-06 2020-09-08 Sarcos Lc Legged robotic device utilizing modifiable linkage mechanism
US10533542B2 (en) 2014-05-06 2020-01-14 Sarcos Lc Rapidly modulated hydraulic supply for a robotic device
US10512583B2 (en) 2014-05-06 2019-12-24 Sarcos Lc Forward or rearward oriented exoskeleton
US10406676B2 (en) 2014-05-06 2019-09-10 Sarcos Lc Energy recovering legged robotic device
US9517561B2 (en) * 2014-08-25 2016-12-13 Google Inc. Natural pitch and roll
USD760759S1 (en) 2014-09-01 2016-07-05 Apple Inc. Display screen or portion thereof with graphical user interface
CN104401419B (en) * 2014-11-25 2017-03-01 北京工业大学 A kind of new biped humanoid robot system based on Pneumatic artificial muscle
US20160213496A1 (en) * 2015-01-28 2016-07-28 Steering Solutions Ip Holding Corporation Integrated power generation for human exoskeletons and method of generating power
US10390973B2 (en) 2015-05-11 2019-08-27 The Hong Kong Polytechnic University Interactive exoskeleton robotic knee system
USD760267S1 (en) 2015-06-04 2016-06-28 Apple Inc. Display screen or portion thereof with graphical user interface
CN105313117A (en) * 2015-11-30 2016-02-10 华南理工大学 Adjustable-stiffness driver based on non-linear elastic element and driving method thereof
US9789919B1 (en) * 2016-03-22 2017-10-17 Google Inc. Mitigating sensor noise in legged robots
USD799545S1 (en) 2016-05-18 2017-10-10 Apple Inc. Display screen or portion thereof with icon
USD814515S1 (en) 2016-06-10 2018-04-03 Apple Inc. Display screen or portion thereof with icon
KR102637517B1 (en) 2016-09-06 2024-02-19 삼성전자주식회사 Power transmitting device, motion assist apparatus and controlling method thereof
US10821614B2 (en) 2016-11-11 2020-11-03 Sarcos Corp. Clutched joint modules having a quasi-passive elastic actuator for a robotic assembly
US10765537B2 (en) 2016-11-11 2020-09-08 Sarcos Corp. Tunable actuator joint modules having energy recovering quasi-passive elastic actuators for use within a robotic system
US10919161B2 (en) 2016-11-11 2021-02-16 Sarcos Corp. Clutched joint modules for a robotic system
US10828767B2 (en) 2016-11-11 2020-11-10 Sarcos Corp. Tunable actuator joint modules having energy recovering quasi-passive elastic actuators with internal valve arrangements
USD818494S1 (en) 2017-06-04 2018-05-22 Apple Inc. Display screen or portion thereof with animated graphical user interface
US10843330B2 (en) 2017-12-07 2020-11-24 Sarcos Corp. Resistance-based joint constraint for a master robotic system
US11331809B2 (en) 2017-12-18 2022-05-17 Sarcos Corp. Dynamically controlled robotic stiffening element
US11833688B2 (en) * 2018-01-08 2023-12-05 Petoi, Llc Legged robots and methods for controlling legged robots
CN108606834B (en) * 2018-02-05 2021-07-20 中国矿业大学 Soft robot control system based on magnetorheological fluid and control method thereof
WO2019173751A1 (en) * 2018-03-08 2019-09-12 Apptronik, Inc. Exoskeleton device with improved actuation system
US11278235B2 (en) 2018-10-23 2022-03-22 Massachusetts Institute Of Technology Neural efferent and afferent control of spring equilibrium, damping, and power in backdrivable and non-backdrivable series-elastic actuators comprising variable series stiffness mechanisms
US11241801B2 (en) 2018-12-31 2022-02-08 Sarcos Corp. Robotic end effector with dorsally supported actuation mechanism
US11351675B2 (en) 2018-12-31 2022-06-07 Sarcos Corp. Robotic end-effector having dynamic stiffening elements for conforming object interaction
US10906191B2 (en) 2018-12-31 2021-02-02 Sarcos Corp. Hybrid robotic end effector
WO2020203762A1 (en) * 2019-03-29 2020-10-08 本田技研工業株式会社 Joint device
CN110654473B (en) * 2019-09-30 2021-08-03 武汉轻工大学 Bionic foot component
US11298287B2 (en) 2020-06-02 2022-04-12 Dephy, Inc. Systems and methods for a compressed controller for an active exoskeleton
US11147733B1 (en) 2020-06-04 2021-10-19 Dephy, Inc. Systems and methods for bilateral wireless communication
US11148279B1 (en) 2020-06-04 2021-10-19 Dephy, Inc. Customized configuration for an exoskeleton controller
US11389367B2 (en) 2020-06-05 2022-07-19 Dephy, Inc. Real-time feedback-based optimization of an exoskeleton
USD951978S1 (en) 2020-06-21 2022-05-17 Apple Inc. Display screen or portion thereof with graphical user interface
US11173093B1 (en) 2020-09-16 2021-11-16 Dephy, Inc. Systems and methods for an active exoskeleton with local battery
US11833676B2 (en) 2020-12-07 2023-12-05 Sarcos Corp. Combining sensor output data to prevent unsafe operation of an exoskeleton
CN112692872B (en) * 2020-12-21 2022-07-22 哈尔滨工业大学 Pneumatic-based continuous variable-rigidity spinal joint
US11794345B2 (en) 2020-12-31 2023-10-24 Sarcos Corp. Unified robotic vehicle systems and methods of control
NL2027310B1 (en) * 2021-01-13 2022-07-25 Univ Delft Tech Transfemoral knee-ankle prosthesis
USD1006036S1 (en) 2021-04-06 2023-11-28 Apple Inc. Display or portion thereof with icon
US11826907B1 (en) 2022-08-17 2023-11-28 Sarcos Corp. Robotic joint system with length adapter
US11717956B1 (en) 2022-08-29 2023-08-08 Sarcos Corp. Robotic joint system with integrated safety
US11924023B1 (en) 2022-11-17 2024-03-05 Sarcos Corp. Systems and methods for redundant network communication in a robot
US11897132B1 (en) 2022-11-17 2024-02-13 Sarcos Corp. Systems and methods for redundant network communication in a robot

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252102A (en) * 1989-01-24 1993-10-12 Electrobionics Corporation Electronic range of motion apparatus, for orthosis, prosthesis, and CPM machine
US5571205A (en) * 1991-12-05 1996-11-05 James; Kelvin B. System for controlling artificial knee joint action in an above knee prosthesis
US6067892A (en) * 1998-03-18 2000-05-30 Erickson; Joel R. Artificial muscle actuator assembly
US20030163206A1 (en) * 2002-02-28 2003-08-28 Honda Giken Kogyo Kabushiki Kaisha Parallel linkage and artificial joint device using the same
US20060069448A1 (en) * 2002-08-30 2006-03-30 Honda Giken Kogyo Kabushiki Kaisha Joint device for artificial leg, method and control unit for controlling the joint device

Family Cites Families (269)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2529968A (en) 1948-06-15 1950-11-14 Sartin Hansel Mechanism for artificial legs
US2489291A (en) 1948-07-09 1949-11-29 Ulrich K Henschke Leg prosthesis
US2921480A (en) * 1956-01-30 1960-01-19 Pacific Scientific Co Control line regulator
US3098645A (en) 1961-01-11 1963-07-23 Walter J Owens Laminated torsion bar suspension
US3207497A (en) 1963-07-02 1965-09-21 Dura Corp Torsion spring assembly
US3844279A (en) 1973-05-14 1974-10-29 R Konvalin Adjustable leg brace
AT334521B (en) * 1974-03-08 1976-01-25 Forsch Orthopadie Technik ANKLE
US4463291A (en) 1979-12-31 1984-07-31 Andale Company Automatic control system and valve actuator
US4921293A (en) 1982-04-02 1990-05-01 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Multi-fingered robotic hand
US4442390A (en) 1982-07-06 1984-04-10 Davis Kenneth W Feedback system for a linear actuator
US4518307A (en) 1982-09-29 1985-05-21 The Boeing Company Compliant robot arm adapter assembly
IN161425B (en) 1983-05-12 1987-11-28 Westinghouse Brake & Signal
US4546298A (en) 1983-05-12 1985-10-08 Westinghouse Brake & Signal Co. Electric actuators
IN160902B (en) 1983-05-12 1987-08-15 Westinghouse Brake & Signal
US4546296A (en) 1983-05-12 1985-10-08 Westinghouse Brake & Signal Electric actuators
IN161427B (en) 1983-05-12 1987-11-28 Westinghouse Brake & Signal
US4569352A (en) 1983-05-13 1986-02-11 Wright State University Feedback control system for walking
CA1276710C (en) 1983-11-30 1990-11-20 Kazuo Asakawa Robot force controlling system
US4600357A (en) 1984-02-21 1986-07-15 Heath Company Gripper force sensor/controller for robotic arm
US4657470A (en) 1984-11-15 1987-04-14 Westinghouse Electric Corp. Robotic end effector
SE454943B (en) 1986-06-26 1988-06-13 Ossur Hf ACCESSORIES, SPECIAL FOR AMPUTATION STUMP
JP2645004B2 (en) 1987-02-27 1997-08-25 株式会社東芝 Control device for multi-degree-of-freedom manipulator
JPS6471686A (en) 1987-09-09 1989-03-16 Komatsu Mfg Co Ltd Flexible arm robot
US4936295A (en) 1987-09-22 1990-06-26 Crane Larry A Lateral support for ankle
US4865376A (en) 1987-09-25 1989-09-12 Leaver Scott O Mechanical fingers for dexterity and grasping
EP0356464B1 (en) 1988-01-20 1994-04-27 Moog Inc. Vehicle suspension system, and method of operating same
US4921393A (en) 1988-03-09 1990-05-01 Sri International Articulatable structure with adjustable end-point compliance
US4843921A (en) 1988-04-18 1989-07-04 Kremer Stephen R Twisted cord actuator
US5088478A (en) 1988-05-10 1992-02-18 Royce Medical Company Gel and air cushion ankle brace
USRE34661E (en) 1988-05-10 1994-07-12 Royce Medical Company Gel and air cushion ankle brace
US4964402A (en) 1988-08-17 1990-10-23 Royce Medical Company Orthopedic device having gel pad with phase change material
US5062673A (en) 1988-12-28 1991-11-05 Kabushiki Kaisha Toyota Chuo Kenkyusho Articulated hand
US4923475A (en) 1989-02-21 1990-05-08 Gosthnian Barry M Inflatable limb prosthesis with preformed inner surface
US5049797A (en) 1990-07-02 1991-09-17 Utah State University Foundation Device and method for control of flexible link robot manipulators
US5092902A (en) 1990-08-16 1992-03-03 Mauch Laboratories, Inc. Hydraulic control unit for prosthetic leg
US5181933A (en) 1991-02-28 1993-01-26 Phillips L Van Split foot prosthesis
US6071313A (en) 1991-02-28 2000-06-06 Phillips; Van L. Split foot prosthesis
US5112296A (en) 1991-04-30 1992-05-12 The Board Of Supervisors Of Louisiana State University Biofeedback activated orthosis for foot-drop rehabilitation
US5367790A (en) 1991-07-08 1994-11-29 Gamow; Rustem I. Shoe and foot prosthesis with a coupled spring system
US5701686A (en) 1991-07-08 1997-12-30 Herr; Hugh M. Shoe and foot prosthesis with bending beam spring structures
JPH05216504A (en) 1992-02-06 1993-08-27 Fanuc Ltd Adaptive sliding mode control system for control object including spring system
US5327790A (en) 1992-06-19 1994-07-12 Massachusetts Institute Of Technology Reaction sensing torque actuator
US5294873A (en) 1992-10-27 1994-03-15 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Kinematic functions for redundancy resolution using configuration control
US5358513A (en) 1992-12-09 1994-10-25 Medtronic, Inc. Parameter selection and electrode placement of neuromuscular electrical stimulation apparatus
US5405409A (en) 1992-12-21 1995-04-11 Knoth; Donald E. Hydraulic control unit for prosthetic leg
US5443521A (en) 1992-12-21 1995-08-22 Mauch Laboratories, Inc. Hydraulic control unit for prosthetic leg
US5329705A (en) 1993-02-16 1994-07-19 Royce Medical Company Footgear with pressure relief zones
US5456341A (en) 1993-04-23 1995-10-10 Moog Inc. Method and apparatus for actively adjusting and controlling a resonant mass-spring system
AU688348B2 (en) 1993-07-09 1998-03-12 Kinetecs, Inc. Exercise apparatus and technique
US5476441A (en) 1993-09-30 1995-12-19 Massachusetts Institute Of Technology Controlled-brake orthosis
US5502363A (en) 1994-01-04 1996-03-26 University Of Maryland-Baltimore County Apparatus for controlling angular positioning and stiffness modulations of joint of robotic manipulator
US5458143A (en) 1994-06-09 1995-10-17 Herr; Hugh M. Crutch with elbow and shank springs
US6206934B1 (en) 1998-04-10 2001-03-27 Flex-Foot, Inc. Ankle block with spring inserts
US6144385A (en) 1994-08-25 2000-11-07 Michael J. Girard Step-driven character animation derived from animation data without footstep information
US5662693A (en) 1995-06-05 1997-09-02 The United States Of America As Represented By The Secretary Of The Air Force Mobility assist for the paralyzed, amputeed and spastic person
US5650704A (en) 1995-06-29 1997-07-22 Massachusetts Institute Of Technology Elastic actuator for precise force control
US5748845A (en) 1995-07-31 1998-05-05 Motorola, Inc. FES method and system for controlling the movement of a limb
US5643332A (en) 1995-09-20 1997-07-01 Neuromotion Inc. Assembly for functional electrical stimulation during movement
US6056712A (en) 1995-10-31 2000-05-02 Grim; Tracy E. Multi-functional orthosis for the foot, heel, ankle and lower leg
US5718925A (en) 1995-11-15 1998-02-17 Ossur Hf. Apparatus for making a prosthesis socket
US7311686B1 (en) 1995-12-28 2007-12-25 Ossur Hf Molded orthopaedic devices
DK0799894T3 (en) 1996-02-09 2004-08-09 Degussa Process for the preparation of (S) -cyanhydrins
US5888212A (en) 1997-06-26 1999-03-30 Mauch, Inc. Computer controlled hydraulic resistance device for a prosthesis and other apparatus
US6113642A (en) 1996-06-27 2000-09-05 Mauch, Inc. Computer controlled hydraulic resistance device for a prosthesis and other apparatus
US7288076B2 (en) 1996-08-29 2007-10-30 Ossur Hf Self-equalizing resilient orthopaedic support
US5898948A (en) 1996-10-31 1999-05-04 Graham M. Kelly Support/sport sock
US6064912A (en) 1997-03-28 2000-05-16 Kenney; John P. Orthotic/electrotherapy for treating contractures due to immobility
US6136039A (en) 1997-05-06 2000-10-24 Ossur Hf Dual durometer silicone liner for prosthesis
US5932230A (en) 1997-05-20 1999-08-03 Degrate; Frenchell Topical analgesic formulation containing fruits, oils and aspirin
US5888213A (en) 1997-06-06 1999-03-30 Motion Control, Inc. Method and apparatus for controlling an externally powered prosthesis
US5944760A (en) 1997-08-04 1999-08-31 Roland J. Christensen Family Limited Partnership Prosthetic foot with reinforcing member
US6202806B1 (en) 1997-10-29 2001-03-20 Lord Corporation Controllable device having a matrix medium retaining structure
AU3007299A (en) 1998-03-17 1999-10-11 Gary S. Kochamba Method and apparatus for stabilizing tissue
US6511512B2 (en) 1998-04-10 2003-01-28 Ossur Hf Active shock module prosthesis
CA2321591C (en) 1998-04-10 2007-01-30 Van L. Phillips Coil spring shock module prosthesis
US6517503B1 (en) 1998-09-18 2003-02-11 Becker Orthopedic Appliance Company Orthosis knee joint
US6267742B1 (en) 1998-09-29 2001-07-31 Brown Medical Industries Biplanar foot dorsiflexion collapsible posterior splint
JP2000145914A (en) 1998-11-17 2000-05-26 Tsubakimoto Chain Co Bearing linear actuator with backstop mechanism
ATE272993T1 (en) 1999-03-01 2004-08-15 Ossur Hf MULTIPLE PROSTHETIC OR ORTHOPEDIC Cuff WITH DIFFERENT ELASTICITY
US6666796B1 (en) 1999-09-16 2003-12-23 Aerovironment, Inc. Walking assisting apparatus
FI110159B (en) 1999-12-17 2002-12-13 Respecta Oy Lower extremity prosthesis
CN1237949C (en) 2000-01-20 2006-01-25 麻省理工学院 Electronically controlled prosthetic knee
DE60138944D1 (en) 2000-03-14 2009-07-23 Ossur Hf ELASTIC COMPOSITE MATERIAL
ATE456340T1 (en) 2000-03-15 2010-02-15 Ossur Hf APPARATUS AND METHOD FOR PRODUCING A PROSTHETIC SUCTION CUFF
US6532400B1 (en) 2000-03-24 2003-03-11 Intelligent Inference Systems Corporation Biologically-inspired multi-segmented robot
EP1880694B1 (en) 2000-03-29 2012-01-11 Massachusetts Institute of Technology Controllable prosthetic joint system
US6585774B2 (en) 2000-04-25 2003-07-01 Simbex, Llc Dynamic variable geometry fitting system for use with a body appliance
US6811571B1 (en) 2000-05-02 2004-11-02 Van L. Phillips Universal prosthesis with cushioned ankle
US20030195439A1 (en) 2000-05-30 2003-10-16 Caselnova Ronald J. Thermal pad and boot designed for applying hot or cold treatment
GB2368017B (en) 2000-06-20 2004-05-12 Bournemouth University Higher Apparatus for electrical stimulation of the leg
US6923834B2 (en) 2000-10-04 2005-08-02 Ossur Hf Artificial limb socket containing volume control pad
CA2424407A1 (en) 2000-10-04 2002-04-11 Ossur Hf Prosthetic socket and socket component assembly
AU2002231278A1 (en) 2000-10-26 2002-05-06 Van L. Phillips Foot prosthesis having cushioned ankle
US6702076B2 (en) 2001-01-16 2004-03-09 Michael T. Koleda Shaft vibration damping system
US6660042B1 (en) 2001-02-02 2003-12-09 Rutgers, The State University Of New Jersey Methods of biomimetic finger control by filtering of distributed forelimib pressures
US6443993B1 (en) 2001-03-23 2002-09-03 Wayne Koniuk Self-adjusting prosthetic ankle apparatus
US7153242B2 (en) 2001-05-24 2006-12-26 Amit Goffer Gait-locomotor apparatus
JP3760186B2 (en) 2001-06-07 2006-03-29 独立行政法人科学技術振興機構 Biped walking type moving device, walking control device thereof, and walking control method
US6752774B2 (en) 2001-06-08 2004-06-22 Townsend Design Tension assisted ankle joint and orthotic limb braces incorporating same
US7650204B2 (en) 2001-06-29 2010-01-19 Honda Motor Co., Ltd. Active control of an ankle-foot orthosis
WO2003005934A2 (en) 2001-07-10 2003-01-23 California Institute Of Technology Cognitive state machine for prosthetic systems
AU2002322712A1 (en) 2001-07-26 2003-02-17 Van L. Phillips Socket insert having a bladder system
DE10142491B4 (en) 2001-08-30 2004-10-07 össur h.f. Sealing arrangement with lips for a prosthetic socket
DE10142492A1 (en) 2001-08-30 2003-04-03 Carstens Orthopaedie Und Mediz Prosthetic socket with seal
US7260436B2 (en) 2001-10-16 2007-08-21 Case Western Reserve University Implantable networked neural system
US6921376B2 (en) 2001-10-23 2005-07-26 The Jerome Group, Inc. Cervical brace
DE10164892B4 (en) 2001-11-05 2009-08-27 össur h.f. Stocking liner for use with a cup-shaped prosthesis stem
JP3790816B2 (en) 2002-02-12 2006-06-28 国立大学法人 東京大学 Motion generation method for humanoid link system
JP2003236783A (en) 2002-02-18 2003-08-26 Japan Science & Technology Corp Bipedal walking transfer device
JP4182726B2 (en) 2002-02-20 2008-11-19 日本精工株式会社 Linear actuator
US20090030530A1 (en) 2002-04-12 2009-01-29 Martin James J Electronically controlled prosthetic system
WO2003086245A2 (en) 2002-04-12 2003-10-23 James Jay Martin Electronically controlled prosthetic system
DE60336519D1 (en) 2002-04-26 2011-05-05 Honda Motor Co Ltd Self-positioning device for mobile robotic legs
DE60221717T2 (en) 2002-05-06 2008-06-05 Somas Orthopaedie B.V. DEVICE FOR BELATED FOOT
CN100438828C (en) 2002-07-08 2008-12-03 奥瑟Hf公司 Socket liner incorporating sensors to monitor amputee progress
US20040064195A1 (en) 2002-07-15 2004-04-01 Hugh Herr Variable-mechanical-impedance artificial legs
US7303538B2 (en) 2002-07-23 2007-12-04 Ossur Hf Versatile orthopaedic leg mounted walkers
US7597674B2 (en) 2002-07-23 2009-10-06 össur hf Versatile orthopaedic leg mounted walker
US7094058B2 (en) 2002-08-16 2006-08-22 Ossur Hf Educational prosthesis device and method for using the same
US20050004472A1 (en) 2002-08-17 2005-01-06 Greg Pratt Medical socket contour scanning system
US7736394B2 (en) 2002-08-22 2010-06-15 Victhom Human Bionics Inc. Actuated prosthesis for amputees
US7314490B2 (en) 2002-08-22 2008-01-01 Victhom Human Bionics Inc. Actuated leg prosthesis for above-knee amputees
AU2002951193A0 (en) 2002-09-04 2002-09-19 Northern Sydney Area Health Service Movement faciliatation device
US7105122B2 (en) 2002-10-08 2006-09-12 Ossur Hf Prosthesis socket direct casting device having multiple compression chambers
US7094212B2 (en) 2002-10-11 2006-08-22 Ossur Hf Rigid dressing
US7037283B2 (en) 2002-10-18 2006-05-02 Ossur Hf Casting product and method for forming the same
DE60314000D1 (en) 2002-10-24 2007-07-05 Lockheed Corp SYSTEM FOR TREATING MOTION MALFUNCTIONS
AU2003290526A1 (en) 2002-11-07 2004-06-03 Ossur Hf Ankle-foot orthosis
US6966882B2 (en) 2002-11-25 2005-11-22 Tibion Corporation Active muscle assistance device and method
US7909884B2 (en) 2002-12-20 2011-03-22 Ossur Hf Suspension liner system with seal
US7025793B2 (en) 2002-12-20 2006-04-11 Ossur Hf Suspension liner with seal
US8034120B2 (en) 2002-12-20 2011-10-11 Ossur Hf Suspension liner system with seal
US7295892B2 (en) 2002-12-31 2007-11-13 Massachusetts Institute Of Technology Speed-adaptive control scheme for legged running robots
CA2510977C (en) 2002-12-31 2012-09-18 Ossur Hf Wound dressing comprising an absorbent core with a plurality of receptacles formed therein
US7465281B2 (en) 2003-04-18 2008-12-16 Ossur, Hf Versatile hardenable cast or support
US7874223B2 (en) 2003-04-24 2011-01-25 Thomas Sugar Adjustable compliant mechanism
WO2004096083A2 (en) 2003-04-24 2004-11-11 Arizona Board Of Regents Acting On Behalf Of Arizona State University Spring-over-muscle actuator
US7198071B2 (en) 2003-05-02 2007-04-03 Össur Engineering, Inc. Systems and methods of loading fluid in a prosthetic knee
US7101487B2 (en) 2003-05-02 2006-09-05 Ossur Engineering, Inc. Magnetorheological fluid compositions and prosthetic knees utilizing same
JP4315766B2 (en) 2003-05-21 2009-08-19 本田技研工業株式会社 Walking assist device
EP1653893A4 (en) 2003-06-20 2009-11-11 Ossur Hf Prosthetic socket with self-contained vacuum reservoir
JP4290494B2 (en) 2003-07-08 2009-07-08 株式会社ルネサステクノロジ Semiconductor memory device
US8007544B2 (en) 2003-08-15 2011-08-30 Ossur Hf Low profile prosthetic foot
AU2004268576A1 (en) 2003-08-21 2005-03-10 Ischem Corporation Automated methods and systems for vascular plaque detection and analysis
US20050049652A1 (en) 2003-08-25 2005-03-03 Kai-Yu Tong Functional electrical stimulation system
US7270644B2 (en) 2003-09-05 2007-09-18 Ossur Hf Ankle-foot orthosis having an orthotic footplate
WO2005025464A2 (en) 2003-09-11 2005-03-24 The Cleveland Clinic Foundation Apparatus for assisting body movement
US7531711B2 (en) 2003-09-17 2009-05-12 Ossur Hf Wound dressing and method for manufacturing the same
US7396975B2 (en) 2003-09-17 2008-07-08 Ossur Hf Wound dressing and method for manufacturing the same
US8075633B2 (en) 2003-09-25 2011-12-13 Massachusetts Institute Of Technology Active ankle foot orthosis
US7534220B2 (en) 2003-09-29 2009-05-19 Ossur Hf Adjustable ergonomic brace
US6969408B2 (en) 2003-09-30 2005-11-29 Ossur Engineering, Inc. Low profile active shock module prosthesis
US6942629B2 (en) 2003-10-02 2005-09-13 Dynasplint Systems, Inc. Adjustable splint device for relieving contractures
SE526430C2 (en) 2003-10-17 2005-09-13 Oessur Hf Artificial multi-axis knee joint
US20070282480A1 (en) 2003-11-10 2007-12-06 Pannese Patrick D Methods and systems for controlling a semiconductor fabrication process
US7107180B2 (en) 2003-11-14 2006-09-12 Ossur Hf Method and system for determining an activity level in an individual
US20050107889A1 (en) 2003-11-18 2005-05-19 Stephane Bedard Instrumented prosthetic foot
US7637959B2 (en) 2004-02-12 2009-12-29 össur hf Systems and methods for adjusting the angle of a prosthetic ankle based on a measured surface angle
WO2005079712A2 (en) 2004-02-12 2005-09-01 össur hf System and method for motion-controlled foot unit
US7826894B2 (en) 2004-03-22 2010-11-02 California Institute Of Technology Cognitive control signals for neural prosthetics
USD503480S1 (en) 2004-04-22 2005-03-29 Ossur Hf Ankle-foot orthosis
US7217060B2 (en) 2004-04-30 2007-05-15 Ossur Hf Prosthesis locking assembly
WO2005110293A2 (en) 2004-05-07 2005-11-24 Ossur Engineering, Inc. Magnetorheologically actuated prosthetic knee
USD503802S1 (en) 2004-05-28 2005-04-05 Ossur Hf Prosthesis liner
US7581454B2 (en) 2004-05-28 2009-09-01 össur hf Method of measuring the performance of a prosthetic foot
US7347877B2 (en) 2004-05-28 2008-03-25 össur hf Foot prosthesis with resilient multi-axial ankle
CN100450460C (en) 2004-05-28 2009-01-14 奥苏尔公司 Prosthetic or orthotic sleeve having external surface peripheral profiles
US7770842B2 (en) 2004-08-24 2010-08-10 Honeywell International Inc. Aircraft flight control surface actuation system communication architecture
US7429253B2 (en) 2004-09-21 2008-09-30 Honda Motor Co., Ltd. Walking assistance system
WO2006034210A2 (en) 2004-09-21 2006-03-30 Thomas Sugar Adjustable stiffness jack spring actuator
US7597675B2 (en) 2004-12-22 2009-10-06 össur hf Knee brace and method for securing the same
US7794418B2 (en) 2004-12-22 2010-09-14 Ossur Hf Knee brace and method for securing the same
US7896827B2 (en) 2004-12-22 2011-03-01 Ossur Hf Knee brace and method for securing the same
US7198610B2 (en) 2004-12-22 2007-04-03 Ossur Hf Knee brace and method for securing the same
US7713225B2 (en) 2004-12-22 2010-05-11 Ossur Hf Knee brace and method for securing the same
US7762973B2 (en) 2004-12-22 2010-07-27 Ossur Hf Spacer element for prosthetic and orthotic devices
CA2863933C (en) 2004-12-22 2018-08-07 Ossur Hf Systems and methods for processing limb motion
US7513881B1 (en) 2005-01-12 2009-04-07 Ossur Hf Knee immobilizer
US7465283B2 (en) 2005-01-12 2008-12-16 Ossur, Hf Cast assembly with breathable double knit type padding
JP4178187B2 (en) 2005-01-26 2008-11-12 国立大学法人 筑波大学 Wearable motion assist device and control program
US7161056B2 (en) 2005-01-28 2007-01-09 Ossur Hf Wound dressing and method for manufacturing the same
EP1843724B1 (en) 2005-02-02 2018-07-25 Össur hf Sensing systems and methods for monitoring gait dynamics
CN101151071B (en) 2005-02-02 2010-12-08 奥瑟Hf公司 Prosthetic and orthotic systems usable for rehabilitation
US8500823B2 (en) 2005-03-31 2013-08-06 Massachusetts Institute Of Technology Powered artificial knee with agonist-antagonist actuation
US8864846B2 (en) 2005-03-31 2014-10-21 Massachusetts Institute Of Technology Model-based neuromechanical controller for a robotic leg
US8512415B2 (en) 2005-03-31 2013-08-20 Massachusetts Institute Of Technology Powered ankle-foot prothesis
US20060249315A1 (en) 2005-03-31 2006-11-09 Massachusetts Institute Of Technology Artificial human limbs and joints employing actuators, springs, and variable-damper elements
US20070043449A1 (en) 2005-03-31 2007-02-22 Massachusetts Institute Of Technology Artificial ankle-foot system with spring, variable-damping, and series-elastic actuator components
US20070123997A1 (en) 2005-03-31 2007-05-31 Massachusetts Institute Of Technology Exoskeletons for running and walking
US7313463B2 (en) 2005-03-31 2007-12-25 Massachusetts Institute Of Technology Biomimetic motion and balance controllers for use in prosthetics, orthotics and robotics
US20070162152A1 (en) 2005-03-31 2007-07-12 Massachusetts Institute Of Technology Artificial joints using agonist-antagonist actuators
US7240876B2 (en) 2005-04-21 2007-07-10 Ossur, Hf Dispenser box
NL1029086C2 (en) 2005-05-20 2006-11-27 Somas Groep B V Hip portese, method for preventing hip dislocation and use of a hip portese.
USD523149S1 (en) 2005-05-24 2006-06-13 Ossur Hf Prosthetic or orthotic sleeve
JP4332136B2 (en) 2005-06-03 2009-09-16 本田技研工業株式会社 Limb body assist device and limb body assist program
US7527253B2 (en) 2005-06-09 2009-05-05 Arizona Board Of Regents Adjustable stiffness leaf spring actuators
WO2007008803A2 (en) 2005-07-11 2007-01-18 Ossur Hf Energy returing prosthetic joint
WO2007023625A1 (en) 2005-08-23 2007-03-01 Matsushita Electric Industrial Co., Ltd. Polymer actuator
US7485152B2 (en) * 2005-08-26 2009-02-03 The Ohio Willow Wood Company Prosthetic leg having electronically controlled prosthetic knee with regenerative braking feature
US7531006B2 (en) 2005-09-01 2009-05-12 össur hf Sensing system and method for motion-controlled foot unit
US8048172B2 (en) 2005-09-01 2011-11-01 össur hf Actuator assembly for prosthetic or orthotic joint
US7959589B2 (en) 2005-09-19 2011-06-14 Ossur Hf Adjustable orthotic device
US7431708B2 (en) 2005-09-19 2008-10-07 Ossur Hf Knee brace having lateral/medial width adjustment
WO2007047424A2 (en) 2005-10-12 2007-04-26 Ossur Hf Knee brace
US7449005B2 (en) 2005-11-07 2008-11-11 Ossur Hf. Traction collar and method of use
USD527825S1 (en) 2005-12-21 2006-09-05 Ossur Hf Knee brace
JP4818716B2 (en) 2005-12-27 2011-11-16 富士通株式会社 Robot controller
USD529180S1 (en) 2006-03-01 2006-09-26 Ossur Hf Knee brace
USD533280S1 (en) 2006-03-22 2006-12-05 Ossur Hf Wrist brace
US7914475B2 (en) 2006-03-22 2011-03-29 Ossur Hf Orthopedic brace
US7488349B2 (en) 2006-03-24 2009-02-10 Ossur Hf Ventilated prosthesis system
CN101061984B (en) 2006-04-29 2012-02-08 香港理工大学 Recovery robot system for providing mechanical assistant by using myoelectric signal
US7578799B2 (en) 2006-06-30 2009-08-25 Ossur Hf Intelligent orthosis
US7438843B2 (en) 2006-06-30 2008-10-21 Ossur Hf Method and kit for making prosthetic socket
US7662191B2 (en) 2006-06-30 2010-02-16 össur hf Liner donning and doffing device
US7503937B2 (en) 2006-07-03 2009-03-17 Ossur Hf Prosthetic foot
JP2008087143A (en) 2006-10-05 2008-04-17 Sony Corp Actuator control device
US7632315B2 (en) 2006-10-10 2009-12-15 össur hf Vacuum chamber socket system
US7842848B2 (en) 2006-11-13 2010-11-30 Ossur Hf Absorbent structure in an absorbent article
DE102006059206B4 (en) 2006-12-13 2010-12-30 Otto Bock Healthcare Gmbh Orthopedic device
US7868182B2 (en) * 2007-01-12 2011-01-11 Arduengo Iii Anthony J Solventless one-step process for the production of imidazole-2-thiones
DE102007003028A1 (en) * 2007-01-20 2008-07-24 Mtu Aero Engines Gmbh turbomachinery
USD567072S1 (en) 2007-02-12 2008-04-22 Ossur Hf Strap retainer
USD558884S1 (en) 2007-02-12 2008-01-01 Ossur Hf Knee brace
US8348876B2 (en) 2007-02-12 2013-01-08 Ossur Hf Strap retainer
US8021317B2 (en) 2007-04-26 2011-09-20 Ossur Hf Orthopedic device providing access to wound site
US7868511B2 (en) 2007-05-09 2011-01-11 Motor Excellence, Llc Electrical devices using disk and non-disk shaped rotors
US7876019B2 (en) 2007-05-09 2011-01-25 Motor Excellence, Llc Electrical devices with reduced flux leakage using permanent magnet components
WO2008153675A1 (en) 2007-05-21 2008-12-18 Ossur Hf Orthopedic device
USD576781S1 (en) 2007-07-03 2008-09-16 Ossur Hf Orthotic device
WO2009014644A1 (en) 2007-07-20 2009-01-29 Ossur Hf Prosthetic or orthopedic device having feedback
EP2197396A2 (en) 2007-08-23 2010-06-23 Ossur HF Adjustable orthopedic or prosthetic support device
US8043244B2 (en) 2007-09-13 2011-10-25 Ossur Hf Wearable device
CN101827568A (en) 2007-10-15 2010-09-08 奥索集团公司 Orthopedic device having a patient compliance system
USD583956S1 (en) 2007-12-11 2008-12-30 Ossur, Hf Orthotic device
USD588753S1 (en) 2008-02-12 2009-03-17 Ossur Hf Patella protector assembly
CN102036626B (en) 2008-03-24 2014-07-02 奥瑟Hf公司 Transfemoral prosthetic systems and methods for operating the same
USD596301S1 (en) 2008-04-25 2009-07-14 Ossur Hf Orthopedic device
WO2009139893A1 (en) 2008-05-15 2009-11-19 Ossur Hf Circumferential walker
US20100174384A1 (en) 2008-09-04 2010-07-08 Iwalk, Inc. Hybrid terrain-adaptive lower-extremity systems
USD627079S1 (en) 2008-09-09 2010-11-09 Ossur Hf Container
USD611322S1 (en) 2008-09-09 2010-03-09 össur hf Handle
WO2010065104A1 (en) 2008-12-03 2010-06-10 Ossur Hf Cervical collar having height and circumferential adjustment
KR20110120927A (en) 2009-01-30 2011-11-04 메사추세츠 인스티튜트 오브 테크놀로지 Powered artificial knee with agonist-antagonist actuation
USD629115S1 (en) 2009-08-28 2010-12-14 Ossur Hf Back brace
USD628696S1 (en) 2009-08-28 2010-12-07 Ossur Hf Handle
USD620124S1 (en) 2009-09-14 2010-07-20 Ossur Hf Orthopedic device
USD616555S1 (en) 2009-09-14 2010-05-25 Ossur Hf Orthopedic device
USD616997S1 (en) 2009-09-14 2010-06-01 Ossur Hf Orthopedic device
USD618359S1 (en) 2009-09-14 2010-06-22 Ossur Hf Expansion part for orthopedic device
USD616996S1 (en) 2009-09-14 2010-06-01 Ossur Hf Orthopedic device
USD643537S1 (en) 2009-09-22 2011-08-16 Ossur Hf Pump for an orthopedic device
USD634852S1 (en) 2009-09-22 2011-03-22 Ossur Hf Sole for orthopedic device
USD616556S1 (en) 2009-09-22 2010-05-25 Ossur Hf Orthopedic device
USD646394S1 (en) 2009-11-13 2011-10-04 Ossur Hf Rehabilitative vest component
USD640380S1 (en) 2009-11-13 2011-06-21 Ossur Hf Rehabilitative vest component
USD640381S1 (en) 2009-11-13 2011-06-21 Ossur Hf Rehabilitative vest component
US8716877B2 (en) 2010-05-14 2014-05-06 Thomas Sugar Method and apparatus for harvesting energy from ankle motion
USD641483S1 (en) 2010-05-25 2011-07-12 Ossur Hf Orthosis component
USD641482S1 (en) 2010-05-25 2011-07-12 Ossur Hf Orthosis component
USD634438S1 (en) 2010-06-14 2011-03-15 Ossur Hf Orthopedic walker
USD647623S1 (en) 2010-08-06 2011-10-25 Ossur Hf Height adjustment mechanism for cervical collar
USD647624S1 (en) 2010-08-06 2011-10-25 Ossur Hf Cervical collar
USD637942S1 (en) 2010-08-20 2011-05-17 Ossur Hf Strap retainer
USD647622S1 (en) 2010-08-20 2011-10-25 Ossur Hf Orthopedic device
US8876743B2 (en) 2011-04-20 2014-11-04 Vivonics, Inc. Conformable material for an orthotic device and method of making same
US9032635B2 (en) 2011-12-15 2015-05-19 Massachusetts Institute Of Technology Physiological measurement device or wearable device interface simulator and method of use
US9498401B2 (en) 2011-12-20 2016-11-22 Massachusetts Institute Of Technology Robotic system for simulating a wearable device and method of use
US9221177B2 (en) 2012-04-18 2015-12-29 Massachusetts Institute Of Technology Neuromuscular model-based sensing and control paradigm for a robotic leg

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252102A (en) * 1989-01-24 1993-10-12 Electrobionics Corporation Electronic range of motion apparatus, for orthosis, prosthesis, and CPM machine
US5571205A (en) * 1991-12-05 1996-11-05 James; Kelvin B. System for controlling artificial knee joint action in an above knee prosthesis
US6067892A (en) * 1998-03-18 2000-05-30 Erickson; Joel R. Artificial muscle actuator assembly
US6223648B1 (en) * 1998-03-18 2001-05-01 Joel R. Erickson Artificial muscle actuator assembly
US20030163206A1 (en) * 2002-02-28 2003-08-28 Honda Giken Kogyo Kabushiki Kaisha Parallel linkage and artificial joint device using the same
US20060069448A1 (en) * 2002-08-30 2006-03-30 Honda Giken Kogyo Kabushiki Kaisha Joint device for artificial leg, method and control unit for controlling the joint device

Cited By (217)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8551184B1 (en) 2002-07-15 2013-10-08 Iwalk, Inc. Variable mechanical-impedance artificial legs
US9358137B2 (en) 2002-08-22 2016-06-07 Victhom Laboratory Inc. Actuated prosthesis for amputees
US20060122711A1 (en) * 2002-08-22 2006-06-08 Stephane Bedard Actuated leg prosthesis for above-knee amputees
US20060122710A1 (en) * 2002-08-22 2006-06-08 Stephane Bedard Control device and system for controlling an actuated prosthesis
US7736394B2 (en) 2002-08-22 2010-06-15 Victhom Human Bionics Inc. Actuated prosthesis for amputees
US8231687B2 (en) 2002-08-22 2012-07-31 Victhom Human Bionics, Inc. Actuated leg prosthesis for above-knee amputees
US7867284B2 (en) 2002-08-22 2011-01-11 Victhom Human Bionics Inc. Control device and system for controlling an actuated prosthesis
US20040181289A1 (en) * 2002-08-22 2004-09-16 Stephane Bedard Actuated prosthesis for amputees
US9649206B2 (en) 2002-08-22 2017-05-16 Victhom Laboratory Inc. Control device and system for controlling an actuated prosthesis
US8551029B1 (en) 2003-09-25 2013-10-08 Massachusetts Institute Of Technology Active ankle foot orthosis
US8287477B1 (en) 2003-09-25 2012-10-16 Massachusetts Institute Of Technology Active ankle foot orthosis
US8808214B2 (en) 2003-09-25 2014-08-19 Massachusetts Institute Of Technology Active ankle foot orthosis
US8376971B1 (en) 2003-09-25 2013-02-19 Massachusetts Institute Of Technology Active ankle foot orthosis
US10695256B2 (en) 2003-09-25 2020-06-30 Massachusetts Institute Of Technology Motorized limb assistance device
US9668888B2 (en) 2003-09-25 2017-06-06 Massachusetts Institute Of Technology Active ankle foot orthosis
US7815689B2 (en) 2003-11-18 2010-10-19 Victhom Human Bionics Inc. Instrumented prosthetic foot
US20080058959A1 (en) * 2003-11-18 2008-03-06 Stephane Bedard Instrumented prosthetic foot
US20050107889A1 (en) * 2003-11-18 2005-05-19 Stephane Bedard Instrumented prosthetic foot
US20110130847A1 (en) * 2003-11-18 2011-06-02 Victhom Human Bionics Inc. Instrumented prosthetic foot
US8323354B2 (en) 2003-11-18 2012-12-04 Victhom Human Bionics Inc. Instrumented prosthetic foot
US20080046096A1 (en) * 2003-11-18 2008-02-21 Stephane Bedard Instrumented prosthetic foot
US9526636B2 (en) 2003-11-18 2016-12-27 Victhom Laboratory Inc. Instrumented prosthetic foot
US7955398B2 (en) 2003-11-18 2011-06-07 Victhom Human Bionics, Inc. Instrumented prosthetic foot
US20060224246A1 (en) * 2004-02-12 2006-10-05 Clausen Arinbjorn V Systems and methods for adjusting the angle of a prosthetic ankle based on a measured surface angle
US10195057B2 (en) 2004-02-12 2019-02-05 össur hf. Transfemoral prosthetic systems and methods for operating the same
US8057550B2 (en) 2004-02-12 2011-11-15 össur hf. Transfemoral prosthetic systems and methods for operating the same
US8657886B2 (en) 2004-02-12 2014-02-25 össur hf Systems and methods for actuating a prosthetic ankle
US9271851B2 (en) 2004-02-12 2016-03-01 össur hf. Systems and methods for actuating a prosthetic ankle
US7896927B2 (en) 2004-02-12 2011-03-01 össur hf. Systems and methods for actuating a prosthetic ankle based on a relaxed position
US9345591B2 (en) 2004-03-10 2016-05-24 össur hf Control system and method for a prosthetic knee
US8617254B2 (en) 2004-03-10 2013-12-31 Ossur Hf Control system and method for a prosthetic knee
US7811333B2 (en) 2004-12-22 2010-10-12 Ossur Hf Systems and methods for processing limb motion
US9078774B2 (en) 2004-12-22 2015-07-14 össur hf Systems and methods for processing limb motion
US20110098606A1 (en) * 2005-02-02 2011-04-28 Ossur Hf Sensing systems and methods for monitoring gait dynamics
US8869626B2 (en) 2005-02-02 2014-10-28 össur hf Sensing systems and methods for monitoring gait dynamics
US8858648B2 (en) 2005-02-02 2014-10-14 össur hf Rehabilitation using a prosthetic device
US10369025B2 (en) 2005-02-02 2019-08-06 Össur Iceland Ehf Sensing systems and methods for monitoring gait dynamics
US8048007B2 (en) 2005-02-02 2011-11-01 össur hf Prosthetic and orthotic systems usable for rehabilitation
US8122772B2 (en) 2005-02-02 2012-02-28 össur hf Sensing systems and methods for monitoring gait dynamics
US9462966B2 (en) 2005-02-02 2016-10-11 össur hf Sensing systems and methods for monitoring gait dynamics
US8801802B2 (en) 2005-02-16 2014-08-12 össur hf System and method for data communication with a mechatronic device
US10342681B2 (en) 2005-03-31 2019-07-09 Massachusetts Institute Of Technology Artificial ankle-foot system with spring, variable-damping, and series-elastic actuator components
US9333097B2 (en) 2005-03-31 2016-05-10 Massachusetts Institute Of Technology Artificial human limbs and joints employing actuators, springs, and variable-damper elements
US10485681B2 (en) 2005-03-31 2019-11-26 Massachusetts Institute Of Technology Exoskeletons for running and walking
US9539117B2 (en) 2005-03-31 2017-01-10 Massachusetts Institute Of Technology Method for controlling a robotic limb joint
US11273060B2 (en) 2005-03-31 2022-03-15 Massachusetts Institute Of Technology Artificial ankle-foot system with spring, variable-damping, and series-elastic actuator components
US8734528B2 (en) 2005-03-31 2014-05-27 Massachusetts Institute Of Technology Artificial ankle-foot system with spring, variable-damping, and series-elastic actuator components
US10588759B2 (en) 2005-03-31 2020-03-17 Massachusetts Institute Of Technology Artificial human limbs and joints employing actuators, springs and variable-damper elements
US9149370B2 (en) 2005-03-31 2015-10-06 Massachusetts Institute Of Technology Powered artificial knee with agonist-antagonist actuation
US10080672B2 (en) 2005-03-31 2018-09-25 Bionx Medical Technologies, Inc. Hybrid terrain-adaptive lower-extremity systems
US8864846B2 (en) 2005-03-31 2014-10-21 Massachusetts Institute Of Technology Model-based neuromechanical controller for a robotic leg
US10307272B2 (en) 2005-03-31 2019-06-04 Massachusetts Institute Of Technology Method for using a model-based controller for a robotic leg
US9339397B2 (en) 2005-03-31 2016-05-17 Massachusetts Institute Of Technology Artificial ankle-foot system with spring, variable-damping, and series-elastic actuator components
US11491032B2 (en) 2005-03-31 2022-11-08 Massachusetts Institute Of Technology Artificial joints using agonist-antagonist actuators
US8870967B2 (en) 2005-03-31 2014-10-28 Massachusetts Institute Of Technology Artificial joints using agonist-antagonist actuators
US8512415B2 (en) 2005-03-31 2013-08-20 Massachusetts Institute Of Technology Powered ankle-foot prothesis
US8500823B2 (en) 2005-03-31 2013-08-06 Massachusetts Institute Of Technology Powered artificial knee with agonist-antagonist actuation
US10137011B2 (en) 2005-03-31 2018-11-27 Massachusetts Institute Of Technology Powered ankle-foot prosthesis
US11278433B2 (en) 2005-03-31 2022-03-22 Massachusetts Institute Of Technology Powered ankle-foot prosthesis
US20070056592A1 (en) * 2005-04-13 2007-03-15 The Regents Of University Of California Semi-powered lower extremity exoskeleton
US8057410B2 (en) 2005-04-13 2011-11-15 The Regents Of The University Of California Semi-powered lower extremity exoskeleton
US8814949B2 (en) 2005-04-19 2014-08-26 össur hf Combined active and passive leg prosthesis system and a method for performing a movement with such a system
US9717606B2 (en) 2005-04-19 2017-08-01 össur hf Combined active and passive leg prosthesis system and a method for performing a movement with such a system
US9066819B2 (en) 2005-04-19 2015-06-30 össur hf Combined active and passive leg prosthesis system and a method for performing a movement with such a system
US8852292B2 (en) 2005-09-01 2014-10-07 Ossur Hf System and method for determining terrain transitions
US9351854B2 (en) 2005-09-01 2016-05-31 össur hf Actuator assembly for prosthetic or orthotic joint
US8702811B2 (en) 2005-09-01 2014-04-22 össur hf System and method for determining terrain transitions
US20070050045A1 (en) * 2005-09-01 2007-03-01 Clausen Arinbjorn V Sensing system and method for motion-controlled foot unit
US8048172B2 (en) 2005-09-01 2011-11-01 össur hf Actuator assembly for prosthetic or orthotic joint
US8709097B2 (en) 2005-09-01 2014-04-29 össur hf Actuator assembly for prosthetic or orthotic joint
US7811189B2 (en) 2005-12-30 2010-10-12 Tibion Corporation Deflector assembly
US20070155557A1 (en) * 2005-12-30 2007-07-05 Horst Robert W Deflector assembly
US20070233279A1 (en) * 2006-03-09 2007-10-04 The Regents Of The University Of California Power generating leg
US7883546B2 (en) 2006-03-09 2011-02-08 The Regents Of The University Of California Power generating leg
US7649276B2 (en) * 2006-05-05 2010-01-19 Sri International Wave powered generation
US7557456B2 (en) 2006-05-05 2009-07-07 Sri International Wave powered generation using electroactive polymers
US20070257490A1 (en) * 2006-05-05 2007-11-08 Sri International Wave powered generation using electroactive polymers
US20070257491A1 (en) * 2006-05-05 2007-11-08 Sri International Wave powered generation
US20080016860A1 (en) * 2006-05-05 2008-01-24 Sri International Wave powered generation
US7538445B2 (en) * 2006-05-05 2009-05-26 Sri International Wave powered generation
US8211042B2 (en) 2007-01-05 2012-07-03 Victom Human Bionics Inc. High torque active mechanism for orthotic and/or prosthetic devices
US9066817B2 (en) 2007-01-05 2015-06-30 Victhom Human Bionics Inc. High torque active mechanism for orthotic and/or prosthetic devices
US11007072B2 (en) 2007-01-05 2021-05-18 Victhom Laboratory Inc. Leg orthotic device
US20100160844A1 (en) * 2007-01-05 2010-06-24 Benoit Gilbert High Torque Active Mechanism for Orthotic and/or Prosthetic Devices
US9526635B2 (en) 2007-01-05 2016-12-27 Victhom Laboratory Inc. Actuated leg orthotics or prosthetics for amputees
US20090299480A1 (en) * 2007-01-05 2009-12-03 Victhom Human Bionics Inc. Joint Actuation Mechanism for a Prosthetic and/or Orthotic Device Having a Compliant Transmission
US8435309B2 (en) 2007-01-05 2013-05-07 Victhom Human Bionics Joint actuation mechanism for a prosthetic and/or orthotic device having a compliant transmission
US9808357B2 (en) 2007-01-19 2017-11-07 Victhom Laboratory Inc. Reactive layer control system for prosthetic and orthotic devices
US11607326B2 (en) 2007-01-19 2023-03-21 Victhom Laboratory Inc. Reactive layer control system for prosthetic devices
US10405996B2 (en) 2007-01-19 2019-09-10 Victhom Laboratory Inc. Reactive layer control system for prosthetic and orthotic devices
US9474673B2 (en) 2007-02-14 2016-10-25 Alterg, Inc. Methods and devices for deep vein thrombosis prevention
US8353854B2 (en) 2007-02-14 2013-01-15 Tibion Corporation Method and devices for moving a body joint
US11185460B2 (en) 2007-12-26 2021-11-30 Rex Bionics Limited Self contained powered exoskeleton walker for a disabled user
US7949429B2 (en) * 2007-12-27 2011-05-24 Murata Manufacturing Co., Ltd. Plural actuator system and control method thereof
US8771210B2 (en) 2008-02-08 2014-07-08 Alterg, Inc. Multi-fit orthotic and mobility assistance apparatus
US20090204038A1 (en) * 2008-02-08 2009-08-13 Tibion Corporation Multi-fit orthotic and mobility assistance apparatus
US8052629B2 (en) 2008-02-08 2011-11-08 Tibion Corporation Multi-fit orthotic and mobility assistance apparatus
WO2009120637A1 (en) * 2008-03-24 2009-10-01 Ossur Hf Transfemoral prosthetic systems and methods for operating the same
US10299943B2 (en) 2008-03-24 2019-05-28 össur hf Transfemoral prosthetic systems and methods for operating the same
CN102036626A (en) * 2008-03-24 2011-04-27 奥瑟Hf公司 Transfemoral prosthetic systems and methods for operating the same
US9610208B2 (en) 2008-05-20 2017-04-04 Ekso Bionics, Inc. Device and method for decreasing energy consumption of a person by use of a lower extremity exoskeleton
US10179078B2 (en) 2008-06-05 2019-01-15 Alterg, Inc. Therapeutic method and device for rehabilitation
US20090306548A1 (en) * 2008-06-05 2009-12-10 Bhugra Kern S Therapeutic method and device for rehabilitation
US9351855B2 (en) 2008-06-16 2016-05-31 Ekso Bionics, Inc. Powered lower extremity orthotic and method of operation
US20110105966A1 (en) * 2008-07-23 2011-05-05 Berkeley Bionics Exoskeleton and Method for Controlling a Swing Leg of the Exoskeleton
US8801641B2 (en) 2008-07-23 2014-08-12 Ekso Bionics, Inc. Exoskeleton and method for controlling a swing leg of the exoskeleton
CN102187118A (en) * 2008-08-14 2011-09-14 蒂比昂公司 Actuator system with a multi-motor assembly for extending and flexing a joint
US8058823B2 (en) 2008-08-14 2011-11-15 Tibion Corporation Actuator system with a multi-motor assembly for extending and flexing a joint
US8274244B2 (en) 2008-08-14 2012-09-25 Tibion Corporation Actuator system and method for extending a joint
WO2010019917A1 (en) * 2008-08-14 2010-02-18 Tibion Corporation Actuator system with a multi-motor assembly for extending and flexing a joint
WO2010025403A1 (en) * 2008-08-28 2010-03-04 Raytheon Sarcos, Llc Control logic for biomimetic joint actuators
US8731716B2 (en) 2008-08-28 2014-05-20 Raytheon Company Control logic for biomimetic joint actuators
US8516918B2 (en) 2008-08-28 2013-08-27 Raytheon Company Biomimetic mechanical joint
US20110214524A1 (en) * 2008-08-28 2011-09-08 Raytheon Company Biomimetic Mechanical Joint
US20110213599A1 (en) * 2008-08-28 2011-09-01 Raytheon Company Method of Sizing Actuators for a Biomimetic Mechanical Joint
US20100174384A1 (en) * 2008-09-04 2010-07-08 Iwalk, Inc. Hybrid terrain-adaptive lower-extremity systems
US9351856B2 (en) 2008-09-04 2016-05-31 Iwalk, Inc. Hybrid terrain-adaptive lower-extremity systems
US9345592B2 (en) 2008-09-04 2016-05-24 Bionx Medical Technologies, Inc. Hybrid terrain-adaptive lower-extremity systems
US8419804B2 (en) 2008-09-04 2013-04-16 Iwalk, Inc. Hybrid terrain-adaptive lower-extremity systems
US8900325B2 (en) 2008-09-04 2014-12-02 Iwalk, Inc. Hybrid terrain-adaptive lower-extremity systems
US10285828B2 (en) 2008-09-04 2019-05-14 Bionx Medical Technologies, Inc. Implementing a stand-up sequence using a lower-extremity prosthesis or orthosis
US10105244B2 (en) 2008-09-04 2018-10-23 Bionx Medical Technologies, Inc. Hybrid terrain-adaptive lower-extremity systems
US9211201B2 (en) 2008-09-04 2015-12-15 Iwalk, Inc. Hybrid terrain-adaptive lower-extremity systems
US9554922B2 (en) 2008-09-04 2017-01-31 Bionx Medical Technologies, Inc. Hybrid terrain-adaptive lower-extremity systems
US10070974B2 (en) 2008-09-04 2018-09-11 Bionx Medical Technologies, Inc. Hybrid terrain-adaptive lower-extremity systems
CN102481194A (en) * 2009-01-30 2012-05-30 麻省理工学院 Powered artificial knee with agonist-antagonist actuation
WO2010088616A1 (en) * 2009-01-30 2010-08-05 Massachusetts Institute Of Technology Powered artificial knee with agonist-antagonist actuation
EP2398425A1 (en) * 2009-01-30 2011-12-28 Massachusetts Institute of Technology Powered artificial knee with agonist-antagonist actuation
EP2398425A4 (en) * 2009-01-30 2013-09-18 Massachusetts Inst Technology Powered artificial knee with agonist-antagonist actuation
US8639455B2 (en) 2009-02-09 2014-01-28 Alterg, Inc. Foot pad device and method of obtaining weight data
US9131873B2 (en) 2009-02-09 2015-09-15 Alterg, Inc. Foot pad device and method of obtaining weight data
US20120153875A1 (en) * 2009-06-22 2012-06-21 Brian Glaister Controllable transverse rotation adaptor
US8598815B2 (en) * 2009-06-22 2013-12-03 University Of Washington Through Its Center For Commercialization Controllable transverse rotation adaptor
US10537987B2 (en) 2009-07-01 2020-01-21 Rex Bionics Limited Control system for a mobility aid
US10406002B2 (en) 2010-04-05 2019-09-10 Bionx Medical Technologies, Inc. Controlling torque in a prosthesis or orthosis based on a deflection of series elastic element
US9693883B2 (en) 2010-04-05 2017-07-04 Bionx Medical Technologies, Inc. Controlling power in a prosthesis or orthosis based on predicted walking speed or surrogate for same
US11020250B2 (en) 2010-09-29 2021-06-01 Össur Iceland Ehf Prosthetic and orthotic devices and methods and systems for controlling the same
US9925071B2 (en) 2010-09-29 2018-03-27 össur hf Prosthetic and orthotic devices and methods and systems for controlling the same
US8915968B2 (en) 2010-09-29 2014-12-23 össur hf Prosthetic and orthotic devices and methods and systems for controlling the same
US10874531B2 (en) 2010-12-09 2020-12-29 Ottobock Se & Co. Kgaa Prosthesis for a lower limb
EP2462901A3 (en) * 2010-12-09 2013-03-20 Pierre Chabloz Lower limb prosthesis
FR2968538A1 (en) * 2010-12-09 2012-06-15 Pierre Chabloz PROSTHETIC FOR LOWER MEMBER
US8870969B2 (en) 2010-12-09 2014-10-28 Otto Bock Healthcare Gmbh Prosthesis for a lower limb
US9987152B2 (en) 2010-12-09 2018-06-05 Otto Bock Healthcare Gmbh Prosthesis for a lower limb
US20120165983A1 (en) * 2010-12-22 2012-06-28 Samsung Electronics Co., Ltd. Walking robot and control method thereof
US9376151B2 (en) * 2010-12-22 2016-06-28 Samsung Electronics Co., Ltd. Walking robot and control method thereof
US9839552B2 (en) 2011-01-10 2017-12-12 Bionx Medical Technologies, Inc. Powered joint orthosis
US10537449B2 (en) 2011-01-12 2020-01-21 Bionx Medical Technologies, Inc. Controlling powered human augmentation devices
US9687377B2 (en) 2011-01-21 2017-06-27 Bionx Medical Technologies, Inc. Terrain adaptive powered joint orthosis
US20120283845A1 (en) * 2011-03-11 2012-11-08 Herr Hugh M Biomimetic joint actuators
US9060883B2 (en) * 2011-03-11 2015-06-23 Iwalk, Inc. Biomimetic joint actuators
WO2012125562A1 (en) * 2011-03-11 2012-09-20 Iwalk, Inc. Biomimetic joint actuators
US9872782B2 (en) 2011-03-11 2018-01-23 Bionx Medical Technologies, Inc. Biomimetic joint actuators
US9060884B2 (en) 2011-05-03 2015-06-23 Victhom Human Bionics Inc. Impedance simulating motion controller for orthotic and prosthetic applications
US11185429B2 (en) 2011-05-03 2021-11-30 Victhom Laboratory Inc. Impedance simulating motion controller for orthotic and prosthetic applications
US10251762B2 (en) 2011-05-03 2019-04-09 Victhom Laboratory Inc. Impedance simulating motion controller for orthotic and prosthetic applications
US20130054021A1 (en) * 2011-08-26 2013-02-28 Disney Enterprises, Inc. Robotic controller that realizes human-like responses to unexpected disturbances
US9737419B2 (en) 2011-11-02 2017-08-22 Bionx Medical Technologies, Inc. Biomimetic transfemoral prosthesis
US10575970B2 (en) 2011-11-11 2020-03-03 Össur Iceland Ehf Robotic device and method of using a parallel mechanism
US10543109B2 (en) 2011-11-11 2020-01-28 Össur Iceland Ehf Prosthetic device and method with compliant linking member and actuating linking member
US9032635B2 (en) 2011-12-15 2015-05-19 Massachusetts Institute Of Technology Physiological measurement device or wearable device interface simulator and method of use
US9017419B1 (en) 2012-03-09 2015-04-28 össur hf Linear actuator
US9895240B2 (en) 2012-03-29 2018-02-20 Ösur hf Powered prosthetic hip joint
US10940027B2 (en) 2012-03-29 2021-03-09 Össur Iceland Ehf Powered prosthetic hip joint
US9975249B2 (en) 2012-04-18 2018-05-22 Massachusetts Institute Of Technology Neuromuscular model-based sensing and control paradigm for a robotic leg
US9221177B2 (en) 2012-04-18 2015-12-29 Massachusetts Institute Of Technology Neuromuscular model-based sensing and control paradigm for a robotic leg
WO2013157965A1 (en) * 2012-04-19 2013-10-24 CONTUR 2000 s. c. Active prosthetic shin
US10531965B2 (en) 2012-06-12 2020-01-14 Bionx Medical Technologies, Inc. Prosthetic, orthotic or exoskeleton device
US10786371B2 (en) * 2012-06-21 2020-09-29 Scuola Superiore Di Studi Universitari E Di Perfezionamento Sant'anna Technological aid for transfemoral amputees
US9561118B2 (en) 2013-02-26 2017-02-07 össur hf Prosthetic foot with enhanced stability and elastic energy return
US10369019B2 (en) 2013-02-26 2019-08-06 Ossur Hf Prosthetic foot with enhanced stability and elastic energy return
US11285024B2 (en) 2013-02-26 2022-03-29 Össur Iceland Ehf Prosthetic foot with enhanced stability and elastic energy return
US9788985B2 (en) * 2013-03-14 2017-10-17 Yale University Friction-based orthotic impedence modulation device
US10695197B2 (en) 2013-03-14 2020-06-30 Össur Iceland Ehf Prosthetic ankle and method of controlling same based on weight-shifting
US9707104B2 (en) 2013-03-14 2017-07-18 össur hf Prosthetic ankle and method of controlling same based on adaptation to speed
US20140276304A1 (en) * 2013-03-14 2014-09-18 Yale University Friction-Based Orthotic Impedence Modulation Device
US11576795B2 (en) 2013-03-14 2023-02-14 össur hf Prosthetic ankle and method of controlling same based on decreased loads
US11007105B2 (en) 2013-03-15 2021-05-18 Alterg, Inc. Orthotic device drive system and method
US9889058B2 (en) 2013-03-15 2018-02-13 Alterg, Inc. Orthotic device drive system and method
US9289316B2 (en) * 2013-05-03 2016-03-22 Springactive, Inc. Quasi-active prosthetic joint system
US20140330393A1 (en) * 2013-05-03 2014-11-06 Springactive, Inc. Quasi-Active Prosthetic Joint System
US20160151921A1 (en) * 2013-07-02 2016-06-02 Fondazione Istituto Italiano Di Technologia Improved agonist - antagonist actuated joint
US20160374834A1 (en) * 2013-07-03 2016-12-29 Otto Bock Healthcare Gmbh Orthopedic joint device and method for controlling same
US11534317B2 (en) * 2013-07-03 2022-12-27 Ottobock Se & Co. Kgaa Orthopedic joint device and method for controlling same
US10918558B2 (en) 2013-08-10 2021-02-16 Imobilities Incorporated Portable human exoskeleton system
US9639164B2 (en) * 2013-09-26 2017-05-02 Fujitsu Limited Gesture input method
US20150089455A1 (en) * 2013-09-26 2015-03-26 Fujitsu Limited Gesture input method
US10390974B2 (en) 2014-04-11 2019-08-27 össur hf. Prosthetic foot with removable flexible members
US11446166B2 (en) 2014-04-11 2022-09-20 Össur Iceland Ehf Prosthetic foot with removable flexible members
US20150297365A1 (en) * 2014-04-17 2015-10-22 Worcester Polytechnic Institute Flexible prosthetic appliance
CN106457566A (en) * 2014-07-22 2017-02-22 谷歌公司 Hybrid hydraulic and electrically actuated mobile robot
EP3501760A1 (en) * 2014-07-22 2019-06-26 Boston Dynamics, Inc. Hybrid hydraulic and electrically actuated mobile robot
EP3172019A4 (en) * 2014-07-22 2018-03-28 Google LLC Hybrid hydraulic and electrically actuated mobile robot
US9731416B1 (en) * 2015-03-11 2017-08-15 Google Inc. Legged robot passive fluid-based ankles with spring centering
US10189519B2 (en) * 2015-05-29 2019-01-29 Oregon State University Leg configuration for spring-mass legged locomotion
US20170056275A1 (en) * 2015-08-31 2017-03-02 Korea Institute Of Science And Technology Recognition method of human walking speed intention from surface electromyogram signals of plantar flexor and walking speed control method of a lower-limb exoskeleton robot
US10434027B2 (en) * 2015-08-31 2019-10-08 Korea Institute Of Science And Technology Recognition method of human walking speed intention from surface electromyogram signals of plantar flexor and walking speed control method of a lower-limb exoskeleton robot
US10722386B2 (en) 2015-09-18 2020-07-28 Össur Iceland Ehf Magnetic locking mechanism for prosthetic or orthotic joints
US11707365B2 (en) 2015-09-18 2023-07-25 Össur Iceland Ehf Magnetic locking mechanism for prosthetic or orthotic joints
US9949850B2 (en) 2015-09-18 2018-04-24 Össur Iceland Ehf Magnetic locking mechanism for prosthetic or orthotic joints
US9878751B1 (en) * 2015-10-08 2018-01-30 Boston Dynamics, Inc. Three-piston ankle mechanism of a legged robot and associated control system
US11932332B2 (en) 2015-10-08 2024-03-19 Boston Dynamics, Inc. Three-piston ankle mechanism of a legged robot and associated control system
US10988192B1 (en) 2015-10-08 2021-04-27 Boston Dynamics, Inc. Three-piston ankle mechanism of a legged robot and associated control system
US10898350B2 (en) 2015-11-24 2021-01-26 University Of South Carolina Dynamic linear adjustable prosthetic
WO2017091456A1 (en) * 2015-11-24 2017-06-01 Greenville Health System Dynamic linear adjustable prosthetic
US10898349B2 (en) 2016-04-14 2021-01-26 Marquette University Passive ankle prosthesis with energy return
WO2017180970A1 (en) * 2016-04-14 2017-10-19 Marquette University Passive ankle prosthesis with energy return
US11045154B2 (en) * 2016-12-28 2021-06-29 Medicaroid Corporation Robotic operating table and hybrid operating system
US10548801B2 (en) * 2017-02-16 2020-02-04 Samsung Electronics Co., Ltd. Motion assistance apparatus
US20180228684A1 (en) * 2017-02-16 2018-08-16 Samsung Electronics Co., Ltd. Motion assistance apparatus
US20200069441A1 (en) * 2017-05-12 2020-03-05 Exonetik Inc. Exoskeleton, orthosis, wearable device or mobile robots using magnetorheological fluid clutch apparatus
US11278434B2 (en) * 2017-06-06 2022-03-22 Ottobock Se & Co. Kgaa Orthopedic joint device
CN107468387A (en) * 2017-09-13 2017-12-15 上海理工大学 A kind of artificial limb knee-joint test equipment
US20200206899A1 (en) * 2018-03-22 2020-07-02 HAWE Altenstadt Holding GmbH Human exoskeleton
CN113329720A (en) * 2019-01-17 2021-08-31 奥托·博克保健产品有限公司 Method for controlling an orthopaedic or prosthetic device and orthopaedic or prosthetic device
CN113456322A (en) * 2021-06-30 2021-10-01 吉林大学 Bionic knee joint based on motor drive
CN116729520A (en) * 2023-08-11 2023-09-12 太原理工大学 Bionic four-foot robot based on double-layer corrugated pipe pneumatic soft driver

Also Published As

Publication number Publication date
US20100241242A1 (en) 2010-09-23
US8870967B2 (en) 2014-10-28

Similar Documents

Publication Publication Date Title
US8870967B2 (en) Artificial joints using agonist-antagonist actuators
US10588759B2 (en) Artificial human limbs and joints employing actuators, springs and variable-damper elements
US11491032B2 (en) Artificial joints using agonist-antagonist actuators
US11278433B2 (en) Powered ankle-foot prosthesis
US11273060B2 (en) Artificial ankle-foot system with spring, variable-damping, and series-elastic actuator components
US10137011B2 (en) Powered ankle-foot prosthesis
Cherelle et al. Design and validation of the ankle mimicking prosthetic (AMP-) foot 2.0
US9149370B2 (en) Powered artificial knee with agonist-antagonist actuation
Au et al. Biomechanical design of a powered ankle-foot prosthesis
Au et al. An ankle-foot emulation system for the study of human walking biomechanics
Herr et al. New horizons for orthotic and prosthetic technology: artificial muscle for ambulation
Geeroms et al. Ankle-knee prosthesis with powered ankle and energy transfer for CYBERLEGs α-prototype
Martinez-Villalpando et al. Antagonistic active knee prosthesis. A metabolic cost of walking comparison with a variable-damping prosthetic knee
JP2012516717A (en) Actuator-powered knee prosthesis with antagonistic muscle action
Behrens et al. Design of a fully-passive transfemoral prosthesis prototype
Cherelle et al. Use of compliant actuators in prosthetic feet and the design of the AMP-foot 2.0
Junius et al. On the use of adaptable compliant actuators in prosthetics, rehabilitation and assistive robotics
Endo et al. Development of powered knee prosthesis with small-scale, light-weight, and affordable series-elastic actuator, and its preliminary walking test
Holgate Advancements in prosthetics and joint mechanisms
WO2015073182A1 (en) Robotic device and method of using a parallel mechanism
Shehata et al. Development of a Controlled Semi-Active Prosthetic Ankle
Awad et al. Inertia properties of a prosthetic knee mechanism

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MASSACHUSET

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HERR, HUGH M.;MAGNUSSON, LEE HARRIS;ENDO, KEN;SIGNING DATES FROM 20121203 TO 20130325;REEL/FRAME:030160/0168